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ABSTRACT 
Influenza A virus (IAV) causes respiratory infections in humans and animals. Pigs are 
infected not only by swine influenza virus (SIV), but also by human and avian influenza viruses. 
Pigs serve as the mixing vessel for the generation of novel reassortant viruses with pandemic 
potential as evidenced by the emergence of 2009 human pandemic IAV (pdm09). Therefore, 
IAV infection in pigs poses both an economic concern and a threat to public health. Virus-host 
interplay dictates the outcome of virus infection. The host innate immune system can sense the 
virus infection and produce multiple cytokines and chemokines to control inflammation as well 
as to mount antiviral responses. On the other hand, the host innate immune response can be 
antagonized by IAV-encoded proteins, one being the non-structural protein 1 (NS1). Thus, a 
better understanding of the porcine innate immunity to IAV infection and the innate immune 
evasion strategies by IAV is required for a rational design to combat IAV infections in pigs. 
Innate immune cells in lungs, particularly the alveolar macrophages, are indispensable for 
host protection against IAV infection. They produce pro-inflammatory cytokines including 
interleukin-1 beta (IL-1β) that recruits other immune cells and promotes phagocytic activities. 
IL-1β production is tightly regulated by a cytosolic multiprotein complex called the nucleotide-
binding domain and leucine-rich repeat-containing protein 3 (NLRP3) inflammasome. The 
NLRP3 inflammasome is comprised of NLRP3, apoptosis-associated speck-like protein 
containing caspase activation and recruitment domain (ASC), and pro-caspase-1. The molecular 
mechanism underlying the NLRP3 inflammasome-mediated IL-1β production upon IAV 
infection in the swine host, and the mechanism by which IAV NS1 protein counteracts the 
porcine IL-1β response remain largely unknown. This PhD project was centered on the 
characterization of the NLRP3 inflammasome-mediated IL-1β production in response to IAV 
infection in the swine host; specifically, I first characterized the IL-1β production in primary 
porcine alveolar macrophages (PAMs) in response to different isolates of IAV. Next, I 
investigated the molecular mechanisms by which viral NS1 protein modulates the porcine 
NLRP3 inflammasome activity, and finally I examined the molecular pathways that are involved 
in inflammasome activation upon IAV infection in PAMs. 
This study showed that while various SIV strains could induce NLRP3 inflammasome-
mediated IL-1β production in primary PAMs, the human pdm09 virus induced much less IL-1β 
than did SIVs. Subsequent analyses revealed that the NS1 C-terminus of pdm09, but not that of 
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SIV, was responsible for the significant inhibition of the NLRP3 inflammasome-mediated IL-1β 
production. Mechanistically, the NS1 C-terminus of pdm09 disrupted the interaction between 
NLRP3 and ASC, a prerequisite for the NLRP3 inflammasome assembly; this led to an impaired 
formation of ASC specks, a hallmark of NLRP3 inflammasome activation. NS1 C-terminus of 
pdm09 also suppressed the ubiquitination of porcine ASC. Furthermore, two lysine (K) residues, 
K110 and K140, on porcine ASC were identified as the ubiquitination acceptor sites; mutation of 
these two lysine residues diminished the ubiquitination of ASC and significantly reduced the IL-
1β production in response to the pdm09 virus with the NS1 C-terminal deletion. These results 
revealed that the NS1 C-terminus of pdm09 suppresses ASC ubiquitination to support the 
immune evasion by the virus.  
Further attempts were made to dissect the upstream mechanism of the NLRP3 
inflammasome-mediated IL-1β production upon SIV infection, focusing on the mitochondrial 
dynamics regulated by dynamin-related protein 1 (DRP1). This study showed that SIV infection 
induced not only phosphorylation of DRP1 at serine 579 (S579) that is required for 
mitochondrial fission activity of DRP1, but also mitochondrial fission in PAMs. The reactive 
oxygen species produced from mitochondrial fission was also related to the IL-1β production. 
Phospho-mimetic mutation at S579 on DRP1 could upreguate the NLRP3 inflammasome 
activity, leading to an increased IL-1β production. Furthermore, the requirement of the kinase 
activity of receptor-interacting protein kinase 1 (RIPK1) for the IL-1β production and the 
association of RIPK1 with DRP1 suggested that RIPK1 is an upstream kinase for DRP1 
phosphorylation. These results indicated an integral role of the RIPK1/DRP1 signaling axis in 
modulating the porcine NLRP3 inflammasome-mediated IL-1β production in SIV-infected 
PAMs. 
Taken together, this study defined the mechanism by which SIV induces porcine NLRP3 
inflammasome-mediated IL-1β production and elucidated the strategies pdm09 employs to 
circumvent the host innate immunity. The obtained information will enhance our knowledge of 
the innate immunity to IAV infection in the swine host. 
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CHAPTER 1 LITERATURE REVIEW 
1.1 Influenza A virus (IAV) 
1.1.1 Overview 
IAV is a contagious pathogen that causes airway infection in a wide range of mammalian 
and avian hosts. IAV is the only species in the genus Alphainfluenzavirus, which is one of the 
seven genera in the family Orthomyxoviridae (Ferhadian et al., 2018, Shaw and Palese, 2013). 
This enveloped virus contains eight segments of negative-sense, single-stranded RNAs (ssRNAs) 
for its genome, which enable antigenic changes by mutation and reassortment events. IAVs are 
divided into subtypes based on the surface antigens, hemagglutinin (HA) and neuraminidase 
(NA); there are currently 18 HA subtypes (H1 to H18) and 11 NA subtypes (N1 to N11) 
(Hutchinson, 2018). IAV has the ability to cause pandemics and is the causative agent of 
seasonal flu along with the genus Betainfluenzavirus (Teitzel, 2018), while other genera of 
influenza viruses, Gammainfluenzavirus and Deltainfluenzavirus do not pose as significant of a 
threat to public health as IAV (Zhou et al., 2018). With rapid evolution and interspecies 
transmission, IAV is one of the most important global health threats today. It is responsible for 
annual flu epidemic affecting human populations including several million severe cases and 
estimated up to 646,000 deaths worldwide (Girard et al., 2005, Iuliano et al., 2018). In Canada, a 
death toll caused by IAV infection and its complications is reported to be more than 5,000 per 
year (Thommes et al., 2017). The 2009 pandemic H1N1 has affected millions of people with an 
estimated fatality of up to 575,000 in the world (Dawood et al., 2012). The emergence of this 
novel swine-derived virus through the reassortment of swine influenza virus (SIV) with human 
and avian strains has emphasized the importance of research with SIV and immunity to SIV in 
pigs, since pigs are the intermediate host to generate new viruses with pandemic capacity 
(Nelson and Vincent, 2015). There is possibility of further reassortment among SIVs and human 
IAV strains in pigs leading to the production of new strains with more pathogenicity and better 
transmissibility among humans. Due to public health concerns, there has been a need for 
effective vaccines and therapeutics to cope with the potential pandemic. In parallel, a better 
understanding of the swine host immunity to IAV is required, since the outcome of IAV 
infection depends on the host immune response against infection. 
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1.1.2 Life cycle of IAV 
The IAV genome consists of eight segments of ssRNAs: PB2, PB1 and PA segments 
encode the three subunits of RNA polymerase complex, PB2, PB1 and PA proteins, respectively; 
HA and NA segments encode the two surface glycoproteins, HA and NA, respectively; NP 
segment encodes the nucleoprotein (NP); M segment encodes the matrix protein M1 and 
envelope protein M2 that is expressed via alternative splicing; NS segment encodes the non-
structural protein 1 (NS1) and nuclear export protein (NEP), which is also an alternative splicing 
product. Each RNA segment is associated with the RNA polymerase complex and encapsidated 
by viral NP (Bouvier and Palese, 2008, Shaw and Palese, 2013), forming viral ribonucleoprotein 
(vRNP); this is the minimum unit for IAV replication. 
As shown in Figure 1.1, IAV attaches to the host cell by receptor binding activity of viral 
glycoprotein, HA. The globular head region of this protein binds to the cell surface receptor, 
sialic acid (also called N-acetylneuraminic acid), and then, the virus can be endocytosed to be 
located in the endosomal compartment (Shaw and Palese, 2013). After host cellular proteases 
cleave HA0, which refers to the precursor form of HA, into HA1 and HA2, viral membranes are 
fused with endosomal membranes at acidic pH (Hamilton et al., 2012). As a result, the fusion 
peptide in the HA2 is exposed and inserted into the endosome, thereby inducing the alignment of 
viral and endosomal membranes (Hamilton et al., 2012). Next, uncoating is initiated by the viral 
ion channel protein, M2 that lowers the pH inside the virion by transporting protons from the 
endosome into the virus (Pinto and Lamb, 2006). Consequently, the vRNP complex for each 
gene segment is dissociated from M1 and released into the cytoplasm (Shaw and Palese, 2013). 
Transcription and replication of the viral genome take place in the nucleus. Thus, nuclear entry 
of vRNP is required and is dependent on the nuclear localization signal on NP and three 
polymerase subunits (PB2, PB1 and PA) consisting the vRNP (Martín-Benito and Ortín, 2013). 
Viral mRNA synthesis requires 5’ cap structures from host mRNA, which is generated by host 
RNA polymerase II. PB2 binds to the cap structure on the 5’ end of host pre-mRNA and PB1 
binds to the 5’ and 3’ ends of viral RNA (vRNA), while PA cleaves 10 to 13 nucleotides 
downstream of the 5’ cap. Using this cleaved fragment as the primer, viral mRNA synthesis is 
catalyzed by PB1 (Martín-Benito and Ortín, 2013, Shaw and Palese, 2013). Synthesized viral 
mRNA is transported to the cytoplasm to be translated. Incoming vRNA from the cytoplasm also 
serves as the template for the synthesis of complementary RNA (cRNA), which in turn, is 
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required for the generation of new vRNA (Shaw and Palese, 2013). After vRNA is assembled as 
vRNP, the vRNP is exported to cytoplasm with the help of M1 and NEP, both of which interact 
with a cellular export receptor (Samji, 2009, Shaw and Palese, 2013). Unlike NP, M1 and NEP 
that move to the nucleus to associate with newly produced vRNA, HA, NA and M2 are modified 
in endoplasmic reticulum (ER) and Golgi apparatus, and are transported to the cell membrane 
(Shaw and Palese, 2013). For virion assembly, selective packaging of vRNP is believed to occur 
based on the packaging signals on each vRNA (Shaw and Palese, 2013). HA and NA associate 
with plasma membrane domains called lipid rafts where budding takes place (Nayak et al., 
2004). Finally, virion release occurs with the destruction of sialic acid by NA (Shaw and Palese, 
2013). 
 
 
Reprinted from Nature 459: 931–939 (Neumann et al., 2009) with permission. 
 
Figure 1.1 Life cycle of IAV.  
IAV attaches to the host receptor, sialic acid and is endocytosed. After cleavage of HA, the 
fusion between viral membranes and endosomes occurs. Uncoating allows the vRNPs to be 
released into cytoplasm, followed by its entry into the nucleus. With vRNAs as the template, 
viral mRNAs are transcribed using the 5’ cap snatched from host pre-mRNAs, and cRNAs are 
synthesized for the vRNA replication. Viral proteins are produced and modified, and newly 
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assembled vRNPs are packaged for virion assembly. Upon budding, the sialic acid destruction by 
NA allows the virions to be released.  
 
1.1.3 Immunology of IAV infection 
In IAV-infected animals, the epithelial cells in the airway mucosa are the first to be 
infected (Pulendran and Maddur, 2014). IAV infection then further spreads to the lung 
macrophages and dendritic cells (DCs) in alveoli or within the lung epithelium, which are the 
pivotal cells to trigger inflammation (Iwasaki and Pillai, 2014, Short et al., 2012). The innate 
immunity to IAV begins with the recognition of viral genome via host immune sensors in the 
infected cells (Figure 1.2). The main sensors to detect IAV infection includes toll-like receptors 
(TLRs) and retinoic acid-inducible gene-I (RIG-I) (Ichinohe, 2010). Viral ssRNA or double-
stranded RNA (dsRNA) is recognized by TLR3 or TLR7 in the endosome, and the 5’-
triphosphate dsRNA is recognized by RIG-I both in the cytosol and nucleus (Iwasaki and Pillai, 
2014, Liu et al., 2018). Activation of both of sensors turns on a cascade of signaling events 
leading to the activation of transcription factors, nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-B), interferon (IFN) regulatory factors 3 (IRF3) and 7 (IRF7). This results 
in the production of pro-inflammatory cytokines, type I IFNs and a variety of IFN-stimulated 
genes (ISGs) that support the host antiviral status (Iwasaki and Pillai, 2014). Viral RNA of IAV 
can be sensed by another cytosolic sensor called the nucleotide-binding domain and leucine-rich 
repeat-containing protein 3 (NLRP3) (Allen et al., 2009, Thomas et al., 2009), but whether 
NLRP3 can sense viral RNA by a direct binding is still under debate. Recent evidence suggests 
that NLRP3 recognizes diverse cellular changes induced by viral infection as reviewed in the 
section 1.2.1.3.1. Among pro-inflammatory cytokines, interleukin (IL)-1β and IL-18 are 
synthesized as precursors via NF-B pathway; then, the precursors become biologically active 
after processed by inflammasome complexes consisted of nucleotide-binding oligomerization 
domain-like receptors (NLRs) or non-NLRs along with their adaptor and effector molecules 
(Iwasaki and Pillai, 2014). Recently, Z-DNA binding protein 1 (ZBP1) is proposed as another 
important sensor; the recognition of IAV proteins by ZBP1 triggers NLRP3 inflammasome 
activation and cell deaths (Kuriakose et al., 2016).  
Among innate immune cells, the lung macrophages are crucial in eliminating IAV particles 
and controlling inflammation, which largely depends on the action of pro-inflammatory 
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cytokines including IL-1β, IL-6 and tumor necrosis factor (TNF)-. These cytokines can be 
involved in the inflammatory responses as well as the pathogenesis during the course of IAV 
infection (Van Reeth, 2000). IAV-induced pathological signs in the lung can be derived from the 
combination of direct effects of viral replication and the effects of host responses via 
inflammatory cytokines produced from immune cells including alveolar macrophages (Gordon 
and Read, 2002). 
 
 
Reprinted from Trends Immunol. 32(1):34-41 (Pang and Iwasaki, 2011) with permission. 
 
Figure 1.2 Innate recognition of IAV infection.  
Viral ssRNA is sensed by TLR7 in the endosome (i) or viral 5’-triphosphate RNA is sensed by 
RIG-I (ii). TLR7 signaling mediated its adaptor protein, myeloid differentiation primary 
response protein 88 (MyD88) activates IRF7 and NF-κB, whereas RIG-I signals mediated by its 
adaptor, IFN-β promoter stimulator protein 1 (IPS-1, also called mitochondrial antiviral signaling 
protein [MAVS]) on the mitochondria activates IRF3 and NF-κB. IRF7 and IRF3 translocate to 
the nucleus, thereby inducing the type I IFN, while NF-κB induces the expression of pro-
inflammatory cytokines including pro-IL-1β and pro-IL-18. IAV infection also induces the 
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NLRP3 inflammasome activation (iii), leading to pro-caspase-1 cleavage that is critical for the 
conversion of pro-IL-1β and pro-IL-18 into their mature forms.  
 
DCs are critical in linking innate immunity to adaptive immunity in response to viral 
infection. Upon antigen uptake in IAV-infected lungs, respiratory DCs mature and migrate to the 
mediastinal lymph node where they present processed antigens to naïve T cells (Ho et al., 2011, 
Ingulli et al., 1997). T cells are classified into two subgroups, CD4
+
 and CD8
+
 T cells. After 
antigen recognition, they possess effector functions to support antibody production and to 
eliminate infected cells. IAV-specific CD4
+
 T cells can migrate to the lung. They produce 
cytokines like TNF-, IL-2 and IFN-γ to induce cytotoxicity by CD8+ T cells, and to activate 
alveolar macrophages. They also secrete IL-4 and IL-13 to activate B cells (Kreijtz et al., 2011, 
Zens and Farber, 2014). After the infection is resolved, some of the CD4
+
 T cells acquire 
memory and can clear IAV particles more effectively in case of reinfection. Memory CD4
+
 T 
cells can secrete more cytokines in a more rapid manner than naïve CD4
+
 T cells, particularly for 
IFN-γ (Lai et al., 2011). Memory CD4+ T cell-mediated protection against further IAV infection 
is executed independently of B cells or CD8
+
 T cells; and this protection is cross-reactive to 
different strains (Richards et al., 2010, Zens and Farber, 2014).  
With signals provided by DCs, CD8
+
 T cells proliferate in IAV-infected lungs (Lawrence 
and Braciale, 2004). CD8
+
 T cells also secrete cytokines including IFN-γ, but their main function 
is to eliminate IAV-infected epithelial cells through cytotoxicity (Topham et al., 1997). When 
recognizing antigens presented by major histocompatibility complex (MHC) class I, CD8
+
 T 
cells induce apoptosis of target cells by releasing their enzymes (pore-forming proteins and 
granzymes), or by upregulating the TNF family members (such as Fas ligand) that bind to the 
target cell ligand, Fas to initiate the apoptotic signaling (Hufford et al., 2014). Following 
recovery from infection, some portions of CD8
+
 T cells also remain as long-lived memory CD8
+
 
T cells in preparation for re-infection (Hufford et al., 2014, Kreijtz et al., 2011).  
For humoral immunity, the surface glycoproteins HA and NA are the major targets of 
antibody production. Naïve B cells recognize these antigens provided by DCs in the mediastinal 
lymph nodes and the respiratory mucosa-associated lymphoid tissues, thereby becoming 
antibody-secreting cells (Chiu et al., 2014). Alternatively, some B cells can capture antigens by 
themselves in the lymph nodes and at the site of infection (Waffarn and Baumgarth, 2011). 
While antibody secretion by B cells can occur independently of T cells, it is known that CD4
+
 T 
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cell-mediated B cell responses are critical for more effective antibody production against IAV 
infection (Mozdzanowska et al., 2005). HA-specific antibodies can neutralize IAV, and NA-
binding antibodies interfere with the enzymatic activity of NA, rather than directly neutralizing 
(Kreijtz et al., 2011). Binding of antibodies targeting both HA and NA to infected cells can lead 
to antibody-dependent cell-mediated cytotoxicity executed by natural killer cells (Kreijtz et al., 
2011). IgG and IgM are the predominant antibody classes produced in the lung and in particular, 
IgG is thought to be responsible for preventing systemic dissemination of IAV; IgA secreted 
from the respiratory mucosa inhibits the neutralized antigens from adhering to the epithelium 
(Chiu et al., 2014). After acquiring memory, B cells maintain the ability to generate both IgG and 
IgA, which also serves for cross-protection against other IAV strains (Waffarn and Baumgarth, 
2011).  
 
1.1.4 Swine influenza virus (SIV) 
Influenza infection in pigs causes a mild or subclinical disease in the respiratory tract. 
Symptoms of the acute illness include fever, anorexia, lethargy, nasal discharge and coughing 
(Van Reeth et al., 2012). These symptoms are similarly observed upon infection by different 
viral subtypes, and major difference in virulence is not reported by infection with different 
strains (Van Reeth et al., 2012). While high morbidity is seen, mortality is generally low and 
affected animals can recover in 5 to 7 days. However, secondary infection with other respiratory 
viruses or bacteria can exacerbate the condition (Van Reeth et al., 2012). SIV transmission 
occurs through direct contact or by aerosols. Epithelial cells on the airway are the main sites for 
viral replication, while viruses preferentially target the lower respiratory tract (Van Reeth et al., 
2012). The disease outcome can be affected by inflammatory cytokines such as IL-1, IL-6 and 
TNF-α along with IFN-α. Although they have antiviral activities, high levels of these cytokines 
are responsible for lung inflammation (Van Reeth et al., 2012, Van Reeth et al., 1998, Van Reeth 
et al., 2002). Bronchopneumonia is prominent in infected pigs and microscopic lesions include 
necrotizing bronchitis; bronchiolitis; airway obstruction by necrotic epithelial cells and 
inflammatory cells such as neutrophils (Janke, 2014, Van Reeth et al., 2012).  
Although swine influenza does not often lead to fatal outcomes, it has been a concern of 
economic loss in the swine production industry (Schultz-Cherry et al., 2013). Among different 
influenza species, influenza A, C and D viruses are isolated from pigs (Su et al., 2017). However, 
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only IAV is considered as a critical pathogen for swine influenza (Van Reeth et al., 2012). The 
first case of swine influenza was reported during the pandemic in 1918, while SIV was first 
isolated in the United States in 1930 (Lorusso et al., 2013). As a result of infection of pigs with 
the 1918 pandemic strain, classical swine H1N1 was established (Zell et al., 2013). Since then, 
this lineage of SIV has stably circulated in North America for decades. In the late 1990s, two 
different genotypes of H3N2 subtype emerged, and one of them, a triple reassortant derived from 
avian, swine and human seasonal H3N2 strains, has spread throughout the United States. While 
this virus was endemic in pigs, its reassortment with the classical swine H1N1 also occurred, 
generating novel variant SIVs of H1N1 and H1N2 subtypes (Brockwell-Staats et al., 2009, 
Lorusso et al., 2013). As evidenced by the 2009 pandemic H1N1, the reassortment of IAVs from 
different hosts in pigs highlights the important roles played by pigs for the emergence of new 
viruses. The contribution of pigs to the generation of new viruses can be presented by the mixing 
vessel theory (Scholtissek et al., 1985) with several observations supporting this idea. Pigs are 
permissive to avian and human isolates (Kida et al., 1994), and reassortment among viruses of 
different origins has been displayed for isolates from pigs (Peiris et al., 2001). Another important 
factor is the receptor binding activity of HA, one of the critical determinants in the host 
restriction of IAVs. The binding specificity of HA depends on the types of host cell receptors 
differentially distributed in host animals. The molecular structures of this receptor, sialic acid 
linked to galactose, are divided into two types: avian-type alpha 2,3-linkage and human-type 
alpha 2,6-linkage that are preferably recognized by avian and human isolates, respectively (Zell 
et al., 2013). Swine isolates recognize both structures and pigs express both types of sialic acids 
(Ito et al., 1998), rendering them susceptible to infection by both avian and human strains. Later, 
human cells were also found to harbor both types of these receptors (Shinya et al., 2006), 
showing that the receptor binding activity alone may not fully support this theory. An additional 
model is such that the adaptation of avian strains in swine hosts, as avian-like SIVs, through 
repeated replication in pigs, is able to generate variants that can recognize the human-type sialic 
acid (Ito et al., 1998). Overall, further reassortment among IAV strains in swine hosts may lead 
to the generation of new strains with pandemic capacity. 
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1.1.5 2009 human pandemic IAV (pdm09) 
The pdm09 emerged as a pandemic through the reassortment of IAVs of different origins 
in the intermediate hosts, pigs. The genome segments of pdm09 are derived from multiple 
lineages: PB2 and PA from avian strain of North American lineage; PB1 from human seasonal 
H3N2 strain; HA, NP and NS from classical swine H1N1 of North American lineage; NA and M 
from avian-like swine H1N1 of Eurasian lineage (Neumann et al., 2009). This virus is thus, 
antigenically close to swine H1N1, while distinct from human seasonal strains (Garten et al., 
2009). The initial emergence of this H1N1 subtype virus in Mexico was quickly followed by the 
worldwide spread through human-to-human transmission, leading to the first IAV pandemic in 
the 21st century. However, it is suggested that the introduction and circulation of the original 
gene segments in pigs took place years before the pdm09 outbreak in humans (Girard et al., 
2010, Vijaykrishna et al., 2010). In humans, the pdm09 generally induced higher rates of 
infection in the younger population rather than the old; this may be attributable to the possession 
of cross-reactive antibodies initially raised against the 1918 pandemic-like viruses in the older 
generation (Girard et al., 2010, Tscherne and García-Sastre, 2011). Genetic signatures for human 
adaptation or increased pathogenicity characteristic for highly pathogenic strains were not found 
in the pdm09 strains. For example, the pdm09 PB2 protein harbours glutamic acid at the 627th 
amino acid (aa), common for avian strains, instead of lysine that is typical for human strains. 
While PB1-F2 protein and C-terminal region of NS1 protein encoded by 1918 pandemic IAV 
strains are involved in pathogenicity, the PB1 and NS segments of pdm09 encode a truncated 
version of PB1-F2 and NS1 proteins, respectively, compared to those of 1918 pandemic strains 
(Garten et al., 2009, Tscherne and García-Sastre, 2011). Although the pdm09 infection elicited 
symptoms that are comparable to seasonal IAVs in humans (Tscherne and García-Sastre, 2011), 
it may acquire virulence by further reassortment, and this potential threat underscores the 
importance of ongoing surveillance in pigs. 
 
1.1.6 Non-structural protein 1 (NS1) of IAV 
NS1 protein is encoded by the NS segment of IAV and is between 202 and 237 aa in 
length. NS1 exerts extensive functions such as supporting viral replication and counteracting the 
host antiviral responses (Figure 1.3), although many of these functions are virus strain- or host-
dependent (Ayllon and García-Sastre, 2014). It has two functional domains: an N-terminal RNA-
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binding domain that can bind several species of RNA such as dsRNA and mRNA in a sequence-
independent manner; and a C-terminal effector domain that interacts with host cellular proteins 
and stabilizes the RNA-binding domain (Hale et al., 2008). NS1 has one or two nuclear 
localization signals that are required for the nuclear import of NS1 (Hale et al., 2008). In infected 
cells, NS1 mainly localizes to the nucleus, while it is also found in cytoplasm indicating that NS1 
functions in both compartments (Hale et al., 2008, Krug, 2015). 
 
1.1.6.1 NS1 acting on the synthesis of viral proteins 
Upon IAV infection, viral mRNAs are preferentially translated over cellular mRNAs 
(Hale et al., 2008). NS1 is one of many proteins that binds the 5’ untranslated region (UTR) of 
viral mRNAs for selective translation (Garfinkel and Katze, 1993); NS1 promotes the translation 
of viral mRNAs, but not that of non-viral mRNAs (de la Luna et al., 1995). While NS1 does not 
impact viral mRNA transcription, it enhances viral mRNA translation that is dependent on the 5’ 
UTR of mRNAs (Enami et al., 1994). NS1 can bind proteins involved in translation such as the 
eukaryotic translation initiation factor 4 gamma 1 (eIF4GI) (Aragón et al., 2000), and it is 
suggested that NS1 recruits eIF4GI to the 5’ UTR of viral mRNAs (Hale et al., 2008). NS1 also 
binds human homologue of Drosophila melanogaster Staufen (hStaufen), a dsRNA-binding 
protein involved in the transport of viral mRNA to polyribosomes where multiple ribosomes 
form a complex for active translation (Falcón et al., 1999). Protein kinase R (PKR) is activated 
either by the recognition of viral dsRNA or via a cellular protein, PACT (which refers to ‘protein 
activator of the IFN-induced protein kinase’) (Li et al., 2006). PKR activation induces the 
phosphorylation of eukaryotic translation factor 2 subunit alpha (eIF2α), thereby suppressing the 
viral RNA and protein synthesis in infected cells (Hatada et al., 1999). However, binding of NS1 
to PKR can subvert either dsRNA- or PACT-mediated PKR activation (Li et al., 2006, Min et al., 
2007). 
 
1.1.6.2 NS1-mediated restriction of the host gene expression 
NS1 inhibits the transportation of polyadenylated mRNAs from the nucleus to the 
cytoplasm and this action is exerted by binding of NS1 to the poly(A) tails of cellular mRNAs 
(Hale et al., 2008, Qiu and Krug, 1994). The effector domain of NS1 binds to the 30 kDa subunit 
of cleavage and polyadenylation specificity factor (CPSF30) and poly(A)-binding protein II 
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(PABPII) (Chen et al., 1999, Twu et al., 2006). CPSF30 recognizes the AAUAAA sequence 
upstream of the cleavage site for polyadenylation of cellular mRNAs (Das et al., 2008). NS1 
binding to CPSF30 or sequestration of CPSF30 by NS1 prevents cleavage and polyadenylation 
of cellular mRNAs, while viral mRNAs are polyadenylated by viral polymerases and not 
affected by this inhibition (Hale et al., 2008). NS1 binding to PABPII blocks the nuclear export 
of mature cellular mRNAs that could avoid the inhibition step at the polyadenylation level (Chen 
et al., 1999). NS1 also blocks the export of cellular mRNAs from the nucleus to the cytoplasm, 
by interacting with cellular proteins involved in nuclear export machinery (Satterly et al., 2007).  
 
 
Reprinted from J Gen Virol. 89(10):2359-2376 (Hale et al., 2008) with permission. 
 
Figure 1.3 Multiple functions of IAV NS1 protein.  
(a) NS1 limits IFN induction by binding to viral RNA and RIG-I. (b) NS1 limits the antiviral 
status established by the PKR and 2’-5’-oligoadenylate synthetase (OAS)/ribonuclease (RNase) 
L pathways. (c) NS1 restricts the maturation and nuclear export of cellular mRNAs. (d) NS1 
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promotes the translation of viral mRNA. (e) NS1 limits apoptosis by activating the 
phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/Akt pathway. 
 
1.2 Inflammasomes and interleukin-1 beta (IL-1β)  
1.2.1 Inflammasomes 
Inflammasomes are cytosolic multiprotein complexes that govern inflammation by 
regulating the pro-inflammatory cytokines, IL-1β and IL-18. Different immune sensors (either 
NLRs or non-NLRs) can assemble into the inflammasomes with apoptosis-associated speck-like 
protein containing caspase activation and recruitment domain (ASC) and inflammatory caspases 
in response to diverse stimuli. Upon this assembly, the inflammatory caspases are modified by 
proteolytic cleavage for their enzymatic activity that is required to process pro-IL-1β and pro-IL-
18 (Pétrilli and Martinon, 2011). Inflammasomes consisting of caspase-1 are considered as 
canonical, while non-canonical inflammasomes involve caspase-4 and -5 (or caspase-11 in 
mouse) (Viganò et al., 2015). The key steps in inflammasome activation is represented by a two-
signal model (Figure 1.4): signal 1 for the enhanced transcription of the inflammasome-forming 
immune sensors and substrates (pro-IL-1β or pro-IL-18) by NF-κB activation; signal 2 for the 
recruitment of adaptor and effector proteins for inflammasome assembly (Mariathasan and 
Monack, 2007). By finding that dysregulation of inflammasomes is related to auto-inflammatory 
disorders and metabolic diseases (Guo et al., 2015), the role of inflammasomes is considered to 
be the maintenance of homeostasis as well as the host defense against pathogen-associated 
molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs).  
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Reprinted from Antiviral Res. 148:32-42 (Sarvestani and McAuley, 2017) with permission. 
 
Figure 1.4 Two-signal model for the inflammasome activation.  
A) Signal 1: Upon endocytosis of PAMPs or phagocytosis of DAMPs, TLR3 and TLR7 
signaling involving their adaptors are activated. Upon sensing RNA, RIG-I and melanoma 
differentiation-associated protein 5 (MDA5) signaling involving their adaptor is activated as 
well. These activate the NF-κB pathway, which upregulates the expression of inflammasome 
receptor (NLR or non-NLR) and pro-IL-1β or pro-IL-18. B) Signal 2: The inflammasome 
receptor undergoes a conformational change upon sensing stimuli, leading to the assembly of 
inflammasome complex with ASC and pro-caspase-1. Upon auto-proteolytic cleavage of pro-
caspase-1, active caspase-1 converts pro-IL-1β or pro-IL-18 into IL-1β or IL-18.  
 
1.2.1.1 Apoptosis-associated speck-like protein containing caspase activation and 
recruitment domain (ASC) 
ASC is a component of inflammasomes. It was initially discovered as a pro-apoptotic 
protein that forms speck-like aggregates in apoptotic cells (Masumoto et al., 1999). It is 
constitutively expressed in many myeloid cells, and functions as a bridge between immune 
sensors (mostly NLRs) and the effector molecule, pro-caspase-1 (Hoss et al., 2017). ASC has 
two domains: N-terminal pyrin domain (PYD) that interacts with another PYD of NLRs and C-
terminal caspase activation and recruitment domain (CARD) that interacts with CARD of pro-
caspase-1. Upon activation, NLRs oligomerize and recruit ASC molecules, which also 
oligomerize and form long filaments. Diffusely distributed ASC throughout the cytoplasm and 
nucleus cluster to a spot where NLRs form a seed. This leads to the formation of a perinuclear 
speck of 1 μm in diameter per each cell (Hoss et al., 2017, Stutz et al., 2013). While ASC PYD 
alone can form filaments, spherical speck formation requires ASC CARD that connects between 
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filaments (Dick et al., 2016). Moreover, the interaction between ASC CARDs provides an 
additional seed for the filament formation by pro-caspase-1 CARD (Dick et al., 2016, Schmidt et 
al., 2016). Conclusively, ASC specks are where pro-caspase-1 recruitment and activation occur 
(Franklin et al., 2018), therefore, they are a hallmark of inflammasome activation. Interestingly, 
ASC specks can be secreted outside the cells where pro-caspase-1 recruitment and IL-1β 
maturation can also occur. The extracellular specks can disseminate inflammatory signals to 
phagocytes that then engulf them (Baroja-Mazo et al., 2014, Franklin et al., 2014).  
Post-translational modifications on ASC play important roles in the regulation of 
inflammasome activity. Absent in melanoma 2 (AIM2) inflammasome activation upon double-
stranded DNA (dsDNA) is restricted by means of the ubiquitination of ASC, which is subject to 
degradation via autophagy (Shi et al., 2012). NLRP3 inflammasome activity can be inhibited by 
an autophagy protein that upregulates the activity of an E3 ligase, TNF receptor-associated factor 
(TRAF) 6, which ubiquitinates ASC (Chiu et al., 2016). Linear ubiquitination of ASC is essential 
for the activation of NLRP3 inflammasome (Rodgers et al., 2014), whereas deubiquitination of 
ASC is required for the same event (Lee et al., 2017c). Ubiquitination of ASC by an E3 ligase, 
TRAF3 upon infection with vesicular stomatitis virus (VSV) is critical for inflammasome-
mediated IL-1β production (Guan et al., 2015). Phosphorylation of ASC also exerts controls on 
the inflammasome activity. ASC speck formation is dependent on c-Jun N-terminal kinase and 
spleen tyrosine kinase (Syk), and upon inflammasome activation ASC is phosphorylated by 
those kinases (Hara et al., 2013). This is supported by another finding that phosphorylation of 
ASC by Syk is required for ASC oligomerization and NLRP3 inflammasome activity (Lin et al., 
2015). ASC is also phosphorylated by another kinase, proline-rich tyrosine kinase 2 that interacts 
and colocalizes with ASC specks to activate the NLRP3 inflammasome (Chung et al., 2016).  
Spatial regulation of ASC by inhibitor of κB kinases (IKKs) is also suggested. IKKα 
negatively regulates the NLRP3 inflammasome by phosphorylating serine residues on ASC, 
which is bound to nuclear IKKα in the resting state, whereas upon lipopolysaccharide (LPS) 
treatment, ASC is released from IKKα. Moreover, IKKε, by phosphorylating a different serine of 
ASC, promotes the translocation of ASC from the nucleus to the cytosol for NLRP3 
inflammasome activation (Martin et al., 2014). 
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1.2.1.2 Caspase-1 
Caspase-1 is a component of canonical inflammasomes. Caspases (refers to cysteine-
aspartic proteases) are a family of enzymes, most of which are involved in programmed cell 
deaths or inflammation. Caspases are expressed as a precursor, pro-caspase, which generally 
consists of the N-terminal pro-domain, either CARD or death effector domain (DED), the large 
subunit (p20) and the small subunit (p10). The proteolytic cleavage between pro-domain and p20 
as well as between p20 and p10 subunit leads to the formation of active caspase (Sollberger et 
al., 2014, Winkler and Rösen-Wolff, 2015). Caspases are classified into either apoptotic caspases 
or inflammatory caspases. Apoptotic caspase are further divided into initiator caspases (caspase-
2, -8, -9, and -10) and executioner caspases (caspase-3, -6, and -7). Initiator caspases, through 
either CARD (for caspase-2 and -9) or DED (for caspase-8 and -10), are recruited to adaptor 
proteins that react to cell death signals such as cytochrome c, TNF-α or Fas ligand. Executioner 
caspases, which lack the pro-domain, are cleaved by macromolecular complexes containing 
initiator caspases, and perform apoptosis by processing their target molecules (Shalini et al., 
2015, Sollberger et al., 2014). Inflammatory caspases (caspase-1, -4, -5, -11 and -12) are pivotal 
in the regulation of inflammatory responses, and caspase-1, the prototype in this group, is 
integral to the cleavage of pro-IL-1β and pro-IL-18. As with other caspases, caspase-1 is 
expressed as pro-caspase-1, which is enzymatically inactive. Through its N-terminal CARD, pro-
caspase-1 interacts with another CARD of ASC, which is the adaptor protein of NLR or non-
NLR proteins. The recruitment of pro-caspase-1 to ASC is essential for the inflammasome 
formation and subsequently, the auto-proteolysis of pro-caspase-1. Active caspase-1 is a tetramer 
composed of two molecules each of p20 and p10 (Shalini et al., 2015, Sollberger et al., 2014). In 
addition to the cytokine regulation, active caspase-1 may contribute to NF-κB activation, 
independent of its enzyme activity (Lamkanfi et al., 2004). Caspase-1 also executes an 
inflammatory cell death called pyroptosis by cleaving the downstream effector, gasdermin D 
(Shi et al., 2015).  
 
1.2.1.3 Inflammasomes formed by nucleotide-binding oligomerization domain-
like receptors (NLRs) 
NLRs are cytosolic PAMP/DAMP sensors. Among them, NLRP1 is the first identified 
inflammasome-forming innate sensor. Its assembly with ASC, caspase-1 and caspase-5 was 
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found to be required for IL-1β production in LPS-stimulated human monocytes (Martinon et al., 
2002). Later, a two-step mechanism of NLRP1 inflammasome activation was suggested by 
showing that the priming and oligomerization of NLRP1 is induced by muramyl dipeptide and 
adenosine triphosphate (ATP), respectively (Faustin et al., 2007). Another NLR member, NLRP3 
was shown to form a complex with ASC and caspase-1 for IL-1β production, and more IL-1β 
secretion was observed from cells with the mutant NLRP3 (Agostini et al., 2004), indicating the 
involvement of inflammasome activation in abnormal inflammation. A two-signal model for 
NLRP3 inflammasome activation was also proposed: priming signal (signal 1) by TLR agonists 
and activation signal (signal 2) by ATP (Netea et al., 2009). A wide variety of PAMPs, DAMPs 
or cell stress have been displayed to activate the NLRP3 inflammasome. While NLRP7 can 
negatively regulate IL-1β production (Kinoshita et al., 2005), activation of NLRP7 
inflammasome can restrict intracellular bacteria (Khare et al., 2012). NLRP12 inflammasome-
mediated IL-18 production can provide host resistance against Yersinia pestis (Vladimer et al., 
2012). Unlike other inflammasome-forming receptors, two NLRs, the NLR family CARD-
containing protein 4 (NLRC4) and the neuronal apoptosis inhibitor protein (NAIP) form the 
inflammasome together upon sensing of bacterial ligands by NAIP (Yang et al., 2013, Zhao et 
al., 2011). NLRC4 inflammasome assembly, possibly with NAIP, is required for IFN-γ 
production from CD8
+
 T cells in response to bacterial infection (Kupz et al., 2012). 
 
1.2.1.3.1 NLRP3 inflammasome 
Among inflammasome-forming NLRs, NLRP3 has been most widely investigated. A 
variety of stimuli have been known to induce the formation and activation of NLRP3 
inflammasome leading to secretion of IL-1β or IL-18. Importantly, NLRP3 inflammasome-
mediated IL-1β production confers protection in IAV-infected mice (Allen et al., 2009, Thomas 
et al., 2009). 
 
1.2.1.3.1.1 Mechanisms of NLRP3 inflammasome activation 
Upon recognition of ligands by pattern recognition receptors (PRRs), i.e. TLRs or 
RLRs, signal transduction is facilitated through multiple adaptor proteins of the PRRs, leading to 
the activation of the NF-κB pathway. As a result, transcription of NLRP3 and pro-IL-1β is 
initiated (Kattah et al., 2017) and this priming step is called “signal 1” (Figure 1.4). Adaptor 
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proteins of TLRs such as MyD88 and TIR-domain-containing adapter-inducing IFN- (TRIF) 
are known to play roles on the transcriptional and post-transcriptional regulation of NLRP3 (He 
et al., 2016a). Priming by some stimuli may cause NLRP3 activation (He et al., 2016a), while 
priming alone can trigger IL-1β secretion in human monocytes (Netea et al., 2009). Diverse 
stimuli provide “signal 2” that is needed for NLRP3 inflammasome assembly (Figure 1.4). 
Unlike NLRP3, ASC is constitutively expressed in many types of myeloid cells (Hoss et al., 
2017). After NLRP3 senses stimuli, it oligomerizes and its N-terminal PYD interacts with N-
terminal PYD of ASC. This interaction is followed by aggregation between the two, forming a 
supramolecular structure termed a speck. Multiple pro-caspase-1 molecules are recruited to 
speck-formed ASC through CARD-CARD interactions between the ASC and pro-caspase-1 
(Hoss et al., 2017). Auto-cleavage of pro-caspase-1 generates two subunits of active caspase-1, 
p20 and p10. Two sets of a heterodimer of p20 and p10 form a homodimer that can cleave pro-
IL-1β (Walker et al., 1994). Since caspase-1 is an inflammatory caspase, NLRP3 inflammasome 
activation is implicated in inflammatory cell death (Fink and Cookson, 2006, Shi et al., 2015). 
Different mechanisms have been suggested to elucidate the signal 2 required for 
the NLRP3 inflammasome activation (Figure 1.5). An early study demonstrated that IL-1β 
secretion is promoted by ATP or nigericin that induce the depletion of intracellular K
+
 
(Perregaux and Gabel, 1994). This is further supported by studies showing that K
+
 efflux can be 
a common stimulus to induce the NLRP3 inflammasome activation (Franchi et al., 2014, Muñoz-
Planillo et al., 2013, Pétrilli et al., 2007). Although K
+
 efflux-mediated NLRP3 inflammasome 
activation can occur independent of Ca
2+
 influx (Katsnelson et al., 2015), the importance of 
calcium sensing mechanisms has been demonstrated. Extracellular Ca
2+
 or elevated intracellular 
Ca
2+
 sensed by calcium sensing receptors activates the NLRP3 inflammasome (Lee et al., 2012, 
Rossol et al., 2012). In addition to the Ca
2+
 influx, Ca
2+
 release from ER due to phagolysosomal 
rupture can augment the NLRP3 inflammasome activation (Murakami et al., 2012). In fact, the 
contribution of lysosomal disruption was displayed earlier. Phagocytosis of crystals induces the 
leakage of lysosomal contents such as cathepsin B from damaged lysosomes, thereby activating 
the NLRP3 inflammasome (Duewell et al., 2010, Hornung et al., 2008). Reactive oxygen species 
(ROS) has been proposed as another common trigger of the NLRP3 inflammasome activation. 
Cytosolic ROS generated after phagocytosis of particulates activates the NLRP3 inflammasome 
(Dostert et al., 2008). Subsequent reports revealed that NLRP3 inflammasome requires 
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mitochondrial ROS for its activation (Nakahira et al., 2011, Zhou et al., 2011). Furthermore, the 
release of mitochondrial DNA can cause NLRP3 inflammasome activation (Nakahira et al., 
2011, Shimada et al., 2012).  
 
 
 
Reprinted from Nat Med. 21(7):677-87 (Guo et al., 2015) with permission. 
 
Figure 1.5 Mechanisms of the NLRP3 inflammasome activation.  
A stimulus (e.g. LPS sensed by TLR4) activates the NF-κB pathway, promoting the mRNA 
expression of NLRP3 and IL-1β. This priming step is followed by post-translational 
modifications such as deubiquitination of NLRP3 and ubiquitination/phosphorylation of ASC. 
NLRP3 inflammasome activation requires signal 2 that include the relocalization of NLRP3 to 
the mitochondria, the release of mitochondrial ROS/DNA or cardiolipin, ion fluxes (e.g. K
+
 
efflux) and cathepsin release from disturbed lysosomes. For NLRP3 inflammasome assembly, 
NLRP3 nucleates ASC into filaments through PYD-PYD interaction forming the ASC speck. 
Pro-caspase-1 is recruited to ASC through CARD-CARD interaction, leading to the auto-
proteolytic cleavage of pro-caspase-1. Active subunits of caspase-1 (p20 and p10) cleave 
precursor forms of IL-1β or IL-18. Domain structures of NLRP3 inflammasome components are 
shown in the inset.  
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1.2.1.3.1.2 Ubiquitination and NLRP3 inflammasome 
Ubiquitination is a post-translational modification process by which ubiquitin 
proteins are covalently conjugated to substrate proteins. Ubiquitin is an 8.6-kDa protein, which is 
highly conserved among eukaryotes (Zuin et al., 2014). Its linkage to substrates was initially 
known to be required for proteasomal degradation of the substrate proteins; however it has been 
further identified to play crucial roles in a variety of cell signaling pathways. Ubiquitination is a 
three-step process mediated by three enzymes: E1 activating enzymes, E2 conjugating enzymes 
and E3 ligases. In addition, ubiquitins can be recycled after being removed from target proteins 
by deubiquitinases (Kattah et al., 2017). The substrate selectivity is generally determined by E3 
ligases that link the C-terminal glycine of an ubiquitin molecule to the ɛ-amino group of a lysine 
(K) residue on the substrate. Monoubiquitination occurs by binding of a single ubiquitin to each 
lysine in the substrate; subsequent linkages of more ubiquitins to lysine residues located on the 
first ubiquitin leads to different types of polyubiquitination (Davis and Gack, 2015). Additional 
ubiquitin molecules can be linked on a lysine residue among seven lysines (K6, K11, K27, K29, 
K33, K48 and K63) or on the first methionine (M1) residue, eventually leading to different 
consequences. M1-linked ubiquitination, also called linear ubiquitination is mediated by an E3 
ligase complex, a linear ubiquitin assembly complex (LUBAC), and is involved in signal 
transduction such as the NF-κB activation (Davis and Gack, 2015). K48-linked ubiquitination 
can target the substrates for proteasomal degradation, while K63-linked ubiquitination leads to 
signal transduction by affecting the stability or localization of target proteins; other linkages are 
involved in rather diverse activities including cell development, signaling regulation, autophagy 
or protein degradation (Davis and Gack, 2015, Kattah et al., 2017). In some cases, unanchored 
ubiquitin chains that are not linked to the substrate can participate in signaling events (Kattah et 
al., 2017).  
Given that protein modifications by ubiquitins occur for a variety of cellular 
functions, it is of no surprise that ubiquitination and its related enzymes play pivotal roles in 
immune modulation. Ubiquitination and deubiquitination have been described to regulate the 
inflammasome activity (Bednash and Mallampalli, 2016). Deubiquitinases are required for 
inflammasome-dependent IL-1β production (Lopez-Castejon et al., 2013) and more specifically, 
deubiquitination of NLRP3 is reported to be important for the activation of the NLRP3 
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inflammasome (Guo et al., 2016, Han et al., 2015, Juliana et al., 2012, Kawashima et al., 2017, 
Py et al., 2013, Yen et al., 2015). On the contrary, autophagy-mediated or proteasomal 
degradation of ubiquitinated NLRP3 leads to suppression of the NLRP3 inflammasome (Song et 
al., 2016, Yan et al., 2015). Upon activation of several different inflammasomes, caspase-1 can 
be ubiquitinated, which may downregulate the inflammasome activity (Van Opdenbosch et al., 
2014). A recent report shows that ubiquitination-mediated degradation of caspase-1 is prevented 
by Zika virus NS1 protein leading to NLRP3 inflammasome activation (Zheng et al., 2018). Pro-
IL-1β also undergoes ubiquitination, which leads to either its maturation into IL-1β or its 
degradation (Ainscough et al., 2014, Duong et al., 2015, Harris et al., 2011). Interestingly, upon 
human papillomavirus infection, ubiquitination of pro-IL-1β followed by the proteasomal 
degradation is mediated by a viral oncoprotein that hijacks the cellular E3 ligase (Niebler et al., 
2013). ASC ubiquitination was initially reported in a study of AIM2 inflammasome-related 
autophagy in response to dsDNA; for the inhibition of AIM2 inflammasome-mediated IL-1β, 
ubiquitinated ASC is delivered to an autophagic adaptor, p62 and subject to autophagy for 
degradation (Shi et al., 2012). Similarly, NLRP3 inflammasome activity is restricted by p62 that 
interacts with an E3 ligase, TRAF6, which ubiquitinates ASC (Chiu et al., 2016). Linear 
ubiquitination of ASC is essential for the activation of NLRP3 inflammasome (Rodgers et al., 
2014), whereas a deubiquitinase, ubiquitin-specific peptidase 50 interacts with ASC and 
deubiquitinates the ASC for NLRP3 inflammasome activation (Lee et al., 2017c). Notably, 
ubiquitination of ASC by an E3 ligase, TRAF3 upon infection with VSV is critical for 
inflammasome-mediated IL-1β production (Guan et al., 2015).  
 
1.2.1.3.1.3 Mitochondria acting on the NLRP3 inflammasome 
Mitochondria-mediated pathophysiological changes positively or negatively 
regulate the NLRP3 inflammasome. Mitochondria that generate ROS are readily eliminated by 
mitophagy, whereas inhibition of this event causes the ROS accumulation and the loss of 
mitochondrial membrane potential. The correlation between autophagy and ROS-mediated 
NLRP3 inflammasome activation is demonstrated. While autophagy proteins can inhibit the 
NLRP3 inflammasome, depletion of them enhances caspase-1 activity by damaging 
mitochondrial homeostasis (Nakahira et al., 2011). Another study shows that upon agonist 
treatment, NLRP3 can localize to the ER-mitochondria that enables NLRP3 to sense ROS (Zhou 
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et al., 2011). ROS sensing mechanism by NLRP3 is proposed by the same group. In the resting 
state, thioredoxin-interacting protein (TXNIP) is bound to the antioxidant molecule, thioredoxin. 
Inflammasome activators let the TXNIP dissociate from thioredoxin upon ROS production; in 
turn, TXNIP binds to NLRP3 to activate the NLRP3 inflammasome (Zhou et al., 2010). 
However, NLRP3 inflammasome activation can be triggered independent of ROS, as shown by 
an NLRP3 agonist that induces mitochondrial dysfunction, but does not induce ROS (Iyer et al., 
2013). Mitochondrial DNA released into cytosol activates the NLRP3 inflammasome as well 
(Nakahira et al., 2011). Another study explains this phenomenon in relation to mitochondrial 
membrane potential, which is a proton gradient in the inner mitochondrial membrane. NLRP3 
agonists can dissipate the mitochondrial membrane potential during apoptosis; this leads to the 
release of oxidized mitochondrial DNA that binds to NLRP3 to activate the NLRP3 
inflammasome (Shimada et al., 2012). However, it is contradicted by another finding showing 
that the maintenance of the intact mitochondrial membrane potential is required for the 
inflammasome activation upon infection with RNA viruses, including IAV. Mitochondrial 
uncoupling protein 2, responsible for transporting anions from the inner to the outer 
mitochondrial membrane, reduces the mitochondrial membrane potential, thereby suppressing 
the NLRP3 inflammasome activity (Ichinohe et al., 2013).  
Mitochondrial components are also implicated in the regulation of the NLRP3 
inflammasome. Several isoforms of voltage-dependent anion channels that are outer 
mitochondrial proteins are required for NLRP3 inflammasome activation (Zhou et al., 2011), 
whereas a mitochondrial protease, HtrA serine peptidase 2 restricts the activation (Rodrigue-
Gervais et al., 2018). Cardiolipin, an inner mitochondrial membrane phospholipid has been 
demonstrated to interact with NLRP3 and activate the NLRP3 inflammasome (Iyer et al., 2013). 
Interestingly, cytochrome c released from the inner mitochondrial membrane during apoptosis 
inhibits the cardiolipin-NLRP3 interaction and NLRP3 inflammasome activity (Shi and Kehrl, 
2016). An outer mitochondrial membrane protein, mitofusin (Mfn) 2 interacts with NLRP3 upon 
RNA virus infection and activates the NLRP3 inflammasome activation (Ichinohe et al., 2013). 
Inactive NLRP3 is cytosolic, but upon activation, NLRP3 is recruited to mitochondria by 
MAVS; this translocation and NLRP3 oligomerization are important for the NLRP3 
inflammasome activation (Park et al., 2013b, Subramanian et al., 2013). In response to cytosolic 
dsRNA, MAVS can activate the NLRP3 inflammasome by inducing membrane permeabilization 
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(Franchi et al., 2014).  
 
1.2.1.4 Inflammasomes formed by non-NLRs 
Non-NLR proteins can also form inflammasomes. The best example is a protein called 
AIM2 that belongs to an IFN-inducible protein class. Unlike NLRs, it consists of the N-terminal 
PYD and the C-terminal domain, HIN200 (that refers to ‘hematopoietic IFN-inducible nuclear 
antigens with 200 amino acid repeats’). Upon sensing of cytosolic dsDNA or DNA virus by 
HIN200 domain, the AIM2 inflammasome is activated through assembly with ASC and pro-
caspase-1 (Fernandes-Alnemri et al., 2009, Hornung et al., 2009). Initially, the AIM2 
inflammasome was known to be triggered by cytosolic dsDNA, but not inducers of other 
inflammasomes (Rathinam et al., 2010). However, further findings suggest that bacterial or 
fungal pathogens can activate both AIM2 and NLRP3 inflammasomes (Karki et al., 2015, Park 
et al., 2014, Wu et al., 2010). In spite of different structures, AIM2 and NLRP3 are commonly 
involved in some signaling pathways (Sagulenko et al., 2013). Recent studies have demonstrated 
the activation of AIM2 inflammasome upon RNA virus infection. Induction of AIM2 
inflammasome upon enterovirus 71 limits viral replication (Yogarajah et al., 2017), whereas 
activation of AIM2 inflammasome is implicated in IAV-induced mortality (Zhang et al., 2017a). 
RIG-I is an inflammasome-forming RLR. Independent of NLRP3, it forms the inflammasome by 
binding to ASC to regulate IL-1β production upon RNA virus infection, while MDA5 only 
upregulates NLRP3 (Poeck et al., 2010). Its role to activate NLRP3 inflammasome via 
interaction with ASC and caspase-1 upon IAV infection is also described (Pothlichet et al., 
2013). Pyrin is not a classical member of NLR, but it also assembles into the inflammasome that 
is analogous to NLRP3 inflammasome, while not affecting the NLRP3 inflammasome (Yu et al., 
2006). Critical roles of pyrin inflammasome on IL-1β production upon bacterial infection have 
been demonstrated (Gavrilin et al., 2009, Xu et al., 2014). 
 
1.2.2 IL-1β 
The IL-1 superfamily is a group of IL-1-related proteins involved in pro- or anti-
inflammatory responses. This superfamily is divided into three subfamilies, IL-1, IL-18 and IL-
36 (Table 1.1). IL-1β belongs to the IL-1 subfamily along with IL-1α, IL-33 and IL-1 receptor 
(IL-1R) antagonist (IL-1Ra) (Dinarello, 2018). IL-1 cytokines (IL-1α and IL-1β) have specific 
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receptors including IL-1R1 and IL-1R2, and a co-receptor, IL-1R3. IL-1β binds either IL-1R1 to 
induce pro-inflammatory action or a decoy receptor, IL-1R2 to block the IL-1 signaling. For pro-
inflammatory responses, IL-1β binding to IL-1R1 induces a structural change of IL-1R1 that 
further allows the binding of the co-receptor, IL-1R3 to IL-1R1. As a result, their adaptor 
protein, MyD88 is recruited, which then turns on pro-inflammatory signals via the NF-κB 
pathway (Dinarello, 2018).  
 
Table 1.1 IL-1 family members with their receptors and functions.  
 
Subfamily Member Receptor Function 
IL-1 
IL-1α IL-1R1 Pro-inflammatory 
IL-1β 
IL-1R1 Pro-inflammatory 
IL-1R2 Anti-inflammatory 
IL-1Ra IL-1R1 Anti-inflammatory 
IL-33 IL-1R4 Pro-inflammatory 
IL-18 
IL-18 IL-1R5 Pro-inflammatory 
IL-37 IL-1R5 Anti-inflammatory 
IL-36 
IL-36α, IL-36β, IL-36γ IL-1R6 Pro-inflammatory 
IL-36Ra IL-1R6 Anti-inflammatory 
IL-38 IL-1R6 Anti-inflammatory 
Adapted from Immunol Rev. 281(1):8-27 (Dinarello, 2018) with permission. 
 
IL-1β is primarily produced by immune cells of the myeloid lineage such as monocytes, 
macrophages and DCs, and its expression is induced during disease conditions. However, IL-1α 
is constitutively produced from epithelial/endothelial cells in the case of sterile inflammation, 
which is induced by non-microbial subjects or cell injury (Dinarello, 2018, Garlanda et al., 
2013). IL-1β is expressed as an inactive form and needs to be processed for biological activity; 
IL-1α is active either as its precursor or mature form. Transcription of IL-1β is initiated by pro-
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inflammatory stimuli (including microbial ligands), inflammatory cytokines (such as TNF or IL-
1 itself) or physiological changes in cells (Allan et al., 2005, Fenton, 1992). Upon activation of 
downstream signaling cascades, transcription factors bind the IL-1β gene promoter and the DNA 
regulatory region, which consists of multiple elements, for example, activator protein 1 (AP-1) 
and NF-κB binding sites, and the LPS response enhancer (Watkins et al., 1999). While the 5’ cap 
and poly (A) tail prevent mRNA degradation, the stability of IL-1β mRNA can be enhanced by 
granulocyte-macrophage colony-stimulating factor, TNF or LPS (Watkins et al., 1999). Since IL-
1β mRNA does not have a signal sequence that is required to be transported to ER-bound 
ribosomes, it is transported to free ribosomes for translation (Watkins et al., 1999). Post-
translational processing of pro-IL-1β is necessary for its maturation into IL-1β. The proteolytic 
cleavage of pro-IL-1β is conducted by caspase-1, whose activation largely depends on the signal 
sensing by inflammasome-forming PRRs, although proteases like elastase, cathepsin G and 
chymase derived from neutrophils and mast cells can also cleave pro-IL-1β (Afonina et al., 
2015). Different models for the IL-1β secretion pathway are proposed. While other inflammatory 
cytokines are secreted through a conventional pathway, i.e. transportation through the ER-Golgi 
route, IL-1β is not secreted in that way due to not having a signal peptide (Lopez-Castejon and 
Brough, 2011). The unconventional secretion pathways suggested are as follows: IL-1β can be 
localized to lysosomes that are exocytosed; IL-1β can be released with microvesicles that detach 
from plasma membranes or released with other small vesicles called exosomes that surround IL-
1β; IL-1β can be released upon cell lysis (Eder, 2009, Lopez-Castejon and Brough, 2011). 
IL-1β exerts a variety of functions on the immune system. Its action on vascular 
endothelial cells upregulates adhesion molecules and increases the vascular permeability to help 
leukocytes adhere to blood vessel walls (Dinarello, 2009). Macrophages stimulated with IL-1β 
produce cyclooxygenase-2, which is responsible for generating prostaglandins and leukotrienes 
that regulate the constriction and dilation of blood vessels (Tizard, 2009b). These changes are 
required for the recruitment and infiltration of inflammatory cells to the site of infection. 
Secretion of IL-1β itself along with other pro-inflammatory cytokines like TNF-, IL-6 and IL-8 
by monocytes and macrophages can be induced by IL-1β (Dinarello, 1991). In addition, IL-1β 
promotes phagocytosis and antigen presentation by macrophages and DCs. IL-1β also stimulates 
liver cells to produce acute-phase proteins that support inflammatory responses and pathogen 
destruction (Tizard, 2009b). Pro-inflammatory responses lead by IL-1β contribute to causing 
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critical signs of inflammation such as fever, redness and swelling (Tizard, 2009b). IL-1β, in 
synergy with other interleukins, enhances the differentiation of IL-17-producing helper T cells, 
which are pro-inflammatory (Acosta-Rodriguez et al., 2007, Sutton et al., 2006). IL-1β can 
promote B cell- and T cell-mediated antibody production as well (Dinarello, 2009, Nakae et al., 
2001). 
 
1.2.2.1 Regulation of IL-1β production by IAV proteins 
While viral RNA itself has the ability to activate the NLRP3 inflammasome (Allen et 
al., 2009, Thomas et al., 2009), different viral proteins of IAVs have been reported to regulate 
the NLRP3 inflammasome-mediated IL-1β production. An early study demonstrated that the 
NS1 protein of the mouse-adapted strain, influenza A/Puerto Rico/08/1934/H1N1 (PR8) inhibits 
caspase-1 activation and IL-1β production in human macrophages (Stasakova et al., 2005). NS1 
of the 1918 pandemic strain, by binding to RIG-I, can inhibit RIG-I-mediated IL-1β production, 
leading to increased virulence in ferrets (Pothlichet et al., 2013). Furthermore, NS1 inhibits 
NLRP3 inflammasome-mediated IL-1β production by downregulating pro-IL-1β transcription 
and by interacting with NLRP3 (Cheong et al., 2015). More recently, the residues critical for 
NS1 protein’s RNA-binding and tripartite motif-containing protein 25 (TRIM25)-binding 
activities, R38/K41 and E96/E97, respectively, are found to be required for NS1 to inhibit the 
NLRP3 inflammasome activity (Moriyama et al., 2016). IAV M2 protein exerts an ion channel 
activity required for virion uncoating (Pinto et al., 1992). Perturbation of cellular ionic 
concentrations mediated by transmembrane region of this protein contributes to the NLRP3 
inflammasome-mediated IL-1β production (Ichinohe et al., 2010). PB1-F2 is a non-structural 
protein, which is a virulence factor (Zamarin et al., 2006); studies have been performed since the 
effects of PB1-F2 on IL-1β production from different animals were evaluated (Meunier and von 
Messling, 2012). By challenging mice with PB1-F2 peptides, the roles of PB1-F2 to activate the 
NLRP3 inflammasome and recruit leukocytes were identified; this function was mapped to the 
C-terminus of PB1-F2 from pathogenic strains including PR8 (McAuley et al., 2013). A further 
study by the same group showed that PB1-F2 from PR8 and avian H7N9 strains can cause 
NLRP3 inflammasome-mediated IL-1β production by inducing the mitochondrial ROS (Pinar et 
al., 2017). In contrast, PB1-F2 that targets the mitochondria functions to inhibit the NLRP3 
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inflammasome by blocking the recruitment of NLRP3 to the mitochondria (Yoshizumi et al., 
2014). 
 
1.3 Innate immune cells and sensors 
The innate immune system is the first line of host defense against pathogens and 
endogenous/exogenous danger signals. It is important for the effective clearance of pathogens 
and the healing process, and also for the onset of adaptive immunity. Inflammation is one of the 
first and the most critical responses in the innate immune system. Inflammation is intended to 
protect the host by eliminating the pathogens/danger signals and restoring the damaged tissues, 
however it has to be terminated timely to prevent prolonged inflammation as it can bring about 
both positive and negative consequences for the host health. Due to its double-edged sword-like 
roles, the tight control of inflammation is essential for the resolution of infection. Pathogens have 
genomes or structures that are distinguished from the normal host components. Their structural 
motifs or characteristic signatures of nucleic acids are called pathogen-associated molecular 
patterns (PAMPs). Sensing the PAMPs or uncommon physiological changes in and around the 
host cells by pattern recognition receptors (PRRs) triggers the innate immune signaling required 
for inflammation (Iwasaki and Pillai, 2014). Signals from activated PRRs are transduced to the 
adaptor molecules and transcription factors, so that the pro-inflammatory cytokines/chemokines, 
such as IFNs and ISGs are secreted and/or expressed. Subsequent events include a set of 
reactions to recruit other immune cells, eliminate the pathogens, process the infected or dead 
cells, and repair damaged tissues (Iwasaki and Pillai, 2014). Innate immune cells are specialized 
for these functions, although non-immune cells also express PRRs and mediate the immune 
signaling (Takeuchi and Akira, 2010). Successful innate immunity is accomplished through 
interplay between immune cells and non-immune cells. Some types of innate immune cells are 
responsible for antigen processing and presentation playing as a bridge between innate and 
adaptive immunity (Vyas et al., 2008). 
 
1.3.1 Innate immune cells 
Immune cells are leukocytes that are either from myeloid or lymphoid progenitors derived 
from multipotent hematopoietic stem cells in the bone marrow. Based on the shapes, leukocytes 
can be classified into two populations: mononuclear leukocytes and polymorphonuclear 
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granulocytes (neutrophils, eosinophils, basophils and mast cells) (Tizard, 2009d). Mononuclear 
leukocytes are further divided into two subpopulations: (phagocytic) monocytes and (non-
phagocytic) lymphocytes (Tizard, 2009d). Monocytes are further differentiated into macrophages 
or DCs. Among others, macrophages, DCs, neutrophils and mast cells are the representative 
members in the innate immune system by playing crucial roles such as phagocytosis, production 
of immune mediators and antigen presentation (Janeway and Medzhitov, 2002). These functions 
lead to the protection against pathogens and prevention of injury by danger signals. 
 
1.3.1.1 Macrophages 
Phagocytosis is an important event in innate immunity, which is played by phagocytic 
leukocytes such as macrophages, DCs and neutrophils. While some macrophages are derived 
from their progenitors in yolk sac or fetal liver, most of the macrophages responding to microbial 
infection are derived from stem cells in the bone marrow (Gordon and Plüddemann, 2017). 
Monocytes developed from these stem cells circulate in the blood. The maturation of monocytes 
into macrophages occurs as they enter into tissues, where differentiated macrophages are 
distributed to exert their roles (Tizard, 2009b). At the site of infection, neutrophils are the first to 
show up to engulf pathogens, which is then followed by the appearance of macrophages, which 
can phagocytose more effectively than neutrophils. Macrophages are specialized in phagocytosis 
and the clearance of pathogens or dead neutrophils, but their functions are not restricted to those. 
They are also responsible for the immune surveillance to trigger inflammation as well as anti-
inflammatory actions required for tissue repair and healing. These two-faceted functions are 
possible with the presence of two different populations of macrophages: M1 cells for pro-
inflammatory responses and M2 cells for anti-inflammatory roles (Tizard, 2009c).  
In the lungs, different types of macrophages including alveolar macrophages (AMs), 
interstitial macrophages and exudate macrophages reside (Nicol and Dutia, 2014). Among them, 
AMs are one of the first cells to respond to respiratory pathogens (Tumpey et al., 2005). These 
cells are located in the alveolar space formed by the epithelium consisting of type I and II 
pneumocytes, which are responsible for the maintenance of the space and the secretion of 
surfactant substances, respectively (Short et al., 2014). AMs are predominant immune cells in 
this space (Duan et al., 2017), and are also involved in homeostasis of the surfactant proteins 
(Halstead and Chroneos, 2015). Upon IAV infection, AMs produce pro-inflammatory cytokines 
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including IL-1β, IL-6 and TNF-α that mediate inflammation and recruit other immune cells; they 
produce type I IFNs that limit the spread of IAV. In addition, AMs are critical for activating the 
T cell response as well as antibody response upon IAV infection (He et al., 2017, Wijburg et al., 
1997); more pathogenicity is observed in different animals that are deficient in AMs (Cardani et 
al., 2017, Kim et al., 2013, Kim et al., 2008, Purnama et al., 2014, Schneider et al., 2014). IAV 
infection can deplete AMs by inducing their death, which may increase the susceptibility to 
secondary bacterial infection (Ghoneim et al., 2013), while AM depletion upon co-infection with 
IAV and bacteria can be prevented by IL-1 signaling (Bansal et al., 2018). Furthermore, infection 
of type I pneumocytes by IAV can be inhibited by AMs (Cardani et al., 2017). 
 
1.3.1.2 Dendritic cells (DCs) 
DCs are critical for linking the innate immunity to adaptive immunity by functioning in 
both antigen processing and antigen presentation. Two subpopulations of DCs exist: myeloid 
DCs that are derived from blood monocytes, and plasmacytoid DCs that are derived from 
lymphoid precursors (Tizard, 2009a). Myeloid DCs are distributed in tissues and are responsible 
for immune surveillance; plasmacytoid DCs are located in lymphoid organs, and are responsible 
for type I IFN production and T cell activation. After produced from bone marrow progenitors, 
DCs exist as immature cells (Tizard, 2009a). Immature DCs are activated upon recognition of 
antigens via their PRRs or in response to pro-inflammatory cytokines; this activation enhances 
their recruitment to the site of infection and promotes phagocytosis (Tizard, 2009a). Their 
maturation by encountering antigens also leads to the migration to lymph nodes in which they 
interact with T cells and B cells for antigen presentation (Clark et al., 2000). Importantly, mature 
DCs are the only type of antigen-presenting cells that can stimulate naïve T cells (Tizard, 2009a). 
Critical involvement of DCs on protection against IAV infection has been well demonstrated 
(Bhardwaj et al., 1994, Fonteneau et al., 2003).  
 
1.3.1.3 Neutrophils 
Neutrophils are a class of polymorphonuclear granulocytes that contain multilobular 
nuclei and granule-filled cytoplasm. They are derived from the same progenitor in bone marrow 
as macrophages and constitute the major population of leukocytes (Tizard, 2009d). From the 
bloodstream, they are recruited to the site of infection by chemotaxis, thereby becoming the first 
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cells that respond to infection. Due to the lifespan of only a few days and lack of ability to 
repeatedly ingest, neutrophils are frequently replaced with new cells. Phagocytic activity of 
neutrophils is enhanced by opsonization, a process by which pathogens are coated by opsonins. 
By producing reactive oxygen species (ROS) or releasing antimicrobial enzymes from granules, 
neutrophils can destroy the ingested pathogens (Tizard, 2009d). Additionally, the cells can 
release their own proteins and chromatin to form extracellular networks called neutrophil 
extracellular traps, which are designed to kill extracellular microbes without phagocytosis 
(Brinkmann et al., 2004). Although neutrophils express different TLRs along with RIG-I-like 
receptors (RLRs), the inflammasome-forming NLRs are not defined yet (Clarke et al., 2010, 
Hayashi et al., 2003, Tamassia et al., 2008). In addition to microbicidal functions, they 
participate in the immune regulation by secreting both pro-inflammatory and anti-inflammatory 
cytokines (Mantovani et al., 2011). Neutrophils can attract and interplay with T cells to promote 
adaptive immunity, and in turn, cytokines from activated T cells can support the functions of 
neutrophils (Pelletier et al., 2010a, Pelletier et al., 2010b). Upon IAV infection, a number of 
neutrophils are recruited to the airways where they play protective roles on the host. Together 
with AMs, neutrophils can alleviate the IAV-induced pathology and reduce mortality (Fujisawa, 
2008, Tate et al., 2008, Tumpey et al., 2005). Neutrophil-mediated IL-1β production from AMs 
upon IAV infection is also reported (Peiró et al., 2018). 
 
1.3.1.4 Mast cells 
Mast cells originate in the bone marrow and then migrate and mature in specific 
locations (Abraham and St John, 2010). Their distribution in connective tissue, the skin and 
respiratory/digestive mucosa allows them to encounter and respond to pathogens in the early 
phase of infection (St John and Abraham, 2013). The cytoplasm of mast cells is filled with 
granules from which regulatory molecules are released upon inflammation. Mast cells quickly 
initiate inflammation by secreting these molecules such as histamine and serotonin, and later, 
they also secrete cytokines and chemokines (Abraham and St John, 2010). Like other innate 
immune cells, mast cells induce inflammation upon sensing pathogens with a variety of PRRs or 
signals from other cells. Moreover, the cells harbor receptors for the Fc region of IgE molecules 
enabling mast cells to release their granule components upon recognition of antigen/allergen-
bound IgE antibodies (Tizard, 2009b). Due to this behavior, mast cells can not only cause allergy 
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and anaphylaxis, but also play protective roles against parasites (Abraham and St John, 2010). 
Mast cells are activated upon IAV infection through RIG-I signaling and their roles in lung 
pathology are reported (Graham et al., 2013, Hu et al., 2012, Josset et al., 2012). 
 
1.3.2 Innate immune sensors  
Innate immune sensors are receptors that recognize extracellular and intracellular PAMPs 
or DAMPs. There are three main classes based on the domain structures: nucleotide-binding 
oligomerization domain-like receptors (NLRs) are cytosolic sensors to detect a wide range of 
molecules and cellular stress; toll-like receptors (TLRs) are membrane-bound sensors detecting 
both PAMPs and DAMPs in either cell surface or endosomal compartments; retinoic acid-
inducible gene I-like receptors (RLRs) are cytosolic RNA sensors (Brubaker et al., 2015). 
 
1.3.2.1 Nucleotide-binding oligomerization domain-like receptors (NLRs)  
NLRs are primarily expressed in immune cells, while some NLR family proteins are 
expressed ubiquitously (Shaw et al., 2008). NLRs are a class of PRRs that contain three major 
domains: a variable N-terminal domain, a C-terminal leucine-rich repeat (LRR) domain and a 
central domain called NACHT, which was named after the five proteins that contain this domain 
(NAIP [neuronal apoptosis inhibitor protein], CIITA [MHC class II transactivator], HET‐ E 
[plant het gene product involved in vegetative incompatibility], and TP1 [telomerase-associated 
protein 1]) (Albrecht et al., 2003). The LRR domain can sense ligands or PAMPs; the N-terminal 
domain, which is either pyrin domain (PYD), caspase activation and recruitment domain 
(CARD) or baculovirus inhibitor of apoptosis protein repeat (BIR) domain, interacts with 
different adaptor proteins to mediate downstream signaling (Proell et al., 2008). The NACHT 
domain is responsible for self-oligomerization, which is further required for the signaling 
cascade through the N-terminal domain (Martinon and Tschopp, 2005). Based on the N-terminal 
domain structures, the NLRs are divided into four subfamilies: NLRs with PYD (NLRP, i.e. 
NLRP1 to NLRP14); NLRs with CARD (NLRC, i.e. NOD1, NOD2, NLRC3 to NLRC5); NLR 
with BIR (NLRB, i.e. NAIP); NLR with acidic transactivation domain (ATD) (NLRA, i.e. 
CIITA) (Figure 1.6). The diversity in the N-terminal domain can lead to different signaling 
events. The activators of NLR members and their modes of action are shown in Table 1.2. 
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Figure 1.6 Domain architecture of the NLR family proteins.  
NLRs are divided into four subfamilies (NLRP, NLRC, NLRB and NLRA) based on the N-
terminal domains. PYD, pyrin domain; CARD, caspase activation and recruitment domain; BIR, 
baculovirus inhibitor of apoptosis protein repeat; ATD, acidic transactivation domain; NACHT, 
for NAIP, CIITA, HET-E and TP1; LRR, leucine-rich repeat; FIIND, function to find domain. 
 
 
1.3.2.1.1 NLRs with pyrin domain (NLRP) 
Among NLRs with PYD, NLRP1 and NLRP3 have been most widely investigated. 
These two members function by forming the protein complex, inflammasome with ASC and pro-
caspase-1 to induce pro-inflammatory cytokines such as IL-1β and IL-18. NLRP1 is the first of 
its kind that is known to act through the assembly of the inflammasome. In LPS-stimulated 
human monocytes, the inflammasome consisting of NLRP1, ASC, caspase-1 and caspase-5 was 
discovered (Martinon et al., 2002). A structurally characteristic feature for NLRP1 is that it has 
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two more C-terminal domains, the ‘function to find’ domain (FIIND) and CARD besides the 
LRR domain. Interestingly, cleavage of the FIIND is needed for NLRP1 inflammasome 
activation (Finger et al., 2012, Frew et al., 2012). NLRP1-mediated caspase-1 activation upon 
anthrax toxin in mouse macrophages was reported (Boyden and Dietrich, 2006); a subsequent 
study showed the formation of NLRP1 inflammasome upon the toxin (Nour et al., 2009). Later, 
bacterial muramyl dipeptide was identified as a ligand for the NLRP1 inflammasome (Faustin et 
al., 2007). In response to both ligands, NLRP1 association with the nucleotide-binding 
oligomerization domain-containing protein (NOD) 2 is critical for IL-1β secretion (Hsu et al., 
2008). In addition to responding to microbial products, the NLRP1 inflammasome is also 
activated by cellular stress such as ATP depletion (Liao and Mogridge, 2013).  
Since initial discoveries have shown that mutations in the gene encoding NLRP3 are 
implicated in several auto-inflammatory diseases in humans (Hoffman et al., 2001), researchers 
have focused on the roles of NLRP3 in inflammation. Early studies displayed that NLRP3 alone 
can inhibit the NF-κB pathway (O'Connor et al., 2003), but by interacting with ASC, it is able to 
activate the pathway (Manji et al., 2002). Like NLRP1, NLRP3 forms the inflammasome with 
ASC and pro-caspase-1; in macrophages from an auto-inflammatory disorder patient with an 
NLRP3 mutation, more IL-1β secretion is observed (Agostini et al., 2004). With a growing 
number of studies illustrating the importance of ASC on caspase-1 activity (Mariathasan et al., 
2004, Srinivasula et al., 2002, Stehlik et al., 2003), more details on the activation of the NLRP3 
inflammasome started to be unveiled. Later, the specific roles of NLRP3 and ASC on NLRP3 
inflammasome-mediated IL-1β production in response to bacterial RNA (Kanneganti et al., 
2006b), or upon stimulation with TLR agonists followed by bacterial infection or toxin treatment 
(Mariathasan et al., 2006, Sutterwala et al., 2006) were demonstrated. Further, malarial 
hemozoin and fungal products were added to the list of agonists that can activate the NLRP3 
inflammasome (Lamkanfi et al., 2009, Shio et al., 2009). Importantly, dependency of caspase-1 
activity on the expression of NLRP3 and ASC upon infection with RNA viruses including IAV 
is reported (Kanneganti et al., 2006a). This is supported by in vivo studies showing that 
protective roles are exerted by the NLRP3 inflammasome against IAV-induced pathology (Allen 
et al., 2009, Thomas et al., 2009). Another study indicates that T cell responses upon IAV 
infection are mediated by ASC and caspase-1, while NLRP3 is not critical for the protection 
against IAV infection (Ichinohe et al., 2009). NLRP3 inflammasome activation by viral DNA is 
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demonstrated using adenovirus; this complex is activated by mammalian genomic DNA or 
bacterial DNA as well (Muruve et al., 2008). Afterwards, a variety of different pathogens have 
been reported to activate the NLRP3 inflammasome (Ito et al., 2012, Lawrence et al., 2013, 
Rajan et al., 2011, Segovia et al., 2012, Wang et al., 2018, Wang et al., 2017). Stimuli of NLRP3 
are not restricted to microbial products, since various danger-associated particulates (Cassel et 
al., 2008, Dostert et al., 2008, Eisenbarth et al., 2008, Hornung et al., 2008) or even endogenous 
danger molecules can induce the NLRP3 inflammasome activation (Duewell et al., 2010, 
Martinon et al., 2006, Yamasaki et al., 2009). Because the aforementioned NLRP3 
inflammasome activators are not chemically related, studies have focused on the upstream 
mechanism of NLRP3 inflammasome activation. For example, the production of ROS, lysosomal 
damage, ER stress, and ion fluxes have been described to play roles on the activation of the 
NLRP3 inflammasome (Duewell et al., 2010, Hornung et al., 2008, Menu et al., 2012, Murakami 
et al., 2012, Pétrilli et al., 2007).  
NLRP2 inhibits NF-B by interacting with the inhibitor of κB kinase (IKK), but can 
induce IL-1β by interacting with ASC (Bruey et al., 2004). NLRP2 is known to form an 
inflammasome to regulate IL-1β production in astrocytes (Minkiewicz et al., 2013). NLRP6, in 
association with ASC, activates the NF-B pathway and contributes to caspase-1-mediated IL-1β 
production (Grenier et al., 2002). In contrast, another study indicates that NLRP6 is not involved 
in IL-1β production, and rather inhibits the NF-κB activation; NLRP6 deficiency can confer 
resistance against bacterial infection in mice (Anand et al., 2012). A finding that NLRP6 binds 
viral RNA to activate the IFN signaling in response to enteric viruses in the intestines suggests 
its role as a viral RNA sensor (Wang et al., 2015c). NLRP7 either negatively regulates caspase-
1-mediated IL-1β production (Kinoshita et al., 2005), or inhibits the pro-IL-1β synthesis 
(Messaed et al., 2011). NLRP7 senses intracellular bacteria, and NLRP7 inflammasome-
mediated IL-1β production in response to microbial lipopeptides can limit bacterial replication 
(Khare et al., 2012). NLRP10, the only NLR member without the LRR domain, inhibits the NF-
κB pathway and IL-1β production by associating with ASC and caspase-1 (Wang et al., 2004). 
According to a mouse study, NLRP10 is critical for antigen presentation by DCs rather than 
modulation of inflammasome activity (Eisenbarth et al., 2012). Contribution of NLRP10 to the 
adaptive immunity is also shown by an investigation on NLRP10-mediated helper T cell 
responses against fungal infection (Joly et al., 2012), while this was not the case for parasite 
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infection, because inflammation and adaptive immunity were upregulated by NLRP10 deficiency 
(Clay et al., 2017). Upon bacterial infection, inflammatory cytokine production was positively 
regulated by NLRP10 and this was regardless of inflammasome activity (Lautz et al., 2012). 
NLRP12 is defined as a negative regulator of inflammatory cytokines upon bacterial infection 
(Silveira et al., 2017, Zaki et al., 2014). A contradicting report shows that NLRP12 
inflammasome-mediated IL-18 production recruits IFN-γ, thereby conferring protection against 
Yersinia pestis infection (Vladimer et al., 2012). NLRP12 is also responsible for enhanced 
neutrophil infiltration and contributes to the pathogenesis in IAV-infected mice (Hornick et al., 
2018). 
Interestingly, implications of NLRP proteins in the downregulation of the IFN 
signaling have been reported. NLRP4 recruits an E3 ligase responsible for the degradation of 
TANK (which refers to ‘TNF receptor-associated factor family member-associated NF-κB 
activator’)-binding kinase 1 (TBK1), thereby suppressing type I IFN induction in response to 
dsRNA (Cui et al., 2012). A subsequent study indicates that NLRP4 forms a signaling complex 
with multiple ubiquitin-modifying enzymes to inhibit the TBK1-mediated IFN induction (Lin et 
al., 2016). NLRP11 translocates to the mitochondria and inhibits MAVS-mediated IFN signaling 
upon RNA virus infection (Qin et al., 2017); it also limits TLR signaling by degrading TRAF6 
(Wu et al., 2017). 
 
1.3.2.1.2 NLRs with caspase activation and recruitment domain (NLRC) 
NOD1 is ubiquitously expressed, while NOD2 is primarily expressed in immune 
cells (Inohara et al., 2005). NOD1 and NOD2 sense bacterial peptidoglycan after degradation of 
bacterial cell walls (Caruso et al., 2014). This sensing is followed by self-oligomerization of 
NODs, and the recruitment of receptor-interacting serine/threonine-protein kinase 2 (RIPK2) 
mediated by the CARD-CARD interaction between RIPK2 and NODs (Caruso et al., 2014). 
RIPK2 further activates the NF-κB signaling or mitogen-activated protein kinase (MAPK) 
signaling that results in the expression of pro-inflammatory cytokines (Caruso et al., 2014). In 
addition to bacterial components, NODs can also recognize viral RNAs. Upon sensing ssRNA of 
RNA viruses, NOD2 associates with MAVS, thereby activating the IRF3-mediated type I IFN 
production (Sabbah et al., 2009), while NOD1 activation upon viral dsRNA detection induces the 
innate immune responses independent of MAVS (Vegna et al., 2016). The importance of NOD2 
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in the control of CD8
+
 T cell or regulatory T cell response upon IAV infection is also revealed 
(Egarnes and Gosselin, 2018, Lupfer et al., 2014).  
NLRC3 was initially known to inhibit T cell functions (Conti et al., 2005). 
Degradation of TRAF6 by NLRC3 can induce the downregulation of NF-κB pathway and the 
suppression of pro-inflammatory cytokines (Schneider et al., 2012). NLRC3 also interferes with 
the type I IFN signaling mediated by the stimulator of interferon genes (STING) in response to 
cytosolic DNA or a DNA virus, herpes simplex virus 1 (Zhang et al., 2014b). Further, its 
function to inhibit NLRP3 inflammasome through the interaction with ASC and pro-caspase-1 is 
also demonstrated (Eren et al., 2017, Gültekin et al., 2015). NLRC5 is a transcriptional activator 
of MHC I genes (Meissner et al., 2010) and is important for viral clearance (Lupfer et al., 2017). 
However, its function as a regulator of antiviral and inflammatory response is under debate. 
Some studies have shown NLRC5 to negatively regulate the RIG-I-mediated type I IFN and 
inflammatory cytokines (Benko et al., 2010, Cui et al., 2010). In contrast, other studies have 
shown NLRC5 to enhance antiviral gene expression (Kuenzel et al., 2010), as well as its 
interaction with RIG-I to promote the IFN response against IAV infection (Ranjan et al., 2015). 
Interestingly, it is also known to be required for NLRP3 inflammasome activation upon bacterial 
infection (Davis et al., 2011), showing that its signaling pathway may overlap with other NLRs. 
NLRC4 functions by forming an inflammasome; its conformation is changed by NAIP that binds 
to bacterial proteins, and as a result, the NAIP/NLRC4 inflammasome can be activated (Yang et 
al., 2013, Zhao et al., 2011). As in the case of NLRC5, interplay and association between 
NLRC4 and NLRP3 upon bacterial infection have also been determined (Man et al., 2014, Qu et 
al., 2016). Enteric bacteria-induced NLRC4 inflammasome activation can provide protection 
from rotavirus infection in the intestines (Zhang et al., 2014a), however there is no direct 
evidence that the NAIP/NLRC4 inflammasome is critical for the inflammation upon viral 
infection. Several studies demonstrate that NLRC4 is not involved in inflammatory response 
during IAV infection (Allen et al., 2009, Ichinohe et al., 2009).  
 
1.3.2.1.3 NLR with baculovirus inhibitor of apoptosis protein repeat (NLRB) 
NAIP senses bacterial ligands and assembles with NLRC4, which recruits ASC and 
pro-caspase-1 to form the NAIP/NLRC4 inflammasome. A mouse study suggested that there are 
variants for NAIP, which determine the specificity to different kinds of bacterial ligands for the 
 36 
inflammasome activation (Kofoed and Vance, 2011). In contrast, a single NAIP in humans is 
responsible for inflammasome activation by recognizing different bacterial ligands (Reyes Ruiz 
et al., 2017). Recently, it is reported that NLRC4 inflammasome-mediated protection against 
bacterial pathogens requires IRF8 that regulates the transcription of NAIP (Karki et al., 2018). 
 
1.3.2.1.4 NLR with acidic transactivation domain (NLRA) 
CIITA is the only member of NLRA. It has a similar structure to NLRC5 and 
activates the MHC I and II genes (Martin et al., 1997, Steimle et al., 1993). Further, its roles on 
the negative regulation of cytokines such as IL-4 and IL-10 are described (Gourley et al., 1999, 
Yee et al., 2005). While its function as an innate sensor is not defined, CIITA is known to inhibit 
virus-induced NF-κB activation (Forlani et al., 2016). 
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Table 1.2 NLR members with their activators and modes of action.  
The nomenclature of NLR subfamilies and members is based on human proteins. 
Subfamily Member Activator Mode of action 
NLRP 
NLRP1 LPS, toxin, muramyl dipeptide Inflammasome formation 
NLRP2 Unknown 
Inflammasome formation, 
negative regulation of NF-B 
NLRP3 
Bacterial/fungal products, toxin, 
viral/bacterial nucleic acid, 
particulate matters, ATP, ROS, 
lysosomal damage, ER stress, ion 
fluxes 
Inflammasome formation 
NLRP4 Unknown 
Negative regulation of IFN 
signaling 
NLRP6 Viral RNA 
Inflammasome formation, 
negative regulation of NF-B 
NLRP7 Bacterial lipopeptide Inflammasome formation 
NLRP10 Unknown 
Regulation of antigen 
presentation by DCs 
NLRP12 Yersinia pestis 
Inflammasome formation, 
negative regulation of NF-B 
NLRC 
NOD1 
Bacterial peptidoglycan, viral 
dsRNA 
Positive regulation of NF-B 
and MAPK 
NOD2 Muramyl dipeptide, viral ssRNA 
Positive regulation of NF-B 
and MAPK 
NLRC3 Cytosolic DNA 
Negative regulation of NF-B 
and IFN signaling 
NLRC4 Bacterial proteins 
Inflammasome formation with 
NAIP 
NLRC5 Unknown 
Positive or negative regulation 
of IFN signaling 
NLRB NAIP Bacterial proteins 
Inflammasome formation with 
NLRC4 
NLRA CIITA Unknown 
Activation of MHC I and II 
genes, negative regulation of 
NF-B 
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1.3.2.2 Toll-like receptors (TLRs) 
TLRs are membrane-associated molecules that sense PAMPs and DAMPs; they are 
expressed in a broad range of both immune cells and non-immune cells (Leifer and Medvedev, 
2016). Three main domains that comprise the TLRs are 1) LRR which is a ligand-binding 
ectodomain; 2) transmembrane domain; 3) cytoplasmic Toll-interleukin-1 receptor (TIR) domain 
that mediates downstream signaling (Satoh and Akira, 2016). Among others, TLR3 and TLR7/8 
are the main sensors for viral dsRNA and ssRNA, respectively; they function in early endosomes 
and their signaling induces both pro-inflammatory cytokines and IFNs. TLR3 is expressed in 
most innate immune cells with the exception of plasmacytoid DCs and neutrophils (Chow et al., 
2018). Upon recognition of viral dsRNA or intermediate RNAs, TLR3 recruits its adaptor 
protein, TRIF (Oshiumi et al., 2003). Binding of TRIF to TRAF3 leads to the activation of 
transforming growth factor beta-activated kinase 1 (TAK1). Additionally, TRIF associates with 
TBK1 and IKKε (Sato et al., 2003), which activate the transcription factors, IRF3/7 and NF-κB, 
respectively. TLR7 is expressed in monocytes, macrophages, plasmacytoid DCs and B cells; and 
TLR8 is expressed in monocytes, macrophages and myeloid DCs (Chow et al., 2018). Their 
ligand specificity is slightly different; for example, TLR7 has specificity for GU-rich ssRNA, 
while TLR8 is specific for AU-rich ssRNA (Vabret et al., 2017). TLR7 and TLR8 are similar in 
their mode of signaling transduction. Unlike TLR3, activation of TLR7/8 recruits its adaptor 
protein, myeloid differentiation primary response protein 88 (MyD88). MyD88 associates with 
TRAF6 that ubiquitinates the NF-κB essential modulator (NEMO) (Chen et al., 2006). 
Ubiquitinated NEMO recruits IKKα and IKKβ that phosphorylate the inhibitor of κB (IκB). 
Then, NF-κB translocates to the nucleus for induction of cytokines and IFNs. In addition, 
MyD88 binds IRF7 to form a complex with TRAF6, TRAF3 and IKKα. Phosphorylated IRF7 
dissociates from this complex and translocates to the nucleus for the IFN induction (Kawai et al., 
2004). 
 
1.3.2.3 Retinoic acid-inducible gene I-like receptors (RLRs) 
RLRs are cytosolic RNA sensors and are expressed in most cell types. RLRs consist of 
a DExD/H-box helicase domain and C-terminal repressor domain; among them, RIG-I and 
MDA5 have two tandem CARDs at the N-terminus, additionally (Chow et al., 2018). Expression 
of RLRs is generally maintained at a low level, but it is upregulated upon viral infection or IFN 
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stimulation (Chow et al., 2018). RIG-I senses viral 5’-triphosphate dsRNA generated by different 
RNA viruses, while long dsRNA is preferably recognized by MDA5, whose critical role in 
detecting picornaviruses is revealed (Chiang et al., 2014, Feng et al., 2012). Upon ligand sensing, 
RIG-I undergoes a conformational change by exposing its N-terminal CARDs (Takahasi et al., 
2008). This domain is activated through lysine 63-linked poly-ubiquitination by E3 ligases, 
TRIM25 or Riplet (Gack et al., 2008, Gack et al., 2007, Oshiumi et al., 2010). Activated RIG-I 
interacts with its adaptor protein, MAVS, which further undergoes self-polymerization to form 
aggregates (Hou et al., 2011). MAVS recruits E3 ligases such as TRAF2, -5 or -6 to activate 
cytosolic kinases, TBK1 or IKKε (Liu et al., 2013a). As a result, IRF3, IRF7 and NF-κB 
pathways are activated for the production of IFNs, ISGs and pro-inflammatory cytokines 
(Beachboard and Horner, 2016, Chatterjee et al., 2016). Independent of the MAVS-mediated 
signaling cascade, RIG-I can interact with ASC to form an inflammasome without NLRs, 
thereby leading to production of IL-1β and IL-18 (Poeck et al., 2010, Pothlichet et al., 2013).  
 
1.3.2.4 Other sensors 
PKR is an RNA-dependent kinase in the cytoplasm. It is involved in the activation of 
the NF-κB pathway (Kumar et al., 1994) as well as the stabilization of the IFN mRNAs (Schulz 
et al., 2010). In IAV-infected cells, its activation upon recognition of viral dsRNA leads to the 
phosphorylation of eIF2α, which suppresses viral protein translation and prevents viral 
replication (Li et al., 2006). Recent evidence has shown the roles of Z-DNA binding protein 1 
(ZBP1), which has been known to sense cytosolic DNA (Takaoka et al., 2007), as an RNA 
sensor. ZBP1 recognition of genomic RNA of IAV or newly synthesized viral RNA of DNA 
virus is required for necroptosis and restriction of viral replication (Maelfait et al., 2017, Thapa 
et al., 2016). Sensing IAV proteins by ZBP1 leads to the RIPK1-RIPK3 mediated NLRP3 
inflammasome activation and cell deaths (Kuriakose et al., 2016). STING is known to regulate 
type I IFN induction in response to RNA viruses with different mechanisms. After sensing viral 
RNA, RIG-I interacts with MAVS and STING, thereby activating the STING pathway. Another 
scenario is that cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) 
synthase (cGAS) senses viral RNA with an elusive mechanism, and produces cyclic GMP-AMP 
as the second messenger molecule, which binds and activates STING (Maringer and Fernandez-
Sesma, 2014). The activated STING is phosphorylated and ubiquitinated. Then, STING 
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dimerizes and interacts with TBK1 to phosphorylate IRF3, which leads to type I IFN induction 
(Maringer and Fernandez-Sesma, 2014). Upon IAV infection, viral membrane fusion induces the 
STING-mediated IFN response, independently of cGAS, whereas the HA fusion peptide 
counteracts this action by inhibiting STING dimerization (Holm et al., 2016). 
 
1.4 Mitochondria and innate immune responses 
1.4.1 Mitochondrial control of the innate immunity 
Mitochondria have a variety of functions essential for cell survival, homeostasis and host 
immune responses. Emerging evidence emphasizes the roles mitochondria play as the key 
platform for innate immune regulation. MAVS, a protein that is inserted on the outer 
mitochondrial membrane, is one of the best-known signaling molecules in mitochondria. As an 
adaptor protein of RLRs, MAVS activates the transcription factors NF-κB and IRFs to induce 
pro-inflammatory cytokines and IFNs (Kawai et al., 2005, Seth et al., 2005). MAVS can also 
localize to peroxisomes, and IRF1-mediated IFN-λ is induced when peroxisomal MAVS is 
activated (Odendall et al., 2014). Mitochondrial ROS and DNA are considered to be DAMPs that 
trigger innate immunity. ROS released from mitochondria has been shown to activate 
transcription factors like AP-1 and NF-κB (Sena and Chandel, 2012). Further, mitochondrial 
ROS can induce MAPK-mediated pro-inflammatory cytokines such as IL-6 and TNF (Bulua et 
al., 2011). Mitochondrial DNA triggers TLR9-mediated MAPK signaling for cytokine 
production (Caielli et al., 2016, Zhang et al., 2010); it can also be sensed by cGAS, which 
activates STING for type I IFN response (Rongvaux et al., 2014, West et al., 2015). 
 
1.4.2 Mitochondrial dynamics modulated by viruses 
Mitochondria undergo continuous changes in its dynamics represented by fission, fusion 
and mitophagy. Dynamin-related protein 1 (DRP1) plays a vital role in fission and fusion events. 
For fission, DRP1 is phosphorylated at serine 616 (S616) by different kinases including receptor-
interacting protein kinase 1 (RIPK1), cyclin-dependent kinase 1 (CDK1), and MAPK1 (Kashatus 
et al., 2015, Taguchi et al., 2007, Wang et al., 2014c), or dephosphorylated at serine 637 (S637) 
by the phosphatase, calcineurin (Cereghetti et al., 2008). After DRP1 is recruited to the 
mitothondrial fission factor, oligomerized DRP1 surrounds and constricts the mitochondrial 
membranes (Kim et al., 2018). Since fission occurs to process unhealthy mitochondria, 
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fragmented mitochondria can be subject to mitophagy. In contrast, dephosphorylation at S616 or 
phosphorylation at S637 on DRP1 leads to fusion. Mitochondrial proteins Mfn1/2 and optic 
atrophy 1 are involved in the fusion of outer and inner mitochondrial membranes, respectively 
(Kim et al., 2018). 
Viruses can alter the mitochondrial dynamics to regulate the host innate immune responses 
or the host cell death. Some RNA viruses are reported to induce DRP1-mediated mitochondrial 
fission to regulate cell deaths. Classical swine fever virus, porcine reproductive and respiratory 
syndrome virus (PRRSV) and hepatitis C virus (HCV) cause mitochondrial fission to inhibit 
apoptosis (Gou et al., 2017, Kim et al., 2014, Li et al., 2016c), whereas rotavirus-induced 
mitochondrial fission stimulates apoptosis (Mukherjee et al., 2018). Downregulation of IFN 
signaling can be the result of either suppressed or activated mitochondrial fusion upon dengue 
virus (DENV) infection. DENV proteases cleave Mfn1 to suppress mitochondrial fusion and this 
leads to the attenuated IFN induction (Yu et al., 2015). In contrast, DENV enhances 
mitochondrial fusion by disrupting DRP1-mediated mitochondrial fission, which supports viral 
replication or attenuates the RIG-I-mediated antiviral response (Barbier et al., 2017, Chatel-
Chaix et al., 2016). As to DRP1 phosphorylation upon viral infection, RIPK1 phosphorylates 
DRP1 leading to mitochondrial fission in response to VSV infection (Wang et al., 2014c), while 
CDK1 is required for DRP1 phosphorylation upon rotavirus infection (Mukherjee et al., 2018). 
RIPK1 forms a complex with RIPK3 to induce necroptosis and inflammation (Cho et al., 2009), 
and this complex also plays roles in the host defense and pathogenesis against viral infection 
(Daniels et al., 2017, Downey et al., 2017, Kuriakose et al., 2016). An initial study on DRP1-
mediated NLRP3 inflammasome activation upon viral infection revealed that in response to 
RNA viruses such as VSV, the RIPK1/RIPK3 signaling can induce necroptosis, while it can also 
promote the NLRP3 inflammasome-mediated IL-1β production by inducing DRP1-involved 
mitochondrial damage (Wang et al., 2014c). Regardless of DRP1, a mitochondrial phosphatase, 
phosphoglycerate mutase family member 5, which mediates mitochondrial fission, can induce 
the NLRP3 inflammasome activation upon VSV infection (Moriwaki et al., 2016). Upon IAV 
infection, PB1-F2 protein, which translocates to mitochondria, can cause mitochondrial fission 
that is correlated with the defective NLRP3 inflammasome activation (Yoshizumi et al., 2014). 
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1.5 Innate immune evasion 
1.5.1 Immune evasion strategies by RNA viruses 
Viruses have evolved ways to counteract the host defense at multiple levels. Their 
countermeasures can target innate immune sensing and signaling pathways, control the 
production of antiviral or inflammatory molecules, suppress the MHC gene expression, interfere 
with cytotoxic T cell and B cell responses and modulate apoptosis of infected cells (Alcami and 
Koszinowski, 2000, Smith, 1994, Tortorella et al., 2000). Among a variety of strategies, how 
RNA viruses evade the host innate immunity represented by type I IFN production and pro-
inflammatory responses is reviewed as following examples: 
i) Viruses can sequester viral RNA to escape from host responses. DENV has a strategy to 
hide its dsRNA in the intracellular membrane to avoid IFN induction (Uchida et al., 2014). An 
Ebola virus protein binds viral dsRNA to prevent it from being recognized by RIG-I (Cárdenas et 
al., 2006).  
ii) Viral proteins can directly interact with the host PRRs/adaptor proteins. Respiratory 
syncytial virus (RSV) non-structural proteins interact either with RIG-I to inhibit IFN 
transcription or with MAVS to dissociate the RIG-I-MAVS interaction (Boyapalle et al., 2012, 
Ling et al., 2009). Enterovirus 71 protease 3C associates with RIG-I and inhibits the recruitment 
of MAVS (Lei et al., 2010), while foot-and-mouth disease virus 3A protein interacts with RIG-I 
and MAVS to inhibit IFN-β signaling (Li et al., 2016b).  
iii) Viruses degrade or cleave host PRRs/adaptor proteins. This mechanism is well-
established in picornaviruses that express viral proteases. Encephalomyocarditis virus induces 
the degradation of RIG-I (Papon et al., 2009), while hepatitis A virus proteases cleave MAVS 
and NEMO to inhibit IFN induction (Wang et al., 2014a, Yang et al., 2007). Cleavage of TRIF 
by proteases of hepatitis A virus, coxsackievirus B3 and enterovirus 68 is known to suppress IFN 
induction (Mukherjee et al., 2011, Qu et al., 2011, Xiang et al., 2014). For other viruses rather 
than picornaviruses, rotavirus and classical swine fever virus proteins induce the proteasomal 
degradation of IRF3 (Barro and Patton, 2005, Bauhofer et al., 2007). 
iv) Viruses inhibit the downstream signaling proteins of PRRs. NS3/4A protease of HCV 
inhibits the phosphorylation of IRF3 and IRF3-mediated promoter activation (Foy et al., 2003). 
Non-structural proteins of PRRSV inhibit the phosphorylation and nuclear translocation of IRF3 
(Beura et al., 2010, Li et al., 2010), which is also demonstrated by non-structural proteins of 
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DENV and West Nile virus (WNV) (Angleró-Rodríguez et al., 2014, Dalrymple et al., 2015). 
HCV NS3 protein interacts with TBK1, thereby inhibiting the association between TBK1 and 
IRF3 (Otsuka et al., 2005).  
v) Viruses can suppress ubiquitination-mediated antiviral responses. Ubiquitination is 
involved in the activation of the host IFN induction pathway, and cysteine proteases from viruses 
can function as deubiquitinases to suppress the ubiquitination-dependent IFN induction (Liu et 
al., 2013b). The cysteine protease domain in NSP2 of PRRSV inhibits the ubiquitination of IκBα 
and prevents IκBα degradation and subsequently, IFN induction (Sun et al., 2010). Also, 
hepatitis E virus ORF1 has a cysteine protease domain that functions as a deubiquitinase for 
RIG-I and TBK1, whose ubiquitination is critical for IFN induction (Nan et al., 2014).  
vi) Viruses inhibit the IFN-induced JAK/STAT pathway. Non-structural proteins of RSV 
mediate the inhibition of STAT2 expression and type I IFN responsiveness (Lo et al., 2005). 
Chikungunya virus NSP2 inhibits the IFN-stimulated Janus kinases (JAK)/signal transducer and 
activator of transcription (STAT) signaling by blocking STAT1 phosphorylation and nuclear 
translocation (Fros et al., 2010). In addition, NSP5 of porcine deltacoronavirus cleaves STAT2 to 
impair IFN signaling (Zhu et al., 2017). Multiple non-structural proteins of flaviviruses prevent 
the activation of STAT1 and/or STAT2. NS5 proteins of both DENV and WNV inhibit the 
accumulation of phosphorylated STAT1 (Laurent-Rolle et al., 2010, Mazzon et al., 2009); 
NS2A, NS4A and NS4B proteins of DENV inhibit STAT1 phosphorylation, while NS4B of 
WNV blocks the auto-phosphorylation and activation of JAK1 (Gack and Diamond, 2016); Zika 
virus NS5 causes the proteasomal degradation of STAT2 (Grant et al., 2016, Kumar et al., 2016).  
vii) Viruses can interfere with the cGAS/STING pathway. DENV protease complex 
cleaves STING to inhibit type I IFN induction (Aguirre et al., 2012). Coronavirus papain-like 
proteases suppress the dimerization of STING and assembly of the STING-MAVS-TBK1/IKKε 
complex (Sun et al., 2012). The same protein disrupts the STING-TRAF3-TBK1 interaction and 
inhibits the ubiquitination of the STING-TRAF3-TBK1 complex (Chen et al., 2014).  
viii) Viruses inhibit NF-κB activity and/or secretion of pro-inflammatory cytokines. NF-κB 
activation is blocked by HCV NS5B (Choi et al., 2006) or enterovirus 68 3C protease (Xiang et 
al., 2014). Multiple proteins of porcine epidemic diarrhea virus can suppress NF-κB-mediated 
pro-inflammatory cytokines (Zhang et al., 2017b). Poliovirus 3A protein inhibits the secretion of 
IL-6 and IL-8 (Dodd et al., 2001), and Rift Valley Fever virus NSs are responsible for blocking 
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the production of pro-inflammatory cytokines including TNF- (McElroy and Nichol, 2012).  
ix) Viruses inhibit NLRP3 inflammasome-mediated IL-1β production. Viral proteases of 
enterovirus 71 suppress NLRP3 inflammasome activity by cleaving NLRP3 (Wang et al., 
2015b). V proteins of paramyxoviruses (measles virus, Sendai virus, Nipah virus and human 
parainfluenza virus type 2) interact with NLRP3, thereby inhibiting the NLRP3 inflammasome-
mediated IL-1β production (Komatsu et al., 2018, Komune et al., 2011). C protein of another 
paramyxovirus, human parainfluenza virus type 3 also interacts with NLRP3 to downregulate the 
NLRP3 inflammasome (Shil et al., 2018). 
 
1.5.2 Immune evasion by non-structural proteins of IAV 
1.5.2.1 NS1 protein 
1.5.2.1.1 NS1 antagonizing the host immune signaling 
NS1 blocks the nuclear accumulation of IRF3 (Talon et al., 2000); this is performed 
at the pre-transcriptional level and the residues (arginine 38 and lysine 41) critical for NS1’s 
RNA-binding activity are required for this inhibition (Talon et al., 2000). The dsRNA-binding 
activity of NS1 also suppresses NF-κB-mediated IFN induction (Wang et al., 2000). A cytosolic 
antiviral protein, OAS that detects viral dsRNA is also targeted by NS1. Activated OAS 
produces 2’-5’-oligoadenylate that binds and activates RNase L, which can cleave viral RNA 
(Silverman, 2007); the degraded products activate RIG-I and induce IFNs. Through the dsRNA-
binding activity, NS1 sequesters viral RNA from OAS, thereby suppressing the RNase L-
mediated restriction of IAV replication (Min and Krug, 2006). 
NS1 can also counteract the antiviral responses played by PKR, a dsRNA-dependent 
antiviral protein (Bergmann et al., 2000). PKR activation by dsRNA leads to the phosphorylation 
of its target proteins (Hale et al., 2008). Importantly, phosphorylation of eIF2α leads to the 
inhibition of protein synthesis in infected cells (Hatada et al., 1999). In IAV-infected cells, 
binding of NS1 to PKR diminishes the PKR activation (Min et al., 2007). 
While viral 5’-triphosphate dsRNA is sensed by RIG-I that is important for IFN 
signaling pathway, NS1 mediates the pre-transcriptional block of IFN-β induction by interacting 
with RIG-I (Guo et al., 2007, Pichlmair et al., 2006). After binding to viral RNA, RIG-I 
undergoes a conformational change by exposing its N-terminal CARDs, which are subject to 
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ubiquitination by E3 ligases, TRIM25 or Riplet; this action is required for IRF3 activation and 
IFN induction (Ayllon and García-Sastre, 2014). Binding of NS1 to TRIM25 blocks the 
formation of oligomerized RIG-I and represses the TRIM25-mediated ubiquitination on the 
CARD of RIG-I (Gack et al., 2009, Mibayashi et al., 2007). Interaction of NS1 with another E3 
ligase, Riplet blocks its activation on RIG-I as well (Rajsbaum et al., 2012).  
Phosphorylation and nuclear translocation of STAT proteins, which are required for 
the IFN response, are also blocked by NS1 (Jia et al., 2010). In addition, IFN-induced 
transmembrane protein 3 (IFITM3) can block the IAV entry and replication; its expression is 
regulated by the eukaryotic translation initiation factor 4B (eIF4B). NS1 induces the degradation 
of eIF4B to limit the action of IFITM3 (Wang et al., 2014b).  
NS1 participates in the regulation of pro-inflammatory cytokines, with IL-1β that is 
known to be beneficial for the host (Allen et al., 2009, Schmitz et al., 2005) being one of them. 
NS1 inhibits NLRP3 inflammasome-mediated IL-1β production by interacting with NLRP3 
(Cheong et al., 2015, Moriyama et al., 2016). 
 
1.5.2.1.2 NS1 regulating the host cell death 
Apoptosis is one of antiviral strategies used by the host to suppress viral replication, 
although some pro-apoptotic factors have roles to promote viral propagation (Hale et al., 2008). 
The suppression of apoptosis during early infection can promote viral replication, while 
apoptosis during late infection can support the release of progeny viruses, hence the regulation of 
both pro- and anti-apoptotic mechanisms can be critical for viruses (Hale et al., 2008). NS1 has 
both pro- and anti-apoptotic roles (Ehrhardt et al., 2006, Lam et al., 2008, Shin et al., 2007a, 
Zhirnov et al., 2002) and NS1 is thought to contribute to the suppression and induction of 
apoptosis during the early and late phases of infection, respectively (Hale et al., 2008). PKR 
plays a role in apoptosis during IAV infection, with the inhibition of PKR by NS1 possibly 
leading to the establishment of an anti-apoptotic status (Takizawa et al., 1996). 
Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) produces the messenger molecule, 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3); PIP3 binding by a serine/threonine protein 
kinase, Akt is involved in the maintenance of anti-apoptotic status (Hale et al., 2008). During the 
early phase of infection with IAV, PI3K activation is turned on by the NS1 interaction with the 
p85β subunit of PI3K, leading to the restriction of apoptosis (Ehrhardt et al., 2006, Li et al., 
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2008, Shin et al., 2007c), suggesting that IAV-induced early apoptosis is inhibited by NS1. 
 
1.5.2.2 PB1-F2 and PA-X 
While IAV polymerase proteins, PB2, PB1 and PA can downregulate host innate 
immunity (Graef et al., 2010, Iwai et al., 2010, Yi et al., 2017), non-structural proteins derived 
from IAV polymerase segments can also exert inhibitory functions. PB1-F2 is encoded by +1 
open reading frame (ORF) in the PB1 segment and its presence is strain-dependent (Chen et al., 
2001). In addition to being pro-apoptotic, it has multiple functions such as the contribution to 
virulence, and the regulation of inflammatory or antiviral activities (Klemm et al., 2018). To 
antagonize the IFN signaling, PB1-F2 interacts with MAVS or inhibits the RIG-I-MAVS 
complex formation (Dudek et al., 2011, Varga et al., 2012). Dissipated mitochondrial membrane 
potential by mitochondrial localization of PB1-F2 not only blocks the RIG-I signaling, but also 
interferes with NLRP3 inflammasome activation (Yoshizumi et al., 2014). PB1-F2, in a strain-
dependent way, also modulates the production of pro-inflammatory cytokines (Lee et al., 2017a, 
Pena et al., 2012). PA-X is expressed from the PA segment as a result of ribosomal frameshifting 
(Jagger et al., 2012). With its N-terminal endonuclease domain shared with PA, it exerts host 
shutoff effects by degrading host mRNAs (Desmet et al., 2013, Khaperskyy et al., 2016). PA-X 
inhibits the host IFN or pro-inflammatory responses, but promotes viral growth or increases 
virulence (Hayashi et al., 2015, Lee et al., 2017b, Xu et al., 2017). On the contrary, PA-X can 
repress both host immune responses and viral replication, which lead to decreased pathogenicity 
(Gao et al., 2015, Hu et al., 2015). 
 
1.6 Conclusions of the literature review 
Innate immune responses are critical in determining the consequences of disease outcomes 
in virus-infected hosts. Among different pathways that regulate the host response, NLRP3 
inflammasome-mediated IL-1β production is a key process in inflammation that is required for 
the elimination of viruses. This literature review has provided knowledge on the immunology of 
IAV infection and innate immunity focusing on inflammasomes and IL-1β. The mechanisms of 
NLRP3 inflammasome-mediated IL-1β production, particularly the ones regulated by 
ubiquitination and the roles of mitochondria on the NLRP3 inflammasome activation were 
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discussed. In addition, the immune evasion strategies exerted by non-structural proteins of IAVs 
were explained.  
How IAV infection induces NLRP3 inflammasome-mediated IL-1β production in the 
swine host is elusive, and as a part of immune evasion, whether IAV proteins, particularly NS1 
protein, contribute to the regulation of porcine NLRP3 inflammasome activation awaits 
elucidation. Moreover, how ubiquitination fits in the modulation of the porcine NLRP3 
inflammasome requires clarification. Answering these questions further expands the 
understanding of the host innate immunity upon IAV infection in pigs. 
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CHAPTER 2 RATIONALE, HYPOTHESIS AND OBJECTIVE 
2.1 Rationale 
Influenza A virus (IAV) causes annual outbreaks of respiratory infections worldwide and 
novel reassortant strains can emerge as pandemic viruses. Host responses against the IAV 
infection, particularly the innate immune responses, determine the outcome of infection. 
Activation of the innate immune system not only clears the virus, but also leads to the effective 
protection by adaptive immune responses with virus-specific antibodies. In response to the IAV 
infection, which initially targets the respiratory epithelium, alveolar macrophages (AMs) play an 
important role in controlling the IAV-induced inflammation. AMs secrete cytokines such as IL-
1β to mediate the inflammation and recruit other immune cells upon recognition of the IAV 
infection. While IAV-induced IL-1β production is known to be NLRP3 inflammasome-mediated 
in human and mouse, it is overlooked in swine. Particularly, the underlying mechanisms of the 
NLRP inflammasome regulation in the swine host, and how viral proteins control the porcine IL-
1β signaling are poorly understood. Given the important role of AMs in control of IAV infection 
and the well-known function of viral NS1 protein in antagonizing the host innate immune 
responses, I believe that investigation of how IAV infection triggers the NLRP3 inflammasome-
mediated IL-1β production in porcine alveolar macrophages (PAMs) is a key to the 
understanding of the innate immunity to IAV infection. Further, elucidating the roles of viral 
proteins, specifically NS1, in regulating the porcine NLRP3 inflammasome will provide the 
essential knowledge on the IAV-host cell interactions. The information obtained through this 
study will pave the way to a deeper insight into the immunology of influenza infection in pigs. 
 
2.2 Hypothesis and objective 
Based on the literature, I hypothesized that NLRP3 inflammasome-mediated IL-1β 
production occurs in PAMs upon IAV infection and viral NS1 protein contributes to the 
inhibition of the NLRP3 inflammasome. The main objective of this study is to characterize the 
NLRP3 inflammasome-mediated IL-1β production in response to IAVs including swine 
influenza virus (SIV) as well as to identify the signaling pathway involved in IAV-induced IL-1β 
production, and to define the mechanisms exerted by viral NS1 proteins on the porcine NLRP3 
inflammasome. To achieve the objective, I proposed the following specific aims:  
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Aim 1. Characterization of IL-1β production from PAMs infected with different IAV 
strains.  
Aim 2. Investigation of the mechanisms by which viral NS1 protein regulates porcine 
NLRP3 inflammasome activation. 
Aim 3. Identification of the signaling pathway through which SIV infection induces 
porcine NLRP3 inflammasome-mediated IL-1β production. 
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CHAPTER 3 INFLUENZA A VIRUS INDUCES NLRP3 INFLAMMASOME-
MEDIATED IL-1β PRODUCTION IN PORCINE ALVEOLAR MACROPHAGES. 
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Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination. 
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 51 
3.1 Abstract 
The inflammasome is a molecular platform critical for regulating pro-inflammatory 
cytokine production. NLR-family pyrin domain-containing protein 3 (NLRP3) inflammasome is 
comprised of NLRP3, apoptosis-associated speck-like protein containing caspase activation and 
recruitment domain (ASC) and pro-caspase-1. For NLRP3 inflammasome activation, NLRP3 
aggregates with ASC to form ASC specks where pro-caspase-1 is recruited, and then caspase-1 
is activated for the conversion of pro-IL-1β into IL-1β. Influenza A virus (IAV) infection can 
induce NLRP3 inflammasome-mediated IL-1β secretion in human and mouse, and multiple N-
terminal amino acid clusters of NS1 protein of different IAV strains are reported to suppress the 
NLRP3 inflammasome. However, whether IAV infection induces NLRP3 inflammasome-
mediated IL-1β production in porcine macrophages is not defined. Therefore, in this study, 
porcine IL-1β production in response to different IAVs including swine influenza viruses (SIVs) 
and the 2009 human pandemic H1N1 (pdm09) was characterized. The results showed SIV-
induced IL-1β production from porcine alveolar macrophages (PAMs) was mediated by toll-like 
receptor 3 and NLRP3 inflammasome. While SIV and pdm09 induced comparable levels of pro-
IL-1β expression and NLRP3 transcription, the pdm09 induced less IL-1β than SIV did. Further 
study revealed that NS1 C-terminus of pdm09, but not that of SIV, could significantly inhibit the 
NLRP3 inflammasome-mediated IL-1β production. This inhibition was attributed to the limited 
interaction between NLRP3 and ASC, which led to the impaired ASC speck formation. These 
results showed how IAVs induce IL-1β production in PAMs and revealed a novel mechanism by 
which NS1 protein of the pdm09 suppresses the NLRP3 inflammasome activation. 
 
3.2 Introduction 
Pattern recognition receptors (PRRs) play important roles in host innate immune responses 
to pathogens (Chen and Ichinohe, 2015). Nucleotide-binding domain and leucine-rich repeat-
containing proteins (NLRs) are one of the families of PRRs, among which the NLR-family pyrin 
domain-containing protein 3 (NLRP3) has been extensively investigated. With apoptosis-
associated speck-like protein containing caspase activation and recruitment domain (ASC) and 
pro-caspase-1, the NLRP3 forms a cytosolic protein complex called NLRP3 inflammasome 
(Chen and Ichinohe, 2015, Guo et al., 2015). When NLRP3 inflammasome is activated in 
response to a variety of pathogen-associated molecular patterns (PAMPs), it can then regulate the 
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secretion of inflammatory cytokines including IL-1β, which is a major mediator for 
inflammation (Chen and Ichinohe, 2015, Guo et al., 2015). IL-1β is synthesized as an immature 
form, pro-IL-1β; maturation of pro-IL-1β relies on the NLRP3 inflammasome activation. This 
activation occurs by the formation of ASC specks and activation of caspase-1, which is 
converted from pro-caspase-1 through an auto-processing mechanism (Chen and Ichinohe, 2015, 
Guo et al., 2015).  
NLRP3 inflammasome-mediated IL-1β production plays a critical role in modulating host 
immunity to IAV infection and IAV-induced lung pathology (Allen et al., 2009, Kanneganti et 
al., 2006a, Thomas et al., 2009). Sensing viral RNAs by toll-like receptors (TLRs) or retinoic 
acid-inducible gene-I (RIG-I)-like receptors leads to the expression of pro-IL-1β and NLRP3 
through the NF-κB pathway (signal 1) (Iwasaki and Pillai, 2014, Ong et al., 2016). Recently, Z-
DNA binding protein 1 (ZBP1) is identified as another sensor of IAV for the NLRP3 
inflammasome activation and inflammatory responses (Kuriakose et al., 2016). Activation of 
NLRP3 inflammasome requires the second signal (signal 2) that includes the recognition of viral 
components or virus-induced intracellular processes through mechanisms that are less clearly 
understood (Iwasaki and Pillai, 2014, Ong et al., 2016). While viral RNA itself is shown to 
activate NLRP3 inflammasome (Allen et al., 2009, Thomas et al., 2009), different viral proteins 
of IAVs are reported to regulate the NLRP3 inflammasome. For example, PB1-F2 protein can 
activate or inhibit the NLRP3 inflammasome in a viral strain-dependent manner (McAuley et al., 
2013, Pinar et al., 2017, Yoshizumi et al., 2014), whereas the M2 protein contributes to the 
NLRP3 inflammasome-mediated IL-1β production through its ion channel activity (Ichinohe et 
al., 2010). NS1 protein, which is well known for its interferon (IFN) antagonistic function (Krug, 
2015), is reported to inhibit both caspase-1 activation (Stasakova et al., 2005) and NLRP3-
mediated IL-1β production (Cheong et al., 2015, Moriyama et al., 2016, Pothlichet et al., 2013). 
However, there is still a lack of knowledge on how NLRP3 inflammasome-mediated IL-1β 
production is regulated in porcine cells upon IAV infection. 
In this chapter, the NLRP3 inflammasome-mediated IL-1β production in primary porcine 
alveolar macrophages (PAMs) upon infection with different IAVs was characterized. The 
negative regulation of porcine NLRP3 inflammasome activity by pdm09 NS1 protein was 
demonstrated as well. 
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3.3 Materials and methods 
3.3.1 Isolation of porcine alveolar macrophages (PAMs) 
Sera from 4- to 7-week-old piglets in SIV-free farms were verified by antigen-specific 
enzyme-linked immunosorbent assay (ELISA) using purified SIVs as antigens. The pre-screened 
piglets that were confirmed to be sero-negative against H1N1 and H3N2 subtypes of SIVs were 
selected for PAM isolation from bronchoalveolar lavage fluid (BALF), where most of the cells 
are comprised of alveolar macrophages (Ait-Ali et al., 2007, Gordon and Read, 2002). The purity 
of cells isolated this way was assessed by flow cytometry using mouse anti-pig macrophage 
antibody conjugated with fluorescein isothiocyanate (MCA2317F, Bio-Rad) as described (Liu et 
al., 2015). All experimental procedures were in accordance with the guidelines of the Canadian 
Council on Animal Care and were approved by the University of Saskatchewan Animal 
Research Ethics Committee. The selected piglets were euthanized and sacrificed by the VIDO-
InterVac animal care staff according to the approved protocol. Phosphate-buffered saline (PBS) 
with antibiotics (PBS-Anti) was prepared by combining PBS with 50 μg/ml gentamicin (BS724, 
Bio Basic Canada) and 1 × Antibiotic-Antimycotic (15240-062, Thermo Fisher). The BALF 
from each piglet was collected by adding 50 ml of cold PBS-Anti into trachea and gently 
squeezing both sides of lungs under sterile conditions. Mucus and debris were excluded from 
BALF by using 40 μm cell strainers (352340, Corning). After centrifuging at 400 × g for 10 min 
at 4°C, the cell pellets were resuspended in 20 ml cold PBS-Anti on ice. After another 
centrifugation, the cells were resuspended in 2 ml ammonium chloride lysis buffer (139 mM 
NH4Cl, 17 mM Tris, pH 7.2) and left for 1 min to lyse erythrocytes. PBS-Anti was added up to 
20 ml and the cells were centrifuged as above. Lysed erythrocytes were removed by 
micropipetting. The cells were further resuspended with 20 ml PBS-Anti and pelleted down as 
above conditions once more. The cells were resuspended in complete RPMI 1640 media 
(HyClone RPMI 1640 [SH30027.01, GE Healthcare], 20% fetal bovine serum [FBS, 16000-044, 
Thermo Fisher], 10 mM HEPES [15630-080, Thermo Fisher], 50 μg/ml gentamicin, 1 × 
Antibiotic-Antimycotic) and counted. After another round of centrifugation, the cells were 
resuspended in complete RPMI 1640 media with 10% dimethyl sulfoxide (DMSO, D2660, 
Sigma). The cells were frozen at -80°C overnight in freezing containers (5100-0001, Nalgene) 
and moved to a liquid nitrogen tank for long-term storage, while small aliquots of the cells from 
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each individual piglet were seeded to test the background levels of IL-1β. Based on the results of 
porcine IL-1β ELISA, the cells with less background of IL-1β were selected for further use. 
 
3.3.2 Cell lines and viruses 
Madin-Darby canine kidney (MDCK) cells were cultured with minimum essential medium 
(MEM, M4655, Sigma) supplemented with 10% FBS and 50 μg/ml gentamicin. Human 
embryonic kidney 293T (HEK293T) cells were cultured with Dulbecco’s modified Eagle’s 
medium (DMEM, D5796, Sigma) supplemented with 10% FBS and 50 μg/ml gentamicin. The 
wild-type (WT) IAVs used were influenza A/swine/Saskatchewan/18789/2002/H1N1 (Sk02), 
influenza A/swine/Texas/4199-2/1998/H3N2 (Tx98) and influenza A/Halifax/210/2009/H1N1 
(Hf09) (Table 3.1). A mutant Sk02 virus (Sk02-NS1/1-99) containing only aa 1 to 99 of the N-
terminal NS1 was described previously (Liu et al., 2015). Additional mutant viruses were 
generated as described in the section 3.3.3. All mutant viruses with truncated NS1 were 
propagated in MDCK cells stably expressing NS1 protein of influenza A/Puerto 
Rico/8/1934/H1N1 (PR8) strain (MDCK-NS1), while others were propagated in MDCK cells. 
Viral titres were determined by plaque assay in either MDCK or MDCK-NS1 cells. 
 
3.3.3 Generation of mutant viruses 
Mutant viruses were rescued by the eight-plasmid reverse genetics system as previously 
established and conducted (Hoffmann et al., 2000, Masic et al., 2009a). This system requires the 
WT or mutant cDNA of each IAV segment cloned into the pHW2000 vector that is driven by 
RNA polymerase I and II (Hoffmann et al., 2000). Four mutant viruses were generated in this 
study as indicated in Table 3.1.  
Hf09-816 and Hf09-817 are two isogenic Hf09 viruses that encode truncated NS1, i.e. aa 
1-73 or 1-99, respectively. The mutant Hf09 NS segments harbouring the truncated NS1 coding 
sequence were generated by site-directed mutagenesis. Briefly, three stop codons (for each ORF) 
were inserted after the 73rd or the 99th aa of NS1 (while not changing the NEP coding sequence) 
by overlapping PCR using appropriate mutagenic primers (Supplementary Table 1) and pHW-
Hf09-NS as the template. The fragments were cloned into SphI and NcoI restriction sites of the 
pHW2000 vector and the positive clones were designated as pHW-Hf09-NS-816 and pHW-
Hf09-NS-817 for NS11-73 and NS11-99, respectively. Each of these NS segments and other seven 
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Hf09 segments in the pHW2000 vector were used to rescue the Hf09-816 and Hf09-817 viruses 
(Table 3.1). 
Sk02-616, an isogenic Sk02 virus that contains the NS segment of Hf09 was rescued using 
pHW-Hf09-NS and other seven Sk02 segments in the pHW2000 vector. Sk02-930, is another 
isogenic Sk02 virus, but contains a chimeric NS segment encoding NS1 with aa 1 to 99 from 
Sk02 and aa 100 to 219 from Hf09. Two PCR products containing either Sk02 NS11-99 or Hf09 
NS1100-219 were amplified and joined by overlapping PCR using mutagenic primers 
(Supplementary Table 1) with the WT NS segment of Sk02 (pHW-Sk02-NS) or Hf09 (pHW-
Hf09-NS) as the templates. The chimeric fragment was cloned into SalI and NaeI restriction sites 
of the pHW2000 vector and the successful clone was designated as pHW-Sk02/Hf09-NS-930. 
This chimeric NS segment and other seven Sk02 segments in the pHW2000 vector were used to 
rescue the Sk02-930 virus (Table 3.1).  
The viruses were rescued by co-transfection system as follows. On 35 mm × 10 mm dishes 
(#3294, Corning), 2.2 × 10
5
 cells/dish of MDCK cells and 3.0 × 10
5
 cells/dish of HEK293T cells 
were seeded in 1.2 ml per dish of complete DMEM. Next day, the cells were transfected by 
adding a mixture of 1 μg each of the eight pHW2000-derived constructs plus 16 μl of TransIT-
LT1 (MIR2300, Mirus Bio) in 240 μl Opti-MEM (31985-070, Thermo Fisher). After 6 h, the 
media was replaced by 1 ml Opti-MEM. At 24 h post-transfection (hpt), another 1 ml of Opti-
MEM containing 2 μl of 1 mg/ml tosyl phenylalanyl chloromethyl ketone-treated trypsin (22725, 
Affymetrix) and 80 μl of 5% bovine serum albumin (BSA) (A8806, Sigma) in distilled water 
was added into each dish. When the cells show prominent cytopathic effects (CPEs) between 48 
and 72 hpt, the supernatants containing the viruses were harvested. The rescued viruses were 
passaged twice on MDCK cells and titrated by plaque assay. 
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Table 3.1 List of WT and mutant viruses used in this study. 
 
Viruses from previous studies 
Virus NS1 aa in length Reference 
Sk02 (WT) 1 to 230 (Masic et al., 2009b) 
Tx98 (WT) 1 to 219 (Masic et al., 2009b) 
Hf09 (WT) 1 to 219 (Lin et al., 2012) 
Sk02-NS1/1-99 1 to 99 (Liu et al., 2015) 
 
Viruses generated in this study 
Virus 
NS1 composition  
and aa in length 
NS construct used 
to rescue the virus 
Hf09-816 Hf09 1 to 73 pHW-Hf09-NS-816 
Hf09-817 Hf09 1 to 99 pHW-Hf09-NS-817 
Sk02-616 Hf09 1 to 219 pHW-Hf09-NS 
Sk02-930 
Sk02 1 to 99 and 
Hf09 100 to 219 
pHW-Sk02/Hf09-NS-930 
 
3.3.4 Antibodies and reagents 
Rabbit polyclonal antibodies against IAV NP and NS1 were previously generated in our 
laboratory (Shin et al., 2007b). Goat polyclonal anti-porcine IL-1β antibody (BAF681, R&D 
Systems), rabbit polyclonal anti-porcine caspase-1 (p20) antibody (PAB592Po01, Cloud-Clone 
Corp), mouse monoclonal anti-β-actin antibody (3700, Cell Signaling Technology, CST), mouse 
monoclonal anti-Myc-tag antibody (2276, CST), mouse monoclonal anti-FLAG M2 antibody 
(F3165, Sigma) and rabbit polyclonal anti-ASC antibody (AG-25B-006, Adipogen) were 
purchased from different sources. For the secondary antibodies, IRDye 680RD donkey anti-
rabbit (926-68073), IRDye 800CW donkey anti-mouse (926-32212) and IRDye 800CW donkey 
anti-goat (926-32214) antibodies were purchased from LI-COR Biosciences. Transfection was 
conducted using TransIT-LT1 Transfection Reagent. Ethylenediaminetetraacetic acid (EDTA)-
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free protease inhibitor cocktail tablets (4693132001, Roche) were used in cell lysis and 
immunoprecipitation (IP). An NLRP3 inhibitor, 3,4-methylenedioxy-β-nitrostyrene (MNS) 
(574713, EMD Millipore) was used as previously reported (He et al., 2014) and DMSO was used 
as the vehicle.  
 
3.3.5 Plasmid construction 
Total RNA was extracted from PAMs stimulated with LPS (L3024, Sigma) and ATP 
(A1852, Sigma) by using RNeasy Mini Kit (74104, QIAGEN), and then cDNA was synthesized 
using 2.5 μM oligo (dT), 50 ng random hexamers (N8080127, Thermo Fisher), 0.5 mM dNTP 
mix (18427088, Thermo Fisher) and SuperScript III Reverse Transcriptase (18080044, Thermo 
Fisher). The full-length genes of porcine NLRP3, ASC, pro-caspase-1 and pro-IL-1β were 
amplified using HotStar HiFidelity Polymerase Kit (202602, QIAGEN) and primers that were 
designed based on the GenBank sequences (accession numbers NM_001256770 [NLRP3], 
AB873106 [ASC], AK231984 [pro-caspase-1] and NM_214055 [pro-IL-1β]). The genes were 
cloned into pcDNA3.1 or pCMV-3×Flag (N-terminal tag) vectors and the resulting plasmids 
were designated as pcDNA-NLRP3, pcDNA-ASC, pCMV-Flag-pro-caspase-1 and pcDNA-pro-
IL-1β. Additionally, the full-length genes of porcine NLRP3 and ASC were cloned into pCMV-
3×Flag (N-terminal tag) or pcDNA3.1-3×Myc (C-terminal tag) vector by amplifying the genes 
from pcDNA-NLRP3 or pcDNA-ASC. The resulting plasmids were designated as pcDNA-
NLRP3-Myc, pCMV-Flag-NLRP3, pcDNA-ASC-Myc and pCMV-Flag-ASC. WT and truncated 
NS1 of Hf09 were cloned into pCMV-3×Flag vector and the resulting plasmids were designated 
as pCMV-Flag-Hf09 NS1, pCMV-Flag-Hf09 NS11-73 and pCMV-Flag-Hf09 NS11-99, encoding 
the full-length, N-terminal aa 1 to 73 and aa 1 to 99 of NS1, respectively. NS1 C-termini of Hf09 
and Sk02 were cloned into pcDNA3.1-3×Myc and designated as pcDNA-Hf09 NS1100-219-Myc 
and pcDNA-Sk02 NS1100-230-Myc, respectively. The successful construction of plasmids was 
confirmed by DNA sequencing. The expression plasmids generated for this chapter are listed in 
Table 3.2 and the primers are listed in Supplementary Table 2. 
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Table 3.2 List of expression plasmids used in Chapter 3. 
 
Construct Template used to clone Purpose 
pcDNA-NLRP3 cDNA from PAMs NLRP3 inflammasome reconstitution 
pcDNA-ASC cDNA from PAMs 
NLRP3 inflammasome reconstitution, 
NLRP3-ASC interaction 
pCMV-Flag-pro-caspase-1 cDNA from PAMs NLRP3 inflammasome reconstitution 
pcDNA-pro-IL-1β cDNA from PAMs NLRP3 inflammasome reconstitution 
pcDNA-NLRP3-Myc pcDNA-NLRP3 
NLRP3-ASC interaction,  
ASC speck formation 
pCMV-Flag-NLRP3 pcDNA-NLRP3 NLRP3-ASC interaction 
pcDNA-ASC-Myc pcDNA-ASC NLRP3-ASC interaction 
pCMV-Flag-ASC pcDNA-ASC ASC speck formation 
pCMV-Flag-Hf09 NS1 
pcDNA-Hf09-NS1-
Myc 
NLRP3 inflammasome reconstitution, 
NLRP3-ASC interaction 
pCMV-Flag-Hf09-NS11-73 
pcDNA-Hf09-NS1-
Myc 
NLRP3 inflammasome reconstitution, 
NLRP3-ASC interaction 
pCMV-Flag-Hf09-NS11-99 
pcDNA-Hf09-NS1-
Myc 
NLRP3 inflammasome reconstitution, 
NLRP3-ASC interaction 
pcDNA-Hf09 NS1100-219-
Myc 
pHW-Hf09-NS NLRP3 inflammasome reconstitution 
pcDNA-Sk02 NS1100-230-
Myc 
pHW-Sk02-NS NLRP3 inflammasome reconstitution 
 
 
  
 59 
3.3.6 Infection and treatment of PAMs 
PAMs were seeded on 24-well plates (#3524, Corning) at 1 × 10
6
 cells per well 
considering the low proliferating capacity of alveolar macrophages (Bowden and Adamson, 
1972, Nyunoya et al., 2003). The cells were infected with viruses at a multiplicity of infection 
(MOI) of 1. At indicated time points, cell-free supernatants were collected for ELISA, while the 
cells were lysed with 1 × sodium dodecyl sulfate (SDS) sample buffer and boiled at 95°C for 5 
min for Western blotting. For time-course experiments, the supernatants collected at 8, 16 and 24 
h post-infection (hpi) were used for both ELISA and plaque assay in MDCK cells. To check the 
mRNA expression of porcine NLRP3 upon infection, PAMs were infected with Sk02 or Hf09 at 
an MOI of 1 for 12 h. As a positive control, the cells were stimulated with 200 ng/ml LPS for 12 
h. 
 
3.3.7 Virus purification 
MDCK cells were seeded at 3 × 10
6
 cells/dish on ten 100 mm × 20 mm dishes (430167, 
Corning) and were infected with Sk02 or Tx98 at an MOI of 0.001. Viral fluid was harvested at 
full CPEs at around 48 hpi. After centrifugation at 300 × g for 10 min, the supernatants were 
transferred to ultracentrifuge tubes (Thinwall, Ultra-Clear, 25 × 89 mm, 344058, Beckman 
Coulter) and centrifuged at 25,000 rpm for 2.5 h using a SW 28 rotor. The supernatants were 
discarded and 100 μl Tris-buffered saline (TBS) with EDTA (20 mM Tris, pH 7.8, 150 mM 
NaCl, 2 mM EDTA disodium salt) (TSE) was added to resuspend the pellets followed by 
incubation at 4°C overnight. Next day, 2.5 ml 60% sucrose in TSE, 5 ml 30% sucrose in TSE 
and the resuspended pellets in TSE were added into ultracentrifuge tubes (Thinwall, Ultra-Clear, 
14 × 89 mm, 344059, Beckman Coulter) and centrifuged at 25,000 rpm for 2.5 h using a SW 41 
rotor. Viral band was collected and transferred to new ultracentrifuge tubes (Thinwall, Ultra-
Clear, 14 × 89 mm, 344059, Beckman Coulter) that were filled by 8 ml TSE. After centrifugation 
at 35,000 rpm for 1.5 h, the supernatants were discarded and 200 μl TSE were added followed by 
incubation at 4°C overnight. The resuspended virus was transferred to a microcentrifuge tube and 
the bottom of ultracentrifuge tubes was further washed with additional 500 μl TSE. The purified 
viruses were stored at -80°C until further use. 
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3.3.8 UV inactivation of viruses 
WT SIVs, Sk02 and Tx98 were inactivated by UV irradiation as described previously 
(Shin et al., 2007b) with modifications. Briefly, 0.5 ml of each virus on a 35-mm dish without a 
lid was placed on ice. The viruses were left with a distance of 20 cm from a 30-watt UV lamp for 
20 min. 
 
3.3.9 RNA interference 
Small interfering RNAs (siRNAs) targeting porcine TLR3 or TLR7, and a negative control 
siRNA were purchased from QIAGEN. PAMs were seeded on 24-well plates at 7 × 10
5
 cells per 
well. Immediately after seeding, a mixture of 20 nM of each siRNA with 2 μl Lipofectamine 
RNAiMax Reagent (13778-030, Thermo Fisher) prepared in 50 μl Opti-MEM was added into 
each well. At 24 hpt, the cells were infected with Sk02 at an MOI of 1. At 24 hpi, cell-free 
supernatants were collected for IL-1β ELISA. Knockdown efficiency was measured by 
quantitative PCR as described in the section 3.3.10. 
 
3.3.10 Quantitative PCR 
Total RNA from PAMs was extracted with RNeasy Mini kit (74104, QIAGEN) according 
to the manufacturer’s protocol. Two hundred ng of RNA were treated with 1 U of DNase I 
(18068-015, Thermo Fisher) at room temperature for 15 min and incubated with 1 μl of 25 mM 
EDTA at 65°C for 10 min. Half of the above reaction volume was used for the denaturation step 
using 2.5 μM oligo (dT) and 0.5 mM dNTP mix (18427088, Thermo Fisher) by incubating at 
65°C for 5 min followed by placing on ice. Then, the first-strand cDNA synthesis was completed 
by adding 5 mM dithiothreitol, 40 U of RNaseOUT RNase Inhibitor (10777-019, Thermo Fisher) 
and 200 U of SuperScript III Reverse Transcriptase (18080044, Thermo Fisher) and incubating 
at 50°C for 50 min followed by 85°C for 5 min. For quantitative real-time PCR, each cDNA (2 
μl from the above reaction) was mixed with 0.2 μM each of forward and backward primers, and 
Power SYBR Green PCR Master Mix (4367659, Thermo Fisher). Porcine hypoxanthine 
phosphoribosyltransferase 1 (HPRT1) was selected as the housekeeping gene and primers based 
on the GenBank sequence (accession number DQ845175) were used as reported (Nygard et al., 
2007). Primers for porcine TLR3, TLR7 and NLRP3 were designed based on the GenBank 
sequences (accession numbers KC011280, JQ664686 and NM_001256770, respectively). Primer 
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sequences are shown in Table 3.3. Based on the threshold cycle of the target genes and the 
housekeeping gene, 2
-(ΔΔCt)
 calculation was used to measure the relative expression of the target 
genes by normalizing to the expression level of the housekeeping gene. 
 
Table 3.3 List of primers used for quantitative PCR in Chapter 3. 
 
Target Primer name Sequence (5’-3’) Amplicon size 
Porcine HPRT1 
HPRT1 Fw GGACTTGAATCATGTTTGTG 
91 bp 
HPRT1 Bw CAGATGTTTCCAAACTCAAC 
Porcine TLR3 
TLR3 Fw GAACCATGCACTCTGTTTGC 
101 bp 
TLR3 Bw GCAGTTTGTGATGAAAGGCA 
Porcine TLR7 
TLR7 Fw TCAGAGGCTCATGGATGAAA 
143 bp 
TLR7 Bw GGTGAGCCTGTGGATTTGTT 
Porcine NLRP3 
NLRP3 Fw CCTCTTTGGCCTTGTAAACC 
144 bp 
NLRP3 Bw TGGCTGGGCTCAATCTGTAG 
bp, base pairs. 
 
3.3.11 Antigen-specific IgG ELISA 
Serum IgG specific for SIVs was determined as described previously (Masic et al., 2009b). 
Sk02 and Tx98 viruses were purified and UV-inactivated as described in the section 3.3.7 and 
3.3.8 to be used as antigens. Immulon 2 HB U plates (3655, Thermo Fisher) were coated with 2.5 
μg/ml of antigens in coating buffer (15 mM sodium carbonate, 35 mM sodium bicarbonate, pH 
9.6) and incubated at 4°C overnight. All the following steps were performed at room temperature 
and all reagents or test sera were applied at 100 μl per well. The plates were washed four times 
with TBS (100 mM Tris, pH 7.5, 170 mM NaCl) with 0.05% Tween 20 (P1379, Sigma) (TBST) 
between each step. Next, the plates were blocked with 1% skim milk in TBST at room 
temperature for 1 h. Serum from each piglet that was diluted 1 to 100 in diluent (0.5% skim milk 
in TBST) was applied and incubated at room temperature for 1.5 h. Positive and negative control 
sera were also applied. The plates were incubated with alkaline phosphatase-labeled goat anti-
swine IgG (H+L) (151-14-06, KPL) that was diluted at the ratio of 1:5,000. Colors were 
developed by adding 1 mg/ml of p-nitrophenyl phosphate (PNPP) (N3254, Sigma) in 
diethanolamine buffer (1 M diethanolamine, 0.5 M MgCl2, pH 9.8). The optical density (OD) 
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was measured by reading at 405 nm with reference at 490 nm using xMark Microplate 
Absorbance Spectrophotometer (Bio-Rad). The highest dilution at which the OD of the test 
serum was higher than the cut-off value, which is the mean OD of the negative control sera plus 
two times the standard deviation (SD), was determined as the titre. 
 
3.3.12 Porcine IL-1β ELISA 
Immulon 2 HB U plates (3655, Thermo Fisher) were coated with 2 μg/ml of mouse 
monoclonal anti-porcine IL-1β antibody (MAB6811, R&D Systems) in PBS at room temperature 
overnight. All the following steps were performed at room temperature and all reagents or 
samples were applied at 100 μl per well. The plates were washed four times with TBST between 
each step. Blocking was performed with 1% BSA (A7030, Sigma) in PBS for 1 h. Two-fold 
serial dilutions of recombinant porcine IL-1β protein (681-PI-010, R&D Systems) in diluent 
(0.1% BSA in TBST) was used as the standard. The plates were incubated with samples or the 
standard for 2 h. The plates were then incubated with 50 ng/ml of goat polyclonal anti-porcine 
IL-1β biotinylated antibody (BAF681, R&D Systems) in diluent for 1 h, followed by the 
incubation with alkaline phosphatase streptavidin (016-050-084, Jackson ImmunoResearch) 
diluted at the ratio of 1:5,000 in diluent for another 1 h. For color development, the plates were 
incubated with 1 mg/ml of PNPP in diethanolamine buffer until the OD of the first dilution of the 
standard reached around 2.0. The plates were read at 405 nm with reference at 490 nm using 
xMark Microplate Absorbance Spectrophotometer (Bio-Rad). 
 
3.3.13 NLRP3 inflammasome reconstitution assay 
HEK293T cells were seeded at 1.5 × 10
5
 cells per well on 24-well plates and transfected 
with pcDNA-NLRP3 (30 ng), pcDNA-ASC (20 ng), pCMV-Flag-pro-caspase-1 (20 ng) and 
pcDNA-pro-IL-1β (100 ng) along with other constructs (300 ng of Flag-vector or Flag-tagged 
WT/mutant Hf09 NS1 constructs, or 300 ng of Myc-vector or Myc-tagged mutant Sk02 or Hf09 
NS1 constructs). Transfection was conducted by adding the mixture of plasmids and TransIT-
LT1 Transfection Reagent. At 16 hpt, cell-free supernatants were collected for porcine IL-1β 
ELISA and cells were lysed with 1 × SDS sample buffer for Western blotting. To monitor the 
NLRP3 inflammasome activation levels in response to viral infection, at 12 hpt, the cells were 
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mock-infected or infected with viruses at an MOI of 5. At 12 hpi, cell-free supernatants were 
collected and cells were lysed as mentioned.  
 
3.3.14 Western blotting 
Cell lysates or IP samples were fractionated by SDS-polyacrylamide gel electrophoresis 
(PAGE) and blotted onto 0.45 μm nitrocellulose membranes (1620115, Bio-Rad). The 
membranes were blocked with 5% skim milk in TBS with 0.1% Tween 20 for 1 h and incubated 
with primary antibodies in TBS with 0.1% Tween 20 at 4°C overnight. After incubation with the 
secondary antibodies in TBS with 0.1% Tween 20 at room temperature for 1 h, the membranes 
were scanned with an Odyssey infrared imager (LI-COR Biosciences). 
 
3.3.15 Co-immunoprecipitation (co-IP) 
HEK293T cells were seeded at 1 × 10
6
 per well on 6-well plates (#3506, Corning) and 
were transfected with 1 μg of each plasmid indicated. Transfection was conducted by adding the 
mixture of plasmids and TransIT-LT1 Transfection Reagent. To examine the effects of viral 
infection on the NLRP3-ASC interaction, the transfected cells were infected with Hf09 at an 
MOI of 1 for 12 h. To observe the effects of WT/mutant NS1 of Hf09 on the NLRP3-ASC 
interaction, the cells were incubated for 48 h after transfection. The cells were lysed with 500 μl 
lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% Nonidet P-40 substitute, 1 × protease 
inhibitor cocktail) and clarified by centrifugation at 12,000 × g for 10 min at 4°C. For input, 10% 
of the cell lysates were stored separately. Dynabeads Protein G (10004D, Thermo Fisher) were 
first conjugated with 1 μg of the respective antibodies by incubation at room temperature for 1 h 
and then, were incubated with the cell lysates at 4°C overnight with agitation. After washed 
thrice with TBS, the beads were resuspended in 2 × SDS sample buffer and boiled at 98°C for 5 
min to be analyzed by Western blotting.  
 
3.3.16 Immunofluorescence and confocal microscopy 
HEK293T cells were seeded at 6 × 10
4
 cells per well on LabTek II CC2 chamber slides 
(154941, Thermo Fisher). The cells were transfected with 50 ng of pcDNA-NLRP3-Myc or 
Myc-vector and 30 ng of pCMV-Flag-ASC or Flag-vector for 24 h to validate the specificity of 
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antibodies. Transfection was conducted by adding the mixture of plasmids and TransIT-LT1 
Transfection Reagent. To observe the effects of WT/mutant Hf09 virus on ASC specks, the cells 
were transfected with pcDNA-NLRP3-Myc (50 ng) and pCMV-Flag-ASC (30 ng) for 12 h, and 
infected with Hf09 or Hf09-817 at an MOI of 5 for 12 h. Cells were fixed with 4% 
paraformaldehyde for 10 min and permeabilized with 0.2% Triton X-100 for 5 min at room 
temperature. The cells were incubated with 5% BSA in Dulbecco’s phosphate-buffered saline 
(DPBS) (14040-133, Thermo Fisher) for 1 h at room temperature and probed with the primary 
antibodies (rabbit monoclonal anti-Myc-tag antibody, #2278, CST; goat polyclonal anti-DDDDK 
tag antibody, ab1257, Abcam; mouse monoclonal anti-IAV NP antibody, MCA400, Bio-Rad) 
overnight at 4°C followed by incubation with the secondary antibodies [Alexa Fluor 546 donkey 
polyclonal anti-rabbit IgG (H+L), A10040, Invitrogen; Alexa Fluor 633 donkey polyclonal anti-
goat IgG (H+L), A21082, Invitrogen; Alexa Fluor 488 donkey polyclonal anti-mouse IgG 
(H+L), A21202, Invitrogen] for 1 h at room temperature. The cells were washed with DPBS 
between each step. The cells were counterstained with 4',6-diamidino-2-phenylindole (DAPI) 
(D1306, Invitrogen) for 5 min and coverslips were mounted with ProLong Diamond Antifade 
Mountant (P36961, Invitrogen) overnight. Images were visualized by using a confocal laser 
scanning microscope (TCS SP8, Leica). The numbers of ASC speck-positive cells and IAV NP-
positive cells were counted from five randomly selected fields per each condition, and the 
percentages of speck- and NP-positive cells in NP-positive cells were shown. 
 
3.3.17 Statistical analysis 
The data were analyzed using GraphPad Prism 7 by one-way analysis of variance 
(ANOVA) with Tukey’s multiple comparisons test. Two-way ANOVA with Tukey’s multiple 
comparisons test or Mann-Whitney test was used where specified. The bars indicate the mean ± 
SD. The p-value of less than 0.05 was considered to be statistically significant. 
 
3.4 Results 
3.4.1 SIV infection induces IL-1β production in PAMs. 
To assess the levels of IL-1β produced from PAMs in response to IAV infection, PAMs 
were infected with two different subtypes of IAVs isolated from pigs, Sk02 (H1N1) and Tx98 
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(H3N2) at indicated MOIs (Figure 3.1A). At 24 hpi, cell-free supernatants were collected for 
porcine IL-1β ELISA and the cells were lysed for Western blotting to measure the expression of 
pro-IL-1β and viral proteins. Although PAMs from different piglets showed variable levels of 
IL-1β production in response to SIV infection, the differences in IL-1β levels in response to SIVs 
at indicated MOIs were reproducible when cells from different piglets were used, and the 
representative data using PAMs isolated from a piglet with the lowest background level of IL-1β 
is shown. Pro-IL-1β levels from PAMs infected at an MOI of 1 or 10 were comparable and were 
significantly higher than those in mock cells or cells infected at an MOI of 0.1 (Figure 3.1A). In 
contrast, IL-1β levels in virus-infected cells were significantly higher than that of mock infected 
cells and were viral dose-dependent. Accordingly, the expression of viral NP and NS1 proteins 
were also viral dose-dependent, confirming that PAMs were infected with SIVs. Based on these 
results, an MOI of 1 for 24 h was chosen in the following infection experiments with PAMs, 
except for an experiment to check mRNA expression of NLRP3. Since the above results 
suggested that viral replication is required for IL-1β production in PAMs, experiments were 
conducted to further confirm this finding by inactivating the two virus strains with UV 
irradiation (Figure 3.1B). The effect of UV inactivation on virus replication was confirmed by 
monitoring the NS1 protein expression levels. Compared to WT viruses, UV-inactivated viruses 
lost the ability to induce IL-1β production in PAMs (Figure 3.1B), indicating viral replication is 
necessary for the conversion of pro-IL-1β into mature IL-1β. 
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Figure 3.1 SIV infection induces IL-1β production in PAMs.  
(A) PAMs were infected with two SIV strains, Sk02 and Tx98 at an MOI of 0.1, 1 or 10. At 24 
hpi, cell-free supernatants were collected for porcine IL-1β ELISA and cells were lysed for 
Western blotting to measure the expression of pro-IL-1β and viral proteins. ***, p<0.001. (B) 
PAMs were infected with WT or UV-inactivated viruses of two SIV strains at an MOI of 1 for 
24 h. IL-1β production and pro-IL-1β expression were measured as in (A). ***, p<0.001. 
 
3.4.2 SIV-induced IL-1β production is mediated by TLR3. 
To identify which cytosolic sensor is mainly involved in IL-1β production from PAMs 
infected with SIV, endosomal TLRs for dsRNA or ssRNA were knocked down by siRNAs. 
PAMs were transfected with a negative control siRNA or siRNA specific for porcine TLR3 or 
TLR7 and infected with Sk02. Knockdown efficiency confirmed by comparing the mRNA 
expression levels of TLR3 and TLR7 to that of the housekeeping gene, HPRT1 was more than 
50% (Figure 3.2A). Compared to treatment with a negative control or TLR7 siRNA, TLR3 
silencing led to reduced IL-1β production upon Sk02 infection (Figure 3.2B), indicating that 
TLR3 functions as a sensor of SIV infection for porcine IL-1β production. 
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Figure 3.2 SIV-induced IL-1β production is mediated by TLR3.  
(A) PAMs were transfected with 20 nM of a negative control siRNA (siControl) or siRNAs 
targeting porcine TLR3 (siTLR3) or TLR7 (siTLR7) for 24 h. Knockdown efficiency was 
measured by checking the mRNA expression levels of porcine TLR3 and TLR7 compared to that 
of porcine HPRT1 by quantitative PCR. ***, p<0.001. (B) PAMs were transfected with 
siControl, siTLR3 or siTLR7 for 24 h. The cells were infected with SIV Sk02 at an MOI of 1 for 
24 h. Cell-free supernatants were collected for porcine IL-1β ELISA. **, p<0.01.  
 
3.4.3 SIV-induced IL-1β production is mediated by NLRP3 inflammasome. 
Next, whether the NLRP3 inflammasome is involved in IL-1β production in PAMs upon 
SIV infection was tested. PAMs were first treated with an NLRP3 inhibitor, MNS, which inhibits 
the NLRP3 inflammasome activation by binding to NLRP3 (He et al., 2014), and were then 
infected with Sk02 at an MOI of 1. In virus-infected PAMs, compared to vehicle-treated cells, a 
dose dependent decrease of IL-1β induction upon the inhibitor treatment was observed (Figure 
3.3A), indicating that porcine IL-1β production in SIV-infected PAMs is mediated by NLRP3 
inflammasome. At the tested concentration of MNS, cells did not show noticeable cytotoxicity 
(data not shown). To reaffirm the NLRP3 inflammasome-mediated IL-1β production upon IAV 
infection, the porcine NLRP3 inflammasome was reconstituted in HEK293T cells that are 
deficient in endogenous human NLRP3 inflammasome (Bryan et al., 2009). Porcine NLRP3, 
ASC, pro-caspase-1 and pro-IL-1β genes were cloned from PAMs and the corresponding 
mammalian expression plasmids were constructed. Co-transfection of all four plasmids led to a 
moderate level of IL-1β in the supernatant owing to the engagement of NLPR3, ASC and 
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caspase-1. Only basal level of IL-1β was detected when pro-IL-1β was expressed alone (Figure 
3.3B). These results validated the successful setup of the reconstitution system, showing that IL-
1β maturation and secretion predominantly rely on the porcine NLRP3 inflammasome. To 
confirm the dependency of IL-1β production on NLRP3 inflammasome in the context of IAV 
infection, porcine NLRP3 inflammasome was reconstituted in HEK293T cells for 12 h and then 
were infected with Sk02 at an MOI of 5 for another 12 h. In the presence of all the NLRP3 
inflammasome components and pro-IL-1β, infection with Sk02 induced over 5,000 pg/ml of IL-
1β and a noticeable level of cleaved caspase-1, p20, which was much higher than its counterpart 
in the absence of virus infection (Figure 3.3B). In all samples, viral protein expression and 
cellular β-actin levels were monitored. Together, these results demonstrate that SIV infection 
induces porcine NLRP3 inflammasome-mediated IL-1β production. 
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Figure 3.3 SIV-induced IL-1β production is mediated by NLRP3 inflammasome.  
(A) PAMs were treated with DMSO or an NLRP3 inhibitor, MNS at indicated concentrations for 
2 h and infected with Sk02 at MOI of 1 for 24 h. Porcine IL-1β production was measured by 
ELISA. ***, p<0.001. (B) HEK293T cells were transfected with different combination of the 
plasmids expressing porcine NLRP3, ASC, pro-caspase-1 and pro-IL-1β as indicated. At 12 hpt, 
the cells were mock-infected or infected with Sk02 at an MOI of 5. Porcine IL-1β from the cell-
free supernatants at 12 hpi was measured by ELISA. The expression of pro-IL-1β, the active 
caspase-1, p20 and viral proteins was measured by Western blotting with the cell lysates. ***, 
p<0.001. 
 
3.4.4 2009 human pandemic IAV (pdm09) induces less IL-1β than does the SIV. 
To examine whether other IAV strains in addition to SIVs also induce IL-1β in PAMs, a 
pdm09 strain, Hf09 was used. Surprisingly, IL-1β production at 24 hpi from Hf09-infected 
PAMs was significantly less than that from Sk02-infected PAMs (Figure 3.4A), while the pro-
IL-1β level in Sk02-infected PAMs was slightly higher than that in Hf09-infected PAMs. The 
time course experiments showed that IL-1β production in response to Sk02 increased sharply 
between 8 and 16 hpi, after the virus established its productive replication at around 8 hpi, as 
indicated by the viral growth curve (Figure 3.4B). In contrast, this increase in IL-1β was not 
observed in Hf09-infected PAMs, while the viral titres of Hf09 were comparable to those of 
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Sk02 during the time course. These results showed that less IL-1β production by Hf09 was not 
due to the inefficient replication of Hf09 in PAMs, which was also confirmed by viral NS1 
expression levels (Figure 3.4A). The signal 1 required for NLRP3 inflammasome-mediated IL-
1β production induces the transcriptional upregulation of NLRP3 in addition to pro-IL-1β. Thus, 
the mRNA expression of NLRP3 in PAMs infected with Sk02 or Hf09 was also assessed. 
Porcine NLRP3 transcription was around 2.5 times increased upon viral infection, while this 
increase was comparable between Sk02 and Hf09-infected PAMs (Figure 3.4C). LPS-induced 
upregulation of NLRP3 expression was shown as a positive control. These indicated that the 
remarkable difference in IL-1β levels was possibly attributed to the suppression of NLRP3 
inflammasome activity in cells infected by pdm09.  
 
 
 
Figure 3.4 pdm09 induces less IL-1β than does SIV.  
(A) PAMs were infected with an SIV strain, Sk02 or a human pandemic strain, Hf09 at an MOI 
of 1. At 24 hpi, cell-free supernatants were collected for IL-1β ELISA and the cells were lysed 
for Western blotting to measure the expression of pro-IL-1β and viral NS1 protein. ns, not 
significant, ***, p<0.001. (B) PAMs were infected with Sk02 or Hf09 at an MOI of 1, and the 
supernatants were collected at 8, 16 and 24 hpi. IL-1β was measured by ELISA and viral titres 
were determined by plaque assay on MDCK cells. Two-way ANOVA with Tukey’s multiple 
comparisons test (B, upper panel), ***, p<0.001; Mann-Whitney test (B, lower panel), ns, not 
significant. (C) PAMs were either infected with viruses (Sk02 or Hf09) at an MOI of 1 for 12 h 
or stimulated with 200 ng/ml LPS for 12 h. Expression of porcine NLRP3 mRNA was compared 
to that of porcine HPRT1 by conducting quantitative PCR. ns, not significant. 
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3.4.5 NS1 C-terminus of pdm09, but not that of SIV, inhibits the NLRP3 
inflammasome activation. 
Based on the above results, viral proteins were postulated to contribute to the regulation of 
NLRP3 inflammasome activation. Among others, NS1 protein of IAV is well known for its 
function of antagonizing host immune responses. However, the NS1 protein of pdm09 was 
reported to be inefficient in controlling the host gene expression (Hale et al., 2010). Unexpected 
results obtained above that Hf09 has a strong inhibitory effect on porcine IL-1β production led to 
a further study on whether Hf09 NS1 regulates the NLRP3 inflammasome activity. NS1 C-
terminus has been shown to interact with multiple cellular proteins (Hale et al., 2008), which led 
to a hypothesis that NS1 C-terminus may exert an inhibitory function on the porcine IL-1β 
production. To investigate this, mutant viruses derived from WT Sk02 or Hf09 containing 
mutations in the NS1 protein were constructed (illustrated in Figure 3.5A). Sk02-NS1/1-99 virus 
encoding N-terminal NS1 from aa 1 to 99 was previously generated in our lab; the Sk02-NS1/1-
99 induced more type I IFN secretion from PAMs than its WT did (Liu et al., 2015). In addition, 
two Hf09 mutant viruses encoding truncated NS1 proteins (Hf09-816 and Hf09-817 encoding 
NS1 aa 1 to 73 and aa 1 to 99, respectively) were generated in the current study. They showed 
smaller-sized plaques than that of the WT virus (Figure 3.5B) and grew to titers 0.7 to 1 log 
lower on MDCK-NS1 cells than the WT Hf09 on MDCK cells titers were 7 × 106 plaque-
forming unit (PFU)/ml for Hf09-816 and 1.25 × 10
7
 PFU/ml for Hf09-817 versus 7.5 × 10
7
 
PFU/ml for WT Hf09 (Figure 3.5B). Infection of PAMs with WT Sk02 or Sk02-NS1/1–99 virus 
showed that the deletion of NS1 C-terminal aa 100 to 230 in Sk02 led to a slightly increased pro-
IL-1β expression, but did not alter the IL-1β level. Specifically, Sk02-NS1/1–99 virus induced 
only 1.07-fold more IL-1β than that induced by WT Sk02 (Figure 3.5C). In contrast, upon 
infection of PAMs, the Hf09-816 and Hf09-817 viruses induced 2.53- and 3.05-fold more IL-1β 
production than WT Hf09, respectively, yet they did not significantly affect pro-IL-1β expression 
levels (Figure 3.5D). In the reconstitution system, Hf09-816 and Hf09-817 infection led to a 
striking increase of IL-1β production above the level by WT Hf09 infection, although they did 
not markedly alter the pro-IL-1β level (Figure 3.5E). The level of an active caspase-1 subunit, 
p20, an indicator for NLRP3 inflammasome activation, was also consistently increased in the 
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cells infected with NS1-mutant viruses. These suggested that NS1 C-terminus of pdm09 
suppresses the porcine NLRP3 inflammasome-mediated IL-1β production. 
 
 
 
(Figure 3.5 to be continued) 
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Figure 3.5 NS1 C-terminus of pdm09, but not that of SIV, inhibits porcine NLRP3 
inflammasome activation.  
(A) A schematic representation of genome composition of WT and mutant viruses. The NS1 
protein encoded by different viruses is depicted. (B) Plaque assay results of WT virus in MDCK 
cells and NS1-mutant viruses in MDCK-NS1 cells at indicated dilutions shown above the plaque 
images. (C) PAMs were infected with Sk02 WT or Sk02-NS1/1-99 virus at an MOI of 1. At 24 
hpi, cell-free supernatants were collected for IL-1β ELISA and the cells were lysed for Western 
blotting to measure the expression of pro-IL-1β and viral proteins. ns, not significant. (D) PAMs 
were infected with Hf09 WT or two NS1-mutant virus (Hf09-816 or Hf09-817) at an MOI of 1 
for 24 h. IL-1β ELISA and Western blotting were performed as in (B). *, p=0.0201, **, 
p=0.0015. (E) HEK293T cells were transfected with plasmids expressing porcine NLRP3, ASC, 
pro-caspase-1 and pro-IL-1β. At 12 hpt, the cells were infected with Hf09 WT or NS1-mutant 
viruses at an MOI of 5. IL-1β production at 12 hpi was measured by ELISA and the expression 
of p20, pro-IL-1β and viral proteins was measured by Western blotting. ***, p<0.001.  
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3.4.6 Mutant SIVs with NS1 C-terminus derived from pdm09 inhibits the NLRP3 
inflammasome activation. 
To demonstrate conclusively that the C-terminus of pdm09 NS1 is responsible for the 
inhibition of IL-1β production, additional two mutant viruses in the background of Sk02 were 
generated. Sk02-616 has the entire NS segment from Hf09, and Sk02-930 has a chimeric NS1 
with the N-terminus from Sk02 and C-terminus from Hf09 as illustrated in Figure 3.6A. Plaque 
assay showed that the mutant viruses produced similar-sized plaques to those produced by the 
WT virus and their titres were comparable to that of WT Sk02: 6.25 × 10
7
 PFU/ml for Sk02-616 
and 8.75 × 10
7
 PFU/ml for Sk02-930 versus 4 × 10
7
 PFU/ml for WT Sk02 (Figure 3.6B). 
Infection of PAMs with Sk02-616 or Sk02-930 led to a reduction of IL-1β, while pro-IL-1β 
expression was not significantly impaired (Figure 3.6C). To support that the C-terminus of Hf09 
NS1 has a greater effect on the inflammasome activation rather than on the pro-IL-1β level, the 
expression of pro-IL-1β and p20 upon infection with Sk02 WT and Sk02-930 was monitored in 
the reconstitution system. Indeed, Sk02-930 could inhibit both caspase-1 activation and IL-1β 
production, but did not affect the pro-IL-1β expression (Figure 3.6D).  
Next, caspase-1 activity and IL-1β production in the reconstitution system were examined 
by overexpressing Flag- or Myc-tagged WT or truncated NS1. This experiment showed that co-
expression of the full-length Hf09 NS1 significantly inhibited caspase-1 activation and IL-1β 
production, whereas co-expression of the NS1 with C-terminal deletion (NS11-73 or NS11-99) had 
little or no inhibitory effects (Figure 3.6E). Further, co-expression of the NS1 C-terminal aa 100 
to 219 derived from Hf09 led to a reduction of IL-1β due to less caspase-1 activation, whereas 
this effect was not observed with the NS1 C-terminal aa 100 to 230 derived from Sk02 virus 
(Figure 3.6F). All of these results evidently demonstrated that the C-terminus of the Hf09 NS1 
has an inhibitory effect on NLRP3 inflammasome activation. 
Efforts were also made to map the responsible residues in the C-terminus of pdm09 NS1 
for the inhibition of IL-1β production. NS1 C-terminal aa sequences among SIVs (Sk02 and 
Tx98) and a pdm09 strain, Hf09 that induced high and low levels of porcine IL-1β production, 
respectively, were aligned (Figure 3.6G). In addition, a 1918 pandemic strain, influenza 
A/Brevig Mission/1/1918/H1N1 (BM18), whose NS1 protein is known to inhibit IL-1β 
production in primary human cells (Pothlichet et al., 2013), was included. Sk02 and BM18 had 
230 aa, while Tx98 and Hf09 had 219 aa in full lengths of NS1 protein, implying that the 
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presence of additional 11 aa at the C-terminal end did not contribute to the up- or down- 
regulation of IL-1β production. Identification of unique residues for Hf09 or BM18 NS1 to 
inhibit the IL-1β production was not successful, because among variable aa residues, those 
contained by Hf09 NS1 were also harboured by Tx98 NS1, or those contained by BM18 NS1 
were shared with Sk02 or Tx98 NS1. It suggested that multiple aa clusters in the NS1 C-terminus 
of pdm09 are responsible for the inhibition of IL-1β production. 
 
 
(Figure 3.6 to be continued) 
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(Figure 3.6 to be continued) 
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Figure 3.6 Mutant SIVs with NS1 C-terminus derived from pdm09 inhibits the NLRP3 
inflammasome.  
(A) A schematic representation of genome composition of WT and mutant viruses. The NS1 
protein encoded by different viruses is depicted. (B) Plaque assay results of WT and NS1-mutant 
viruses in MDCK cells at indicated dilutions shown above the plaque images. (C) PAMs were 
infected with Sk02, Sk02-616 or Sk02-930 at an MOI of 1. At 24 hpi, cell-free supernatants were 
collected for IL-1β ELISA and the cells were lysed for Western blotting to measure the 
expression of pro-IL-1β and viral proteins. *, p=0.0104, **, p=0.0012. (D) HEK293T cells were 
transfected with plasmids expressing porcine NLRP3, ASC, pro-caspase-1 and pro-IL-1β. At 12 
hpt, the cells were infected with Sk02 or Sk02-930 at an MOI of 5. IL-1β production at 12 hpi 
was measured by ELISA and the expression of p20, pro-IL-1β and viral proteins was measured 
by Western blotting. **, p=0.0056. (E) HEK293T cells were transfected with plasmids 
expressing porcine NLRP3 inflammasome components and pro-IL-1β along with Flag-vector or 
Flag-tagged WT/N-terminal aa of Hf09 NS1. IL-1β levels and protein expression at 18 hpt were 
measured. **, p=0.002, ***, p<0.001. (F) HEK293T cells were transfected with plasmids 
expressing porcine NLRP3 inflammasome components and pro-IL-1β along with Myc-vector or 
Myc-tagged NS1 C-terminus from Hf09 or Sk02. IL-1β levels and protein expression at 18 hpt 
were measured as in (E). ***, p<0.001. (G) Alignment of the C-terminal aa sequences (from aa 
100 to 219 or 230) of NS1 among SIVs (Sk02 and Tx98), Hf09 and BM18. Sk02 and Hf09 
sequences are shown in blue and red, respectively. Based on the sequence of Sk02, a conserved 
aa among four strains is shown as a hyphen. Consensus symbols indicate as follows: asterisk (*), 
fully conserved residues; colon (:), residues that share strongly similar properties; period (.), 
residues that share weakly similar properties. 
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3.4.7 NS1 C-terminus of pdm09 inhibits the interaction between NLRP3 and ASC. 
In an effort to define the mechanism behind the inhibitory function of pdm09 NS1 on the 
porcine NLRP3 inflammasome, the NLRP3-ASC interaction was examined. First, whether Hf09 
infection can inhibit the NLRP3-ASC interaction was tested by transfecting HEK293T cells with 
plasmids expressing Myc-tagged ASC and Flag-tagged NLRP3 followed by infection of the cells 
with Hf09. Co-IP with anti-Myc antibody followed by Western blotting showed that Flag-
NLRP3 was not in the IP complex when expressed alone (Figure 3.7A, lane 1), whereas it was 
successfully pulled down when ASC-Myc was co-expressed (Figure 3.7A, lane 2). However, 
when comparing between the mock-infected and Hf09-infected conditions, the pulled-down level 
of Flag-NLRP3 was lower in Hf09-infected cells (Figure 3.7A, lane 4), indicating that the 
NLRP3-ASC interaction is inhibited by Hf09 infection. Next, the effects of WT and truncated 
NS1 of Hf09 on the NLRP3-ASC interaction were compared. HEK293T cells were transfected 
with plasmids expressing Myc-tagged NLRP3 and ASC along with Flag-tagged WT or truncated 
NS1, and were subjected to co-IP. Association between NLRP3-Myc and ASC was clearly 
noticeable (Figure 3.7B, lane 2). The NLRP3-ASC interaction was obviously inhibited by the 
expression of Hf09 WT NS1 (Figure 3.7B, lane 4), while the interaction was restored with the 
expression of Hf09 NS11-73 or NS11-99 (Figure 3.7B, lanes 6 and 8). Therefore, the C-terminal 
region, particularly aa 100 to 219 of Hf09 NS1 plays a critical role in interfering with the 
NLRP3-ASC interaction that is essential for the activation of NLRP3 inflammasome.  
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Figure 3.7 NS1 C-terminus of pdm09 inhibits the interaction between NLRP3 and ASC.  
(A) HEK293T cells were transfected with Flag-NLRP3 construct along with Myc-vector or 
ASC-Myc construct, and either mock-infected or infected with Hf09 at an MOI of 1 for 12 h. 
Cell lysates were subjected to co-IP with anti-Myc antibody. IP and input samples were analyzed 
with Western blotting using anti-Myc, anti-Flag and anti-NS1 antibodies. (B) HEK293T cells 
were transfected with ASC construct and Myc-vector or NLRP3-Myc construct in addition to 
plasmids expressing Flag-tagged WT or mutant NS1 of Hf09. At 48 hpt, the cells were harvested 
and cell lysates were subjected to co-IP with mouse anti-Myc antibody. IP and input samples 
were analyzed with Western blotting using anti-ASC, anti-Myc and anti-Flag antibodies. IB, 
immunoblot. 
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3.4.8 NS1 C-terminus of pdm09 inhibits the ASC speck formation. 
Interference of NLRP3-ASC interaction by pdm09 NS1 C-terminus prompted further 
investigation on whether ASC specks formed by aggregation of NLRP3 with ASC, a hallmark of 
NLRP3 inflammasome activation, are affected by NS1 protein. In non-infected cells, transfection 
of either ASC or NLRP3 alone did not induce a noticeable number of specks (Figure 3.8A, top 
three rows). In contrast, co-transfection of porcine ASC and NLRP3 led to the aggregation of 
two proteins, forming the specks in the perinuclear area. Furthermore, in virus-infected cells as 
indicated by NP staining, Hf09-817 encoding NS1 aa 1-99 led to 2-fold more ASC speck 
formation than WT Hf09 (Figure 3.8A, bottom three rows). Specifically, while 6.8% of NP-
positive cells displayed ASC specks in Hf09-infected cells, 14.3% of NP-positive cells exhibited 
ASC specks in Hf09-817-infected cells (Figure 3.8B). These results demonstrated that the pdm09 
NS1 C-terminus suppresses the ASC speck formation, concomitantly with the disruption of 
NLRP3-ASC association. 
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Figure 3.8 NS1 C-terminus of pdm09 inhibits the ASC speck formation.  
(A) HEK293T cells were transfected with Myc-tagged NLRP3 or Myc-vector and Flag-tagged 
ASC or Flag-vector for 24 h and left uninfected (upper three rows). The cells were transfected 
with Myc-tagged NLRP3 and Flag-tagged ASC for 12 h and infected with Hf09 or Hf09-817 at 
an MOI of 5 for 12 h (lower three rows). The cells were fixed, permeabilized, blocked and 
probed with appropriate antibodies followed by DAPI staining. NLRP3-Myc (gray), Flag-ASC 
(green), viral NP (red) and nuclei (blue) were visualized by confocal microscopy. The scale bars 
indicate 10 μm. (B) ASC speck-forming cells and NP-stained cells infected by Hf09 or Hf09-817 
were quantified from five randomly selected fields and the percentages of ASC speck- and NP-
positive cells in total NP-positive cells were shown. Mann-Whitney test, **, p=0.0025. 
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3.5 Discussion 
NLRP3 inflammasome exerts indispensable roles in regulating the innate immunity. In this 
study, porcine NLRP3 inflammasome regulation in response to IAV infection was investigated. 
While SIVs generally induce inflammatory responses in pigs (Khatri et al., 2010, Pomorska-Mól 
et al., 2014), Ma et al. showed pdm09-infected pigs had upregulated expression of genes 
involved in the inflammatory and immune responses (Ma et al., 2011). In terms of the cytokine 
response in human cells infected by pdm09, there have been some controversial reports. Both 
upregulation of inflammatory cytokines (Lee et al., 2011, Sakabe et al., 2011, Yu et al., 2011) 
and poor inflammatory responses were reported (Osterlund et al., 2010, Zeng et al., 2011). 
Nevertheless, there is little information concerning the regulation of IL-1β production, which 
requires the activation of NLRP3 inflammasome upon IAV infection in pigs. Since alveolar 
macrophages are essential for the regulation of lung inflammation and are required for the 
protection against IAV infection (Cardani et al., 2017, Kim et al., 2008, Schneider et al., 2014), 
primary PAMs were utilized to characterize how porcine IL-1β is produced in response to IAV 
infection.  
In this study, swine isolates of IAVs induced IL-1β production, which was mediated by 
TLR3 and NLRP3 inflammasome, in a viral dose- and replication-dependent manner. In contrast, 
Hf09, a pdm09 strain, induced much lower level of IL-1β production. The fact that Hf09 and 
Sk02 replicated to similar titres in PAMs and that they induced similar levels of pro-IL-1β 
suggested that the NLRP3 inflammasome was less active or was suppressed in Hf09-infected 
cells. Similar levels of NLRP3 mRNA transcription induced by Sk02 and Hf09 infection further 
supported that the intensity of signal 1 provided by the two viruses was comparable.  
IAV NS1 protein has been reported to inhibit the NLRP3 inflammasome-mediated IL-1β 
production in mouse or human macrophages (Cheong et al., 2015, Moriyama et al., 2016). In 
addition, NS1 from a highly pathogenic, 1918 pandemic strain, BM18 suppresses RIG-I/NLRP3 
inflammasome-dependent IL-1β production from primary human lung cells (Pothlichet et al., 
2013). Cheong et al. reported that NS1 encoded by human H5N1 or H1N1 strain physically 
interacts with NLRP3 and suppresses the inflammasome activation in THP-1 cells (Cheong et 
al., 2015). Based on an early study using PR8 strain, which showed that deletion of NS1 aa 40 to 
80 increases human IL-1β production (Stasakova et al., 2005), they tested NS1 from a low 
pathogenic strain, influenza A/WSN/1933/H1N1 (WSN33) and its mutant with aa 40-80 deleted 
 83 
(Cheong et al., 2015), however, the mutant NS1 without aa 40-80 could still bind NLRP3. 
Interestingly, another study with the same virus shows that deletion of 28 aa at the NS1 C-
terminal end of the WSN33 virus results in the production of more IL-1β, but less TNF-α and 
chemokines in mice (Anastasina et al., 2015), suggesting that critical regions for the inhibition of 
IL-1β production may be strain-dependent and/or host-dependent. Moriyama et al. demonstrated 
that PR8 NS1 also interacts with NLRP3, thereby inhibiting human or mouse IL-1β production. 
The inhibitory function was mapped to the RNA-binding domain (R38 and K41) and TRIM25-
binding domain (E96 and E97) within the N-terminus of NS1, since PR8 NS1 constructs with 
mutations on those residues were unable to bind NLRP3 (Moriyama et al., 2016), meaning that 
multiple regions of NS1 are involved in the NLRP3 inflammasome regulation. In contrary to the 
aforementioned reports, the current study showed that the mutant pdm09 virus carrying NS1 C-
terminal deletion from aa 100 to 219 induced strikingly higher level of IL-1β than did the WT 
virus. Also, the ectopic expression of the NS1 C-terminal aa 100-219 from Hf09, but not that 
from Sk02 led to a decreased level of IL-1β secretion. In accordance with it, NS1 C-terminus 
derived from Hf09 was responsible for disrupting the interaction between NLRP3 and ASC, and 
suppressing the formation of ASC specks. Thus, the C-terminus of pdm09 NS1 obviously 
possesses inhibitory functions on the porcine NLRP3 inflammasome activation. Intriguingly, 
NS1 C-terminal aa 126-225 of avian H5N1 downregulates the RIG-I-mediated IFN signaling by 
interacting with TRAF3 (Qian et al., 2017). Whether pdm09 NS1 can interact with any of 
porcine NLRP3 inflammasome components or even other proteins that may participate in the 
regulation of the inflammasome activity requires further elucidation. 
NS1 C-terminus contains multiple motifs critical for binding host cellular partners.  
For example, by binding to CPSF30 and PABPII, NS1 can repress the polyadenylation of host 
cellular pre-mRNAs and the nuclear export of cellular mRNAs, respectively (Hale et al., 2008). 
However, PABPII-binding motif (NS1 aa 223 to 230) is not encoded by pdm09 due to a natural 
truncation of 11 aa at the C-terminal end (Tu et al., 2011), and pdm09 NS1 is defective in 
binding CPSF30 (Hale et al., 2010). This prompted an analysis to locate the potential residues in 
pdm09 NS1 involved in regulating the NLRP3 inflammasome. BM18 NS1 was included in the 
NS1 aa alignment with a speculation that C-terminus of this protein may be involved in the 
downregulation of IL-1β production. Unfortunately, aligning the NS1 C-terminal aa 100 to 219 
(or 230) of three IAV strains used in the current study (Sk02, Tx98 and Hf09) and BM18 did not 
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provide any clue in identifying critical residues in Hf09 NS1 for the inhibition of IL-1β. 
Therefore, it will be required to obtain the porcine IL-1β secretion profiles of other IAV strains 
and compare the C-terminal aa sequences together with the additional strains.  
Collectively, NLRP3 inflammasome-mediated IL-1β production was potently induced in 
primary PAMs infected with SIVs, while it was suppressed in pdm09-infected cells due to the 
inhibition of NLRP3 inflammasome activity by NS1. NS1 C-terminus of pdm09 exhibited strong 
inhibitory functions on porcine IL-1β production by interference with NLRP3-ASC interaction 
and ASC speck formation, all of which are critical for the NLRP3 inflammasome activation. This 
unveiled an important mechanism played by pdm09 NS1 to evade the inflammatory responses in 
pigs. 
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TRANSITION BETWEEN CHAPTER 3 AND CHAPTER 4 
In Chapter 3, IL-1β production from PAMs upon infection with SIVs was found to be 
TLR3- and NLRP3 inflammasome-mediated. Testing with additional IAV strains led to a finding 
that a pdm09 strain, Hf09 induced less IL-1β than SIVs. Further study revealed that NS1 C-
terminus of Hf09, but not that of SIV, was able to significantly inhibit the NLRP3 
inflammasome-mediated IL-1β production. Interfered interaction between NLRP3 and ASC 
leading to the suppressed ASC speck formation by NS1 C-terminus of Hf09 was suggested as 
one of the regulatory events behind the inhibition of it. In the following chapter, to dissect the 
mechanism in depth, further investigation is conducted regarding the modifications on ASC, 
which functions as a bridge between the sensor protein, NLRP3 and the effector molecule, 
caspase-1. Aiming to elucidate whether any post-translational modification of ASC is inhibited 
by pdm09 NS1 and if it is related to the ASC speck phenotypes, the study in Chapter 4 
particularly focuses on how ASC ubiquitination is regulated by NS1 C-terminus of Hf09. 
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CHAPTER 4 NS1 C-TERMINUS OF 2009 PANDEMIC INFLUENZA VIRUS INHIBITS 
PORCINE NLRP3 INFLAMMASOME BY SUPRESSING ASC UBIQUITINATION. 
 
 
 
 
 
Portions of the data presented in this chapter were published in  
 
NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-
Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination. 
 
HS Park, G Liu, SN Thulasi Raman, SL Landreth, Q Liu and Y Zhou. (2018) 
 
Journal of Virology, 92(8), e00022-18. 
 
 
 
 
 
Acknowledgement specific for this chapter: 
The human ASC construct was provided by Dr. Takeshi Ichinohe (University of Tokyo) and the 
ubiquitin constructs were provided by Dr. Dirk Bohmann (University of Rochester Medical 
Center) and Dr. Edward Harhaj (Johns Hopkins University School of Medicine). 
 
  
 87 
4.1 Abstract 
NLRP3 inflammasome is regulated at multiple levels, with one level being post-
translational modification. Among others, ubiquitination of ASC has been reported to be 
indispensable for the activation of NLRP3 inflammasome. IAV infection induces NLRP3 
inflammasome-dependent IL-1β production, which is critical in the host innate immunity. Based 
on the results that NS1 C-terminus of pdm09, but not that of SIV, inhibited the NLRP3-ASC 
interaction and ASC speck formation in the previous chapter, the in-depth mechanism behind the 
inhibitory functions was explored. Studies in this chapter showed that porcine ASC could 
undergo ubiquitination upon IAV infection; NS1 C-terminus of pdm09 suppressed the 
ubiquitination on both porcine and human ASC. Moreover, two target lysine residues K110 and 
K140 that are essential for porcine ASC ubiquitination were identified. The importance of these 
two residues in regulating the NLRP3 inflammasome-mediated IL-1β production was also 
demonstrated. These results showed how NS1 protein of the pdm09 suppresses a post-
translational modification to downregulate the NLRP3 inflammasome activation. 
 
4.2 Introduction 
NLRP3 inflammasome is regulated by post-translational modifications. Among different 
types of modifications, ubiquitination and deubiquitination play diverse roles in the regulation of 
inflammasomes (Bednash and Mallampalli, 2016). Ubiquitination is a process by which 
ubiquitin proteins are conjugated to substrate proteins. In addition to proteasomal degradation of 
the substrates, this linkage plays crucial roles in a variety of cell signaling pathways. 
Ubiquitination is a three-step process mediated by E1 activating enzymes, E2 conjugating 
enzymes and E3 ligases. Ubiquitins can also be recycled after being removed from substrates by 
deubiquitinases (Kattah et al., 2017). The substrate selectivity is generally determined by E3 
ligases that link the C-terminal glycine of a ubiquitin molecule to a lysine (K) on the substrate. 
Monoubiquitination occurs by binding of a single ubiquitin to each lysine in the substrate; a 
subsequent linkage of more ubiquitins to lysine residues located on the first ubiquitin leads to 
different types of polyubiquitination (Davis and Gack, 2015). Additional ubiquitin molecules can 
be linked on a lysine residue among seven lysines (K6, K11, K27, K29, K33, K48 and K63) or 
on the first methionine (M1) residue, eventually leading to different consequences. K48-linked 
ubiquitination can target the substrates for proteasomal degradation, while K63-linked 
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ubiquitination leads to signal transduction by affecting the stability or localization of target 
proteins; other linkages are involved in rather diverse activities including cell development, 
signaling regulation, autophagy or protein degradation (Davis and Gack, 2015, Kattah et al., 
2017).  
Deubiquitinases are required for inflammasome-dependent IL-1β production (Lopez-
Castejon et al., 2013) and more specifically, deubiquitination of NLRP3 is reported to be 
important for the activation of the NLRP3 inflammasome (Guo et al., 2016, Han et al., 2015, 
Juliana et al., 2012, Kawashima et al., 2017, Py et al., 2013, Yen et al., 2015). On the contrary, 
autophagy-mediated or proteasomal degradation of ubiquitinated NLRP3 leads to suppression of 
the NLRP3 inflammasome (Song et al., 2016, Yan et al., 2015). Upon activation of several 
different inflammasomes, caspase-1 can be ubiquitinated, which may downregulate the 
inflammasome activity (Van Opdenbosch et al., 2014). Also, pro-IL-1β undergoes 
ubiquitination, which leads to either its maturation into IL-1β or its degradation (Ainscough et 
al., 2014, Duong et al., 2015, Harris et al., 2011). ASC ubiquitination was first reported in a 
study of AIM2 inflammasome-related autophagy in response to double-stranded DNA (Shi et al., 
2012). More recent studies observed ASC ubiquitination upon NLRP3 inflammasome activation. 
While ASC ubiquitination by an E3 ligase, TRAF6 can limit the NLRP3 inflammasome activity 
(Chiu et al., 2016), deubiquitination of ASC is required for the NLRP3 inflammasome activation 
(Lee et al., 2017c). ASC can also be modified by linear ubiquitin assembly complex (LUBAC), 
which is required for the activation of NLRP3 inflammasome (Rodgers et al., 2014). In the 
context of RNA virus infection, ubiquitination of ASC by E3 ligase TRAF3 upon infection with 
vesicular stomatitis virus (VSV) is critical for inflammasome-mediated IL-1β production (Guan 
et al., 2015). In spite of those studies, it remains unknown how ASC ubiquitination regulates 
inflammasome activity during IAV infection. 
In this chapter, ubiquitin modification on ASC upon WT or NS1-mutant pdm09 virus 
infection was examined. It showed that the NS1 C-terminus of the pdm09 strain, Hf09 inhibits 
NLRP3 inflammasome-mediated IL-1β production by suppressing the ubiquitination of porcine 
ASC. Mutational analyses identified the target lysine residues, K110 and K140 found in porcine 
ASC to be critical for the NLRP3 inflammasome-mediated IL-1β production. Thus, these results 
revealed a new mechanism of the innate immune evasion achieved by the NS1 protein of pdm09. 
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4.3 Materials and methods 
4.3.1 Cells and viruses 
HEK293T cells were cultured with DMEM supplemented with 10% FBS and 50 μg/ml 
gentamicin. Human monocytic THP-1 cells were cultured with RPMI 1640 media (30-2001, 
ATCC) supplemented with 10% FBS, 50 μM 2-mercaptoethanol (21985-023, Thermo Fisher), 1 
× penicillin-streptomycin  (100 U/ml penicillin, 100 μg/ml streptomycin) (15140122, Thermo 
Fisher). Hf09, a pdm09 strain, was propagated in MDCK cells. The mutant viruses, Hf09-816 
and Hf09-817 are two isogenic Hf09 viruses that encode truncated NS1, i.e. aa 1-73 or 1-99, 
respectively. Generation and propagation of these viruses were described in the sections 3.3.2 
and 3.3.3. THP-1 cells were seeded at 3 × 10
5
 cells/well on 24-well plates and differentiated into 
adherent macrophages by treatment with 100 ng/ml phorbol 12-myristate-13-acetate (P8139, 
Sigma) for 24 h. The cells were infected with Hf09 or Hf09-817 at an MOI of 5. At 24 hpi, cell-
free supernatants were collected for human IL-1β ELISA. 
 
4.3.2 Antibodies and reagents 
Rabbit anti-NP and anti-NS1 antibodies were generated as described (Shin et al., 2007b). 
Goat polyclonal anti-porcine IL-1β antibody (BAF681, R&D Systems), rabbit polyclonal anti-
porcine caspase-1 (p20) antibody (PAB592Po01, Cloud-Clone Corp), mouse monoclonal anti-β-
actin antibody (#3700, CST), mouse monoclonal anti-green fluorescent protein (GFP) antibody 
(#2955, CST), mouse monoclonal anti-Myc-tag antibody (#2276, CST), mouse monoclonal anti-
FLAG M2 antibody (F3165, Sigma), rabbit polyclonal anti-HA tag antibody (ab9110, Abcam), 
mouse monoclonal anti-ubiquitin antibody (sc-8017, Santa Cruz) were purchased from different 
sources. For the secondary antibodies, IRDye 680RD donkey anti-rabbit (926-68073), IRDye 
800CW donkey anti-mouse (926-32212) and IRDye 800CW donkey anti-goat (926-32214) 
antibodies were purchased from LI-COR Biosciences. Transfection was conducted using 
TransIT-LT1 Transfection Reagent (MIR2300, Mirus-Bio). EDTA-free protease inhibitor 
cocktail tablets (4693132001, Roche) were used in cell lysis and IP. 
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4.3.3 Plasmid construction 
Expression plasmids for porcine NLRP3, ASC, pro-caspase-1 and pro-IL-1β used for 
NLRP3 inflammasome reconstitution and epitope-tagged NLRP3 or ASC were generated as 
described in the section 3.3.5. WT and truncated NS1 of Hf09 were cloned into pcDNA3.1-
3×Myc vector and the resulting plasmids were designated as pcDNA-Hf09-NS1-Myc and 
pcDNA-Hf09 NS11-99-Myc, encoding the full-length and N-terminal aa 1 to 99 of NS1, 
respectively. Mutant ASC constructs with lysines replaced by arginines were generated by site-
directed mutagenesis using pCMV-Flag-ASC as the template. Truncated ASC with aa 1 to 109 
or 1 to 158 was cloned into pCMV-3×Flag vector to generate pCMV-Flag-ASC1-109 and pCMV-
Flag-ASC1-158. The full-length gene of human ASC was cloned into pCMV-3×Flag vector to 
generate pCMV-Flag-huASC using pCA7-ASC (Komune et al., 2011) as the template and 
primers designed based on the GenBank sequence (accession number NM_013258). The HA-
tagged ubiquitin construct, pCMV-HA-ubiquitin, with eight tandem sequences of HA-ubiquitin 
(Treier et al., 1994) was used in ubiquitination assays. pcDNA-HA-ubiquitin (Xiao et al., 2001) 
was used as the template to generate ubiquitin constructs with a mutation K48R (pcDNA-HA-
ubiquitin [K48R]) or K63R (pcDNA-HA-ubiquitin [K63R]). For mutagenesis, primers were 
designed with the online tool, NEBaseChanger provided by New England BioLabs (NEB), and 
PCR was performed with Q5 Hot Start High-Fidelity 2 × Master Mix (M0494S, NEB). Purified 
PCR products were phosphorylated with 10 mM ATP and T4 Polynucleotide Kinase (M0201S, 
NEB) followed by ligation, DpnI digestion and transformation with standard protocols. 
Mutagenesis of some constructs was conducted in classical method. PCR was performed with 
overlapping primer sets containing the mutant sequences using HotStar HiFidelity Polymerase 
Kit. PCR products were subjected to the digestion of parental plasmids with DpnI before used for 
transformation. The mutations and truncations were confirmed by DNA sequencing. The 
expression plasmids generated for this chapter are listed in Table 4.1 and the primers are listed in 
Supplementary Table 3. 
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Table 4.1 List of expression plasmids used in Chapter 4.  
The constructs for NLRP3 inflammasome components and pro-IL-1β used for NLRP3 
inflammasome reconstitution assay were described in Table 3.2. 
 
Construct Template used to clone Purpose 
pcDNA-NLRP3-Myc pcDNA-NLRP3 ASC speck formation 
pCMV-Flag-NLRP3 pcDNA-NLRP3 Ubiquitination assay 
pCMV-Flag-ASC pcDNA-ASC 
ASC speck formation,  
Ubiquitination assay,  
NLRP3 inflammasome reconstitution 
pcDNA-GFP  Ubiquitination assay 
pcDNA-Hf09-NS1-Myc pHW-Hf09-NS Ubiquitination assay 
pcDNA-Hf09-NS11-99-Myc pHW-Hf09-NS Ubiquitination assay 
pCMV-Flag-huASC 
pCA7-ASC 
(Komune et al., 2011) 
Ubiquitination assay 
pCMV-Flag-ASC 
(K21R/K22R/K24R/K26R) 
pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K55R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K79R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K87R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K91R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K96R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K101R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K106R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K110R) pCMV-Flag-ASC 
Ubiquitination assay,  
NLRP3 inflammasome reconstitution 
pCMV-Flag-ASC (K140R) pCMV-Flag-ASC 
Ubiquitination assay,  
NLRP3 inflammasome reconstitution 
pCMV-Flag-ASC 
(K110R/K140R) 
pCMV-Flag-ASC 
(K110R) 
Ubiquitination assay, 
ASC speck formation, 
NLRP3 inflammasome reconstitution 
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pCMV-Flag-ASC (K159R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K175R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC (K183R) pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC1-109 pCMV-Flag-ASC Ubiquitination assay 
pCMV-Flag-ASC1-158 pCMV-Flag-ASC Ubiquitination assay 
pCMV-HA-ubiquitin 
(Treier et al., 1994) 
 Ubiquitination assay 
pcDNA-HA-ubiquitin 
(Xiao et al., 2001) 
 
Ubiquitination assay, 
NLRP3 inflammasome reconstitution 
pcDNA-HA-ubiquitin 
(K48R) 
pcDNA-HA-ubiquitin Ubiquitination assay 
pcDNA-HA-ubiquitin 
(K63R) 
pcDNA-HA-ubiquitin Ubiquitination assay 
 
4.3.4 Ubiquitination assay 
HEK293T cells were seeded at 1 × 10
6
 cells per well on 6-well plates and were transfected 
with 1 μg of pCMV-HA-ubiquitin or pcDNA-HA-WT/mutant ubiquitin together with one of the 
following constructs encoding target proteins: Flag-tagged NLRP3 (pCMV-Flag-NLRP3), 
WT/mutant ASC (pCMV-Flag-WT/mutant ASC) or human ASC (pCMV-Flag-huASC). At 24 
hpt, the cells were infected with viruses at an MOI of 10 for 9 h. For the compensation assay, the 
cells were transfected with 1 μg of pCMV-HA-ubiquitin and pCMV-Flag-ASC along with either 
a plasmid expressing GFP, pcDNA-Hf09-NS1-Myc or pcDNA-Hf09-NS11-99-Myc. At 24 hpt, 
the cells were infected with Hf09-817 as above. Cell lysis and IP were performed as previously 
described with some modifications (Palazón-Riquelme and López-Castejón, 2016). Briefly, the 
cells were lysed with 200 μl of SDS-lysis buffer (20 mM Tris, pH 8.0, 250 mM NaCl, 3 mM 
EDTA, 10% glycerol, 1% SDS, 0.5% Nonidet P-40 substitute) freshly supplemented with 20 
mM N-ethylmaleimide (E3876, Sigma), 5 mM 1,10-phenanthroline monohydrate (P9375, 
Sigma) and 1 × protease inhibitor cocktail, while 5% of the cells were lysed with 1 × SDS 
sample buffer for input. The clarified cell lysates were mixed with 600 μl of SDS-IP buffer (20 
mM Tris, pH 8.0, 250 mM NaCl, 3 mM EDTA, 10% glycerol, 0.1% SDS, 0.5% Nonidet P-40 
substitute) freshly supplemented with 20 mM N-ethylmaleimide, 5 mM 1,10-phenanthroline 
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monohydrate and 1 × protease inhibitor cocktail and incubated with 40 μl slurry of mouse anti-
FLAG M2 affinity agarose (A2220, Sigma) at 4°C for 4 h with agitation. After washed four 
times with 500 μl of SDS-IP buffer, the agarose was mixed with 60 μl of 2 × SDS sample buffer 
and boiled at 95°C for 5 min for elution. The eluted proteins were subjected to SDS-PAGE and 
Western blotting. 
 
4.3.5 NLRP3 inflammasome reconstitution assay 
HEK293T cells were seeded at 1.5 × 10
5
 cells per well on 24-well plates. To examine the 
effect of ubiquitin on the NLRP3 inflammasome activity, cells were transfected with pcDNA-
NLRP3 (30 ng), pcDNA-ASC (20 ng), pCMV-Flag-pro-caspase-1 (20 ng) and pcDNA-pro-IL-
1β (100 ng) along with 100 ng of HA-vector or HA-tagged ubiquitin construct. At 24 hpt, cell-
free supernatants were collected for porcine IL-1β ELISA and cells were lysed with 1 × SDS 
sample buffer for Western blotting. To examine the NLRP3 inflammasome activity upon viral 
infection, the cells were transfected with pcDNA-NLRP3 (30 ng), pCMV-Flag-WT/mutant ASC 
(10 ng), pCMV-Flag-pro-caspase-1 (20 ng) and pcDNA-pro-IL-1β (100 ng). At 12 hpt, cells 
were infected with Hf09-817 at an MOI of 5. Cell-free supernatants and cells harvested at 12 hpi 
were analyzed as mentioned. 
 
4.3.6 Porcine IL-1β ELISA 
Porcine IL-1β from cell-free supernatants was measured as described in the section 3.3.12. 
Briefly, Immulon 2 HB U plates were coated with mouse monoclonal anti-porcine IL-1β 
antibody in PBS at room temperature overnight. The plates were washed four times with TBST 
between each step. Blocking was performed with 1% BSA in PBS for 1 h. Serial dilutions of 
recombinant porcine IL-1β protein in diluent were used as the standard. The plates were 
incubated with samples or the standard for 2 h. The plates were then incubated with goat 
polyclonal anti-porcine IL-1β biotinylated antibody in diluent for 1 h, followed by the incubation 
with alkaline phosphatase streptavidin in diluent for another 1 h. After additional incubation with 
PNPP in diethanolamine buffer for color development, the plates were read at 405 nm with 
reference at 490 nm using xMark Microplate Absorbance Spectrophotometer. 
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4.3.7 Human IL-1β ELISA 
IL-1β secreted from THP-1 cells was measured by human IL-1β DuoSet ELISA kit 
(DY201-05, R&D Systems) according to the manufacturer’s protocol. All the procedures were 
performed at room temperature. A 96-well microplate included in the kit was coated with 100 μl 
per well of mouse anti-human IL-1β capture antibody (Part #840168) that was reconstituted with 
PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2-7.4, 0.2 µm 
filtered). After incubation overnight, the plate was washed thrice with 400 μl Wash Buffer 
(0.05% Tween 20 in PBS, pH 7.2-7.4) per well. Blocking was performed by an hour’s incubation 
with 300 μl Reagent Diluent (1% BSA in PBS, pH 7.2-7.4, 0.2 µm filtered) per well. 
Recombinant human IL-1β standard (Part #840170) was reconstituted with distilled water and 
two-fold serial dilution was performed in Reagent Diluent for the seven-point standard curve. 
Samples or each dilution of the standard were applied at 100 μl per well and left for 2 h. After 
washing as above, the plate was incubated for additional 2 h with 100 μl per well of biotinylated 
goat anti-human IL-1β detection antibody (Part #840169) that was reconstituted and diluted in 
Reagent Diluent. Streptavidin-horseradish peroxidase (Part #843975) diluted in Reagent Diluent 
was added at 100 μl per well followed by incubation for 20 min in the dark. After washing, the 
plate was further incubated with 100 μl per well of Substrate Solution (1:1 mixture of H2O2 and 
tetramethylbenzidine) for 20 min in the dark. Upon adding 100 μl Stop Solution (2 N H2SO4) to 
each well, the OD was measured by reading at 450 nm with reference at 540 nm using xMark 
Microplate Absorbance Spectrophotometer (Bio-Rad). 
 
4.3.8 Cycloheximide (CHX) chase assay 
HEK293T cells were seeded at 1.8 × 10
5
 cells per well on 24-well plates and transfected 
with 200 ng of plasmids expressing Flag-tagged WT ASC or ASC with K110R/K140R mutation. 
At 24 hpt, the cells were treated with 50 μg/ml CHX (C7698, Sigma) for 2, 4, 6 or 8 h before 
harvested. Untreated cells were harvested at 24 hpt. The cells were lysed with 1 × SDS sample 
buffer for Western blotting using anti-Flag and anti-β-actin antibodies.  
 
4.3.9 Western blotting 
Cell lysates or IP samples were fractionated by SDS-PAGE and blotted onto nitrocellulose 
membranes. The membranes were blocked with 5% skim milk in TBS with 0.1% Tween 20 for 1 
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h and incubated with primary antibodies at 4°C overnight. After incubation with the secondary 
antibodies at room temperature for 1 h, the membranes were scanned with an Odyssey infrared 
imager. Image J software (National Institutes of Health, United States) was used for the 
normalization of expression levels. 
 
4.3.10 Immunofluorescence and confocal microscopy 
ASC specks were visualized as described in the section 3.3.16. Briefly, HEK293T cells 
were seeded at 6 × 10
4
 cells per well on LabTek II CC2 chamber slides. The cells were 
transfected with pcDNA-NLRP3-Myc (50 ng) and pCMV-Flag-WT/mutantASC (30 ng) for 24 
h. Cells were fixed with 4% paraformaldehyde for 10 min and permeabilized with 0.2% Triton 
X-100 for 5 min at room temperature. The cells were incubated with 5% BSA in DPBS for 1 h at 
room temperature and probed with rabbit anti-Myc and goat anti-Flag antibodies overnight at 
4°C followed by incubation with the secondary antibodies, Alexa Fluor 546 donkey anti-rabbit 
IgG and Alexa Fluor 633 donkey anti-goat IgG for 1 h at room temperature. The cells were 
counterstained with DAPI for 5 min and the coverslip was mounted with ProLong Diamond 
Antifade Mountant overnight. Images were obtained with a confocal microscope. 
 
4.3.11 Statistical analysis 
The data were analyzed using GraphPad Prism 7 (version 7.0a) by one-way ANOVA with 
Tukey’s multiple comparisons test. Two-tailed unpaired t-test was used where specified. The 
bars indicate the mean ± SD. The p-value of less than 0.05 was considered to be statistically 
significant. 
 
4.4 Results 
4.4.1 Porcine ASC is ubiquitinated and NS1 C-terminus of pdm09 inhibits the 
ubiquitination. 
To examine whether ubiquitin modifications are involved in porcine NLRP3 
inflammasome activity, NLRP3 inflammasome reconstitution assay was conducted by co-
transfecting HA-vector or HA-tagged ubiquitin. When ubiquitin was co-expressed, there was 
increased caspase-1 activation and more IL-1β production (Figure 4.1A), indicating that 
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ubiquitination on the NLRP3 inflammasome components or pro-IL-1β may upregulate the 
inflammasome activity. Based on this finding, two questions were asked: i) whether NLRP3 or 
ASC ubiquitination occurs upon viral infection; ii) whether Hf09 NS1 C-terminus contributes to 
the regulation of this event. HEK293T cells were co-transfected with plasmids expressing HA-
tagged ubiquitin and Flag-tagged NLRP3 or Flag-tagged ASC, and were then infected with Hf09 
WT, Hf09-816 or Hf09-817 virus. NLRP3 was ubiquitinated in this setting; however, the 
ubiquitination levels were not affected by infection with the Hf09 WT, NS1-mutant viruses 
(Figure 4.1B). In contrast, while ASC was slightly ubiquitinated in mock- or WT Hf09-infected 
cells, the ubiquitination levels of ASC were increased in cells infected with NS1-mutant viruses 
(Figure 4.1C). The total cellular ubiquitination levels were not considerably altered by viral 
infection. These results suggested that the NS1 C-terminus of Hf09 plays a role in inhibiting the 
ubiquitination of ASC, but has no effect on NLRP3 ubiquitination. To further confirm the 
inhibitory function of NS1 on ASC ubiquitination, a compensation assay was conducted. In this 
assay, Myc-tagged WT NS1 or truncated NS1 (NS11-99) was pre-expressed together with ASC 
and ubiquitin in HEK293T cells. After 24 h, cells were infected with an NS1-mutant virus, Hf09-
817, to induce the ubiquitination of ASC. While pre-expression of GFP or NS11–99 protein did 
not have any impact on ASC ubiquitination, WT NS1 protein could diminish the ubiquitination 
induced by the Hf09-817 virus (Figure 4.1D), reaffirming that the NS1 C-terminus of Hf09 
suppresses porcine ASC ubiquitination.  
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Figure 4.1 Porcine ASC is ubiquitinated and NS1 C-terminus of pdm09 inhibits the 
ubiquitination.  
(A) HEK293T cells were transfected with plasmids expressing porcine NLRP3 inflammasome 
components and pro-IL-1β along with HA-vector or HA-tagged ubiquitin. IL-1β production at 24 
hpt was measured by ELISA and the expression of p20 and pro-IL-1β was measured by Western 
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blotting. Unpaired t-test, two-tailed, p=0.0279. (B and C) HEK293T cells were transfected with 
HA-vector or HA-ubiquitin and Flag-vector or Flag-NLRP3/ASC constructs. At 24 hpt, the cells 
were infected with WT or NS1-mutant Hf09 viruses at an MOI of 10 for 9 h. Cell lysates in 
denaturing condition were subjected to co-IP with beads conjugated with anti-Flag antibody. IP 
and input samples were used for Western blotting with antibodies indicated. (D) HEK293T cells 
were transfected with HA-vector or HA-ubiquitin and Flag-ASC constructs along with plasmids 
expressing GFP, Myc-tagged WT or mutant NS1 of Hf09. At 24 hpt, the cells were infected with 
Hf09-817 at an MOI of 10 for 9 h. Co-IP was conducted as in (B) and Western blotting was 
performed with antibodies indicated. The asterisks in (C) and (D) indicate IgG heavy chains. 
 
 
4.4.2 NS1 C-terminus of pdm09 inhibits the ubiquitination of human ASC. 
To explore whether the ability of Hf09 NS1 to suppress ASC ubiquitination is limited to 
porcine immunity, ubiquitination assay using a Flag-tagged human ASC construct (Flag-huASC) 
was performed. Interestingly, the ubiquitination level of human ASC was increased in cells 
infected with Hf09-817 compared to that in mock-infected or WT Hf09-infected cells (Figure 
4.2A), showing that Hf09 NS1 C-terminus can inhibit the ubiquitination of both porcine and 
human ASC. To answer an arising question if human IL-1β production is also suppressed by C-
terminal NS1 of Hf09, THP-1 cells were infected by Hf09 or Hf09-817. Indeed, human IL-1β 
produced from cells infected with Hf09-817 was more than that from Hf09 WT-infected cells 
(Figure 4.2B), suggesting that the inhibition of human IL-1β production may be attributed to the 
suppressed ASC ubiquitination by pdm09 NS1 C-terminus. 
 
  
 99 
 
 
Figure 4.2 NS1 C-terminus of pdm09 inhibits the ubiquitination of human ASC.  
(A) HEK293T cells were transfected with HA-ubiquitin and Flag-huASC constructs for 24 h and 
infected with WT Hf09 or Hf09-817 at an MOI of 10 for 9 h. Cell lysates in denaturing condition 
were subjected to co-IP with beads conjugated with anti-Flag antibody. IP and input samples 
were used for Western blotting with antibodies indicated. The asterisk indicates IgG heavy 
chains. (B) THP-1 cells were infected with Hf09 or Hf09-817 at an MOI of 1 for 24 h. Human 
IL-1β levels in cell-free supernatants were analyzed by ELISA. *, p=0.021. 
 
4.4.3 ASC undergoes mixed lysine-linked ubiquitination in response to NS1-mutant 
pdm09 virus. 
Which lysine residue(s) among seven in the ubiquitin molecules is involved in the 
ubiquitination of target proteins may determine the fate of target proteins. Ubiquitination assay 
was conducted using mutant ubiquitin constructs with each lysine (K) replaced by arginine (R) 
among seven lysines on a ubiquitin molecule. Ubiquitination levels of porcine ASC upon Hf09-
817 infection were not diminished when either K48 or K63 was replaced by arginine in the 
ubiquitin (Figure 4.3), suggesting that K48 or K63 alone is not linked to ASC ubiquitination,  
rather, mixed lysines are involved. 
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Figure 4.3 ASC undergoes mixed lysine-linked ubiquitination in response to NS1-mutant 
pdm09 virus.  
HEK293T cells were transfected with HA-tagged WT or K-to-R mutant ubiquitin and Flag-ASC 
constructs. At 24 hpt, the cells were infected with Hf09 WT or Hf09-817 at an MOI of 10 for 9 
h. Cell lysates in denaturing condition were subjected to co-IP with beads conjugated with anti-
Flag antibody. IP and input samples were used for Western blotting with antibodies indicated. 
The asterisk indicates IgG heavy chains. 
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4.4.4 K110 and K140 are ubiquitination sites on porcine ASC. 
Ubiquitination generally occurs by conjugation of ubiquitin molecules on the lysine(s) in 
target proteins. To investigate which lysine(s) in porcine ASC is targeted for ubiquitination, the 
positions of lysine residues in porcine ASC were compared to those in human ASC. As 
illustrated in Figure 4.4A, porcine ASC has 16 lysines, among which 7 lysines (K79, K87, K91, 
K96, K101, K106, and K183) (identified above the bar in Figure 4.4A) are unique for the porcine 
ASC. The K175 residue in porcine ASC corresponds to K174 in human ASC, which was 
reported to be the target site for ubiquitination upon an RNA virus infection (Guan et al., 2015). 
Thus, whether these sites are targeted for ubiquitination was tested first. For that, single lysine-
to-arginine (K-to-R) mutation constructs were made; however, none of the mutations led to a 
reduced level of ASC ubiquitination upon Hf09-817 infection (Figure 4.4B, right panel). The 
mutations were expanded to the remaining lysines. While individual mutations were made on 
K55, K110, K140, and K159, a cluster of lysines (K21, K22, K24, and K26) was simultaneously 
mutated due to their close proximity. However, the replacement of these remaining lysines with 
arginines did not reduce the ubiquitination levels (Figure 4.4B, left panel). ASC has an N-
terminal pyrin domain (PYD) and a C-terminal caspase activation and recruitment domain 
(CARD). Based on the reports that CARD is targeted for different modifications (Guan et al., 
2015, Hara et al., 2013, Lin et al., 2015), whether multiple lysines in the CARD of porcine ASC 
are targeted for ubiquitination was tested. Thus, two truncated ASCs, ASC consisting of aa 1 to 
109 (ASC1–109) and ASC consisting of aa 1 to 158 (ASC1–158) were constructed (Figure 4.4A). 
Upon Hf09-817 infection, the ubiquitination level of ASC1–158 was not altered, while the level on 
ASC1–109 was significantly reduced compared to that of the WT ASC (Figure 4.4C). This finding 
suggested that the two lysines, K110 and K140, within aa 110 to 158, may be the target for 
ubiquitination. Indeed, ASC with a K110R/K140R mutation had an appreciably reduced level of 
ubiquitination compared to that of WT ASC in response to Hf09-817 infection (Figure 4.4D). 
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(Figure 4.4 to be continued) 
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Figure 4.4 K110 and K140 are ubiquitination sites on porcine ASC.  
(A) A schematic representation of WT and two mutant ASC constructs (aa 1-109 and aa 1-158) 
is illustrated with lysine (K) residues. (B, C and D) HEK293T cells were transfected with HA-
ubiquitin and Flag-tagged WT or mutant ASC constructs. At 24 hpt, the cells were infected with 
Hf09 WT or Hf09-817 at an MOI of 10 for 9 h. Cell lysates in denaturing condition were 
subjected to co-IP with beads conjugated with anti-Flag antibody. IP and input samples were 
used for Western blotting with antibodies indicated. The asterisks indicate IgG heavy chains. 
 
 
4.4.5 Inhibition of ASC ubiquitination on K110 and K140 does not impair the ASC 
speck formation or ASC stability. 
To define the effects of ubiquitination at K110/K140 on the ASC protein itself, ASC 
specks formed by porcine NLRP3 along with either WT or K-to-R mutant ASC were examined 
by immunofluorescence staining. Elimination of ASC ubiquitination by the K110R/K140R 
mutation did not alter the overall number or the perinuclear localization pattern of ASC specks 
(Figure 4.5A). Since ubiquitination may affect the stability of target proteins, the stability of 
ASC was monitored by treating the cells transiently expressing WT or K-to-R mutant ASC with 
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CHX, which blocks the translation of new proteins, for different time points before being 
subjected to Western blotting. The expression intensity of either WT or mutant ASC was not 
reduced by CHX treatment (Figure 4.5B), suggesting that the ASC stability is not critically 
affected by preventing the ubiquitination on K110 and K140. 
 
 
 
Figure 4.5 Inhibition of ASC ubiquitination on K110 and K140 does not impair the ASC 
speck formation or ASC stability.  
(A) HEK293T cells were transfected with plasmids expressing Myc-tagged NLRP3 and Flag-
tagged WT/mutant ASC. At 24 hpt, the cells were fixed, permeabilized, immunostained with 
appropriate antibodies, and were counterstained with DAPI. ASC specks formed by 
colocalization of NLRP3-Myc (gray) and Flag-ASC (green) were seen in perinuclear region. 
Nuclei were visualized in blue. The scale bars indicate 5 μm. (B) HEK293T cells were 
transfected with 200 ng of plasmids expressing Flag-tagged WT/mutant ASC. At 24 hpt, the cells 
were treated with CHX for 2, 4, 6 or 8 h before harvested, while untreated cells were harvested at 
24 hpt. The cells were lysed and analyzed by Western blotting with antibodies indicated.  
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4.4.6 Ubiquitination of ASC on K110 and K140 is required for caspase-1 activation 
in response to NS1-mutant pdm09 virus. 
In an attempt to observe the impact of ubiquitination at K110/K140 on the NLRP3 
inflammasome activity, NLRP3 inflammasome reconstitution was conducted using WT/mutant 
ASC. In NLRP3 inflammasome reconstitution followed by Hf09-817 infection, the NLRP3 
inflammasome consisting of WT ASC could induce an appreciable level of active caspase-1, 
p20, and a large amount of IL-1β (Figure 4.6, left panel). In contrast, the inflammasome 
consisting of ASC K110R/K140R produced lower caspase-1 activity, as evidenced by the 
reduced level of both p20 and IL-1β. None of the single mutations (K110R or K140R) on ASC 
had significant effects on caspase-1 activation and IL-1β maturation. The p20 level was almost 
half diminished in the ASC K110R/K140R condition compared to other conditions, while the 
pro-IL-1β expression was not significantly impaired as the normalized data showed (Figure 4.6, 
right panel).  
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Figure 4.6 Ubiquitination of ASC on K110 and K140 is required for caspase-1 activation in 
response to NS1-mutant pdm09 virus.  
HEK293T cells were transfected with plasmids expressing porcine NLRP3, Flag-tagged 
WT/mutant ASC, pro-caspase-1 and pro-IL-1β. At 12 hpt, the cells were infected with Hf09-817 
at an MOI of 5 for 12 h. Porcine IL-1β was measured by ELISA with cell-free supernatants and 
the expression of p20, pro-IL-1β, ASC and viral proteins was measured by Western blotting with 
cell lysates. Expression of p20 and pro-IL-1β was normalized to that of β-actin using Image J. 
**, p=0.002. 
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Figure 4.7 A proposed model of the mechanisms by which NS1 C-terminus of pdm09 
inhibits the porcine NLRP3 inflammasome.  
Viral dsRNA is sensed by TLR3 in the endosome of pdm09-infected alveolar macrophages. This 
activates the NF-κB pathway, which is required for the transcriptional upregulation of NLRP3 
and pro-IL-1β (Signal 1). Cellular stress provoked by viral infection is expected to induce the 
conformational change of NLRP3 (e.g. oligomerization) (Signal 2), while the roles of pdm09 
viral proteins in this process are not fully understood. This results in the PYD-PYD interaction 
between NLRP3 and ASC leading to the formation of ASC specks. Further recruitment of pro-
caspase-1 to ASC by CARD-CARD interaction completes the assembly of NLRP3 
inflammasome. Auto-proteolytic cleavage of pro-caspase-1 into active subunits of caspase-1 is 
required to process the pro-IL-1β, leading to IL-1β secretion. NS1 C-terminus of pdm09 inhibits 
the porcine NLRP3 inflammasome-mediated IL-1β production with two mechanisms. First, it 
suppresses the ubiquitination of porcine ASC on CARD, which is crucial for caspase-1 
activation, but not involved in the formation of ASC specks, while whether this inhibition occurs 
before or upon NLRP3 activation is unclear. Second, it disrupts the NLRP3-ASC interaction, 
thereby impairing the ASC speck formation. The domain structure of NLRP3 inflammasome 
components is shown in the inset. 
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4.5 Discussion 
Ubiquitination and deubiquitination on NLRP3 inflammasome components mediate the 
inflammasome activity. To seek for the in-depth mechanism by which pdm09 NS1 suppresses 
porcine NLRP3 inflammasome activity, whether the NS1 modulates the ASC or NLRP3 
ubiquitination was investigated. Infection with mutant Hf09 viruses with NS1 C-terminal 
deletion caused more ubiquitination of ASC than did the WT virus, but not affecting the 
ubiquitination of NLRP3, implying an inhibitory role of Hf09 NS1 C-terminus on porcine ASC 
ubiquitination. A speculation that NS1 C-terminus plays an enhancing role on ASC 
deubiquitination was eliminated, since WT virus infection induced a low level of ubiquitination, 
which was similar to that in mock-infected cells. One possible explanation could be that the 
pdm09 NS1 influences E3 ligase activity required for ASC ubiquitination. This type of 
regulation is reported in RIG-I ubiquitination by an E3 ligase, TRIM25 that is targeted by NS1 to 
suppress the IFN production (Gack et al., 2009). NS1 C-terminal aa 126-225 of avian H5N1 is 
recently reported to downregulate the RIG-I-mediated IFN signaling through interacting with 
TRAF3 and inhibiting the K63-linked ubiquitination of TRAF3 (Qian et al., 2017). This shows 
that the inhibitory function of NS1 C-terminus on the host immunity is not limited to the 
suppression of NLRP3 inflammasome. Guan et al. discovered that ASC undergoes ubiquitination 
via the E3 ligase TRAF3 by forming the complex of ASC-TRAF3-MAVS upon VSV infection 
(Guan et al., 2015). In that study, MAVS contributes to the stability of ASC and increases the 
interaction of ASC with TRAF3. In this context, it will be of interest to examine if NS1 interacts 
with another adaptor protein that associates with an E3 ligase responsible for the ubiquitination 
of porcine ASC. In addition to K63-linked or linear ubiquitination as previously reported (Guan 
et al., 2015, Rodgers et al., 2014), ASC was modified by mixed lysine-linked ubiquitination. 
This does not seem to be a rare event, since NLRP3 is modified by both K48- and K63-linked 
ubiquitination, and is also deubiquitinated upon activation (Guo et al., 2016, Kawashima et al., 
2017, Py et al., 2013, Song et al., 2016). Different types of ubiquitination are thought to 
modulate the activities of inflammasomes for tight regulation of the innate immune signalling.  
K110 and K140 in porcine ASC were the ubiquitin acceptor sites, suggesting that 
modifications of the C-terminal CARD of ASC, which interacts with another CARD of pro-
caspase-1 (Srinivasula et al., 2002, Wang et al., 2002), are crucial for the inflammasome 
activation. Removal of ASC ubiquitination by K-to-R mutation on the acceptor sites impaired the 
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caspase-1 activity during virus infection, but did not affect the stability of ASC, localization and 
number of ASC specks, suggesting the ubiquitination of porcine ASC contributes to the fully 
functional activation of NLRP3 inflammasome. What remains elusive is whether the 
ubiquitination on ASC CARD has any impacts on the CARD-CARD interaction between ASC 
and pro-caspase-1 upon infection with NS1-mutant virus, or the interaction occurs regardless of 
the ASC ubiquitination. It is noteworthy that deubiquitination of ASC can lead to the 
inflammasome activation (Lee et al., 2017c), which contradicts to the observation in the current 
study. The ambivalence may be due to the diverse interplay between virus and the host signalling 
pathways that is dissimilar to how conventional agonists stimulate the immune system. IAV 
infection can manipulate not only the host gene expression, but also the host ubiquitin system 
(Tisoncik et al., 2011). 
In addition to ASC ubiquitination, other post-translational modifications may also occur on 
any components of the porcine NLRP3 inflammasome to regulate its activation. SUMOylation or 
deSUMOylation, a process by which small ubiquitin-like modifier (SUMO) proteins are 
conjugated to or deconjugated from target proteins can be one of them. Unlike ubiquitination, 
SUMOylation occurs on a lysine residue in the consensus motif as well as other lysines, which 
do not constitute the motif on the target protein (Wilkinson and Henley, 2010). A recent study 
shows the elevated activation of NLRP3 inflammasome upon deSUMOylation on NLRP3 (Barry 
et al., 2018). Interestingly, porcine ASC, but not human ASC, contains the SUMO consensus 
motif, Ψ-K-x-D/E (where Ψ is a hydrophobic residue and x is any residue). Whether porcine 
ASC undergoes SUMOylation/deSUMOylation upon IAV infection and if it is relevant to the 
NLRP3 inflammasome activation are outstanding concerns. 
Hf09 NS1 C-terminus not only suppresses ASC ubiquitination on the CARD, but also 
interferes with the PYD-PYD homotypic interaction between porcine NLRP3 and ASC, which 
leads to the reduced ASC specks as shown in the previous chapter and in Figure 4.7. Therefore, 
the two inhibitory effects by pdm09 NS1 exerted on different domains of ASC are thought to be 
independent each other, and pdm09 NS1 may be equipped with redundant strategies to block 
NLRP3 inflammasome activation. Considering that ubiquitination of human ASC along with 
human IL-1β secretion was also repressed by pdm09 NS1 C-terminus, it is suggested that pdm09 
has acquired the ability to evade the host immunity of both pigs and humans. Further 
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investigation is needed to identify the ubiquitination sites on human ASC and to define whether 
this strategy is also played by other swine-origin human IAVs.  
In summary, porcine ASC could be modified by ubiquitination upon IAV infection, and 
NS1 C-terminus of pdm09 suppressed the ubiquitination on K110/K140, which was critical for 
NLRP3 inflammasome-mediated IL-1β production. Further, the inhibitory function played by 
pdm09 NS1 was also executed on human ASC. These provide new insights into NS1-mediated 
immune evasion in the swine and human hosts infected with IAVs. 
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TRANSITION BETWEEN CHAPTER 4 AND CHAPTER 5 
In Chapter 4, the ubiquitination of porcine ASC was shown to be suppressed by NS1 C-
terminus of pdm09. Further analyses identified that K110 and K140 on CARD of porcine ASC 
were target sites of ubiquitination. Ubiquitination on those residues was indispensable for 
caspase-1 activation, while it is not directly involved in the ASC speck formation or ASC 
stability. Along with observations in Chapter 3, this revealed novel mechanisms by which pdm09 
NS1 exerts to evade the host inflammatory responses. Considering that a high level of IL-1β was 
produced upon swine influenza virus (SIV) infection in Chapter 3, an important question about 
the underlying mechanism for that event is not resolved yet. Thus, the upstream mechanism by 
which SIV induces NLRP3 inflammasome-mediated IL-1β production is explored in the 
following chapter. Based on the knowledge that mitochondria play a central role in controlling 
the innate immunity including the NLRP3 inflammasome activation, how mitochondrial 
dynamics and its related signalling are involved in SIV-induced IL-1β production is a main 
subject in Chapter 5.  
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CHAPTER 5 SWINE INFLUENZA VIRUS INDUCES NLRP3 INFLAMMASOME-
MEDIATED INTERLEUKIN-1 BETA PRODUCTION THROUGH THE 
RIPK1/DRP1 SIGNALING. 
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5.1 Abstract 
Nucleotide-binding domain and leucine-rich repeat-containing protein 3 (NLRP3) 
inflammasome plays a pivotal role in modulating lung inflammation in response to the influenza 
A virus infection. Based on the previous finding that swine influenza virus (SIV) infection 
induced NLRP3 inflammasome-mediated IL-1β production in primary porcine alveolar 
macrophages (PAMs), the upstream signaling events that are involved in this process were 
examined. In this study, results showed that SIV infection led to dynamin-related protein 1 
(DRP1) phosphorylation at serine 579 (S579) and mitochondrial fission in PAMs. 
Concomitantly, IL-1β production was dependent on the reactive oxygen species (ROS) 
production, and NLRP3 inflammasome activity was upregulated by phospho-mimetic mutation 
at S579 on DRP1. Furthermore, the requirement of the kinase activity of receptor-interacting 
protein kinase 1 (RIPK1) for the IL-1β production and the association of RIPK1 with DRP1 
suggested that RIPK1 is an upstream kinase for DRP1 phosphorylation. These results showed a 
critical role of the RIPK1/DRP1 signaling axis, whose activation leads to mitochondrial fission 
and ROS release, in modulating porcine NLRP3 inflammasome-mediated IL-1β production in 
SIV-infected PAMs. 
 
5.2 Introduction 
Interleukin-1 beta (IL-1β) is a pro-inflammatory cytokine that contributes to the effective 
modulation of the host innate and adaptive immunity upon influenza A virus (IAV) infection 
(Allen et al., 2009, Ichinohe et al., 2009, Thomas et al., 2009). IL-1β is tightly regulated by 
pattern recognition receptors (PRRs) such as nucleotide-binding domain and leucine-rich repeat-
containing protein 3 (NLRP3), which functions by forming the NLRP3 inflammasome with its 
adaptor protein, apoptosis-associated speck-like protein containing caspase activation and 
recruitment domain (ASC), and pro-caspase-1. The activation of NLRP3 leads to the conversion 
of pro-caspase-1 into caspase-1, which cleaves pro-IL-1β to generate mature IL-1β and also 
induces pyroptosis (Kuriakose and Kanneganti, 2017, Sarvestani and McAuley, 2017).  
Mitochondria are well appreciated for their roles in innate immunity. Mitochondrial 
proteins are involved in the NLRP3 inflammasome regulation (Ichinohe et al., 2013, Moriwaki et 
al., 2016, Park et al., 2013b). Pathophysiological changes mediated by mitochondria including 
the imbalance in mitochondrial dynamics and the release of cytochrome c, mitochondrial DNA 
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or reactive oxygen species (ROS) can either activate or inhibit the NLRP3 inflammasome 
(Nakahira et al., 2011, Park et al., 2015, Shi and Kehrl, 2016, Yoshizumi et al., 2014, Zhou et al., 
2011). The phosphorylation of dynamin-related protein 1 (DRP1), a guanosine triphosphate 
(GTP) hydrolase (GTPase), on different residues determines mitochondrial dynamics, namely 
fission and fusion. For human DRP1 (transcript variant 1), phosphorylation at serine 616 (S616) 
or dephosphorylation at serine 637 (S637) is linked to mitochondrial fission, whereas 
phosphorylation at S637 is associated with fusion (Zemirli et al., 2018). In order for fission to 
occur, DRP1 is recruited to mitochondria upon its phosphorylation at S616 by kinases including 
receptor-interacting protein kinase 1 (RIPK1) or dephosphorylation at S637 (Cereghetti et al., 
2008, Kashatus et al., 2015, Taguchi et al., 2007, Wang et al., 2014c). The association of DRP1 
with mitochondrial fission proteins leads to mitochondrial fission, which depends on GTP 
hydrolysis by DRP1 (Elgass et al., 2013). The suppression of mitochondrial fission by diverse 
molecules leads to the inhibition of NLRP3 inflammasome activity (Li et al., 2016a, Li et al., 
2016d, Zhou et al., 2016), while this is contradicted by a finding that the impaired mitochondrial 
fission can upregulate the NLRP3 inflammasome activity (Park et al., 2015). 
Viruses can alter the mitochondrial dynamics to subvert the host’s innate immunity or to 
modulate the host cell survival. Various RNA viruses are reported to induce DRP1-mediated 
mitochondrial fission to regulate apoptosis (Gou et al., 2017, Kim et al., 2014, Li et al., 2016c, 
Mukherjee et al., 2018), whereas the dengue virus is reported to regulate mitochondrial fusion 
(Barbier et al., 2017, Chatel-Chaix et al., 2016, Yu et al., 2015). An initial study on DRP1-
mediated NLRP3 inflammasome activation upon viral infection discovered that in response to 
vesicular stomatitis virus (VSV), RIPK1 forms a complex with RIPK3 to induce necroptosis, 
while it also phosphorylates DRP1. The latter event leads to mitochondrial fission, and 
subsequently, ROS can activate NLRP3 leading to IL-1β production (Wang et al., 2014c). In 
contrast, another report showed that the NLRP3 inflammasome activation upon VSV infection 
does not require RIPK1 or DRP1 (Kang et al., 2015). In addition, there are reports showing that 
cyclin-dependent kinase 1 is required for DRP1 phosphorylation and mitochondrial fission upon 
infection with RNA viruses such as hepatitis C virus and rotavirus (Kim et al., 2014, Mukherjee 
et al., 2018). Upon IAV infection, a mitochondrial fusion protein, mitofusin 2, can regulate the 
NLRP3 inflammasome activation (Ichinohe et al., 2013). The IAV PB1-F2 protein, which 
translocates to mitochondria, can cause mitochondrial fission that is associated with the defective 
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NLRP3 inflammasome activation (Yoshizumi et al., 2014). However, there is still a lack of 
information on how DRP1-mediated mitochondrial fission fits in the innate immune signaling in 
IAV-infected cells. 
In the previous chapter, swine influenza virus (SIV) infection induced NLRP3 
inflammasome activation leading to the IL-1β production in primary porcine alveolar 
macrophages (PAMs). In this chapter, whether DRP1-mediated mitochondrial dynamics are 
involved in this process was investigated. The results suggest that upon SIV infection of PAMs, 
mitochondrial fission occurred through the RIPK1/DRP1 signaling axis, which is involved in the 
NLRP3 inflammasome-mediated IL-1β production. 
 
5.3 Materials and methods 
5.3.1 Cells and viruses 
PAMs were isolated from lungs of 4-week-old, SIV-negative piglets by collecting 
bronchoalveolar lavage fluid, where most of the cells are comprised of alveolar macrophages 
(Ait-Ali et al., 2007, Gordon and Read, 2002). The PAMs were characterized by flow cytometry 
using mouse anti-pig macrophage antibody conjugated with fluorescein isothiocyanate 
(MCA2317F, Bio-Rad) (Liu et al., 2015). PAMs were cultured with HyClone RPMI 1640 
medium (SH30027.01, GE Healthcare) supplemented with 20% FBS (16000-044, Thermo 
Fisher), 50 μg/mL gentamicin (BS724, Bio Basic Canada), and 1 × Antibiotic-Antimycotic 
(15240-062, Thermo Fisher). HEK293T cells were maintained in DMEM (D5796, Sigma) 
supplemented with 10% FBS and 50 μg/mL gentamicin. The SIV strain, Sk02 was propagated in 
MDCK cells and titrated by plaque assay as mentioned in the previous chapters. 
 
5.3.2 Antibodies and reagents 
Rabbit polyclonal NP and NS1 antibodies were produced as described (Shin et al., 2007b). 
The commercial antibodies used are as follows. Goat anti-porcine IL-1β antibody (BAF681): 
R&D Systems; rabbit anti-porcine caspase-1 (p20) antibody (PAB592Po01): Cloud-Clone Corp.; 
mouse anti-Myc-tag antibody (#2276), mouse anti-β-actin antibody (#3700), rabbit anti-DRP1 
antibody (#8570) and rabbit anti-phospho-DRP1 (S616) antibody (#3455): Cell Signaling 
Technology; mouse anti-FLAG M2 antibody (F3165): Sigma; IRDye 680RD donkey anti-rabbit 
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(926-68073), IRDye 800CW donkey anti-mouse (926-32212) and IRDye 800CW donkey anti-
goat (926-32214) antibodies: LI-COR Biosciences. The following reagents were used: LPS 
(L3024) and N-acetyl L-cysteine (NAC) (A9165): Sigma; Necrostatin-1 (Nec-1) (BML-AP309): 
Enzo Life Sciences; Mdivi-1 (ab144589): Abcam. 
 
5.3.3 Plasmid construction 
Plasmids expressing porcine NLRP3, ASC, procaspase-1, and pro-IL-1β were generated 
using cDNA synthesized from the total RNA of PAMs that were stimulated with LPS as 
described in the previous chapters. Using the same cDNA, the full-length porcine DRP1 was 
cloned into pcDNA3.1-3×Myc (C-terminal tag) generating pcDNA-DRP1-Myc. Primers were 
designed based on the GenBank sequence of porcine DRP1 transcript variant X1 (accession 
number: XM_021092056). Myc-tagged DRP1 constructs with S579D or S579A mutation 
(pcDNA-DRP1 (S579D)-Myc or pcDNA-DRP1 (S579A)-Myc) were generated by site-directed 
mutagenesis using pcDNA-DRP1-Myc as the template. Porcine RIPK1 was cloned into 
pcDNA3.1-3×Myc or pCMV-3×Flag (N-terminal tag) using cDNA from a porcine alveolar 
macrophage cell line, 3D4/2, generating pcDNA-RIPK1-Myc or pCMV-Flag-RIPK1. Using the 
above construct as the template, the mutant RIPK1 construct with K41A/K42A (pcDNA-RIPK1 
(K41A/K42A)-Myc) was generated by mutagenesis. Myc-tagged human RIPK1 (huRIPK1) 
(#44159, Addgene) was a gift from Xin Lin (Blonska et al., 2004). HA/GFP-tagged human 
RIPK1 (K45A) (#41389, Addgene) was a gift from Francis Chan (Cho et al., 2009) and used as 
the template to generate Myc-tagged human RIPK1 (K45A). All the mutations were confirmed 
by nucleotide sequencing. The expression plasmids generated for this chapter are listed in Table 
5.1 and the primers are listed in Supplementary Table 4. 
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Table 5.1 List of expression plasmids used in Chapter 5.  
The constructs for NLRP3 inflammasome components and pro-IL-1β used for NLRP3 
inflammasome reconstitution assay were described in Table 3.2. 
 
Construct Template used to clone Purpose 
pcDNA-DRP1-Myc cDNA from PAMs 
NLRP3 inflammasome reconstitution, 
RIPK1-DRP1 interaction 
pcDNA-DRP1 (S579D)-
Myc 
pcDNA-DRP1-Myc NLRP3 inflammasome reconstitution 
pcDNA-DRP1 (S579A)-
Myc 
pcDNA-DRP1-Myc NLRP3 inflammasome reconstitution 
huRIPK1-Myc 
(Blonska et al., 2004) 
 NLRP3 inflammasome reconstitution 
huRIPK1 (K45A)-Myc 
HA/GFP-huRIPK1 
(K45A) 
(Cho et al., 2009) 
NLRP3 inflammasome reconstitution 
pcDNA-RIPK1-Myc cDNA from 3D4/2 cells NLRP3 inflammasome reconstitution 
pcDNA-RIPK1 
(K41A/K42A)-Myc 
pcDNA-RIPK1-Myc NLRP3 inflammasome reconstitution 
pCMV-Flag-RIPK1 pcDNA-RIPK1-Myc 
NLRP3 inflammasome reconstitution, 
RIPK1-DRP1 interaction 
 
5.3.4 Infection and treatment of PAMs 
PAMs seeded at 1 × 10
6
 cells per well on 24-well plates were either infected with the Sk02 
virus for 20 h at an MOI of 1 or stimulated with 200 ng/mL LPS for 12 h. The cells were pre-
treated with vehicles or inhibitors for 2 h, and were then infected with the virus or stimulated 
with LPS in the presence of the vehicles or inhibitors. Nec-1 was used at 80 or 160 μM for 
RIPK1 inhibition; Mdivi-1 was used at 5 or 20 μM for DRP1 inhibition, while DMSO was used 
as the vehicle. As a ROS scavenger, NAC was used at 2 or 10 mM and distilled water was used 
as the vehicle. Cell-free supernatants were collected for ELISA. Cells were lysed with 1 × SDS 
sample buffer and boiled for Western blotting. To detect the phosphorylated DRP1 (phospho-
DRP1), the PAMs were seeded at 3 × 10
6
 cells per well on 6-well plates. The cells were infected 
with the Sk02 virus for 4 h at an MOI of 1 or stimulated with 200 ng/mL LPS for 12 h. The cells 
in each well were lysed with 120 μL of M-PER Mammalian Protein Extraction Reagent (78503, 
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Thermo Fisher) containing 1× Halt Protease and Phosphatase Inhibitor Cocktail (78440, Thermo 
Fisher). After centrifugation, the cell lysates were mixed with 5 × SDS sample buffer and were 
subjected to Western blotting. 
 
5.3.5 RNA interference and quantitative PCR 
siRNA targeting porcine RIPK1 was designed by the siRNA design tool provided by 
Dharmacon. The RIPK1-targeting siRNA (5′-UGGAAGAGGAUGUGAAGAAUU-3′) and a 
negative control siRNA (D-001810-01-05, 5′-UGGUUUACAUGUCGACUAA-3′) were 
purchased from Dharmacon. PAMs seeded at 1 × 10
6
 cells per well on 24-well plates were 
transfected with 100 nM of the control siRNA or RIPK1-targeting siRNA using Lipofectamine 
RNAiMAX (13778-030, Thermo Fisher). At 24 hpt, the cells were infected with the Sk02 virus 
for 16 h at an MOI of 1. To show the knockdown efficiency, the relative mRNA expression of 
RIPK1 compared to that of porcine HPRT1 gene was measured by quantitative PCR using cDNA 
from total RNA with a standard protocol. Primers for porcine RIPK1 were designed based on the 
GenBank sequence (accession number XM_005665536) using an online tool, Primer3 
(Untergasser et al., 2012) and those for the housekeeping gene, HPRT1 were used as previously 
reported (Nygard et al., 2007). Primer sequences are indicated in Table 5.2. 
 
Table 5.2 List of primers used for quantitative PCR in Chapter 5. 
 
Target Primer name Sequence (5’-3’) Amplicon size 
Porcine HPRT1 
HPRT1 Fw GGACTTGAATCATGTTTGTG 
91 bp 
HPRT1 Bw CAGATGTTTCCAAACTCAAC 
Porcine RIPK1 
RIPK1 Fw TTCGGAAAGGTGTCCTTGTG 
91 bp 
RIPK1 Bw CGTTGTACTCATTGCGCTTG 
bp, base pairs. 
 
5.3.6 NLRP3 inflammasome reconstitution assay 
The porcine NLRP3 inflammasome reconstitution assay was conducted to examine the 
effects of ectopically expressed proteins on NLRP3 inflammasome activity as described in the 
previous chapters. Briefly, the HEK293T cells seeded at 1.5 × 10
5
 cells per well on 24-well 
plates were co-transfected with expression plasmids for porcine NLRP3 inflammasome 
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components and pro-IL-1β (pcDNA-NLRP3 (30 ng), pcDNA-ASC (20 ng), pCMV-Flag-
procaspase-1 (20 ng), and pcDNA-pro-IL-1β (100 ng)) using TransIT-LT1 Transfection Reagent 
(MIR2300, Mirus Bio). Other plasmids (50 ng of Myc-vector or Myc-tagged human RIPK1 
WT/mutant, 100 ng of Myc-vector or Myc-tagged porcine RIPK1 WT/mutant, 100 ng of Myc-
vector or Myc-tagged DRP1 WT/mutant) were co-transfected to study their effects on NLRP3 
inflammasome activity. At 16 hpt, supernatants were harvested for IL-1β ELISA and the pelleted 
cells were lysed for Western blotting. 
 
5.3.7 Co-IP 
HEK293T cells were seeded at 9 × 10
5
 per well on 6-well plates and were transfected with 
1 μg of Flag-tagged vector or Flag-tagged RIPK1 and Myc-tagged DRP1. At 24 hpt, the cells 
were lysed with 500 μL lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% Nonidet P-40 
substitute, 1 × protease inhibitor cocktail) and clarified by centrifugation at 12,000 × g at 4 °C 
for 10 min. For input, 10% of the cell lysates were mixed with 5× SDS sample buffer and boiled 
at 95 °C for 5 min. For each sample, 35 μL of Dynabeads Protein G (10004D, Thermo Fisher) 
were first conjugated with 1 μg of mouse monoclonal anti-FLAG M2 antibody (F3165, Sigma) 
in 300 μL phosphate-buffered saline (PBS) with 0.02% Tween 20 by agitation at room 
temperature for 1 h. Then, the beads were incubated with the cell lysates at room temperature for 
2 h with agitation. After washed thrice with Tris-buffered saline (50 mM Tris, pH 7.4, 150 mM 
NaCl), the beads were resuspended in 60 μL of 2× SDS sample buffer and boiled as above to be 
analyzed by SDS-PAGE and Western blotting. 
 
5.3.8 Porcine IL-1β ELISA 
Porcine IL-1β in the cell-free supernatants was determined using ELISA as described in the 
previous chapters. Briefly, Immulon 2 HB U plates (#3655, Thermo Fisher) were coated with a 
mouse anti-porcine IL-1β antibody (MAB6811) at 2 μg/mL in PBS overnight. The plates were 
blocked with 1% BSA (A7030, Sigma) in PBS for 1 h, and were incubated with either samples 
or the standard for 2 h. Two-fold serial dilutions of the recombinant porcine IL-1β protein (681-
PI-010, R&D Systems) in diluent (0.1% BSA in Tris-buffered saline with 0.05% Tween 20) was 
used for the standard curve. Next, the plates were incubated with goat anti-porcine IL-1β 
biotinylated antibody (BAF681, R&D Systems) at 50 ng/mL in the diluent for 1 h, and further 
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incubated for 1 h with alkaline phosphatase-streptavidin (016-050-084, Jackson 
ImmunoResearch) that was diluted in a ratio of 1:5,000 by the diluent. After incubation with 1 
mg/mL of PNPP in the diethanolamine buffer (1 M diethanolamine, 0.5 M MgCl2, pH 9.8), 
optical densities were measured at 405 nm with a reference at 490 nm using the xMark 
Microplate Absorbance Spectrophotometer (Bio-Rad). 
 
5.3.9 Western blotting 
Cell lysates or IP samples were subjected to SDS-PAGE followed by blotting on 
nitrocellulose membranes. The membranes were blocked with 5% skim milk (or 5% BSA for the 
detection of phospho-DRP1) in TBS with 0.1% Tween 20 for 1 h and incubated with primary 
antibodies at 4 °C overnight. The membranes were further incubated with secondary antibodies 
at room temperature for 1 h and were scanned with an Odyssey Infrared Imager (LI-COR 
Biosciences). 
 
5.3.10 Confocal Microscopy 
To check the mitochondrial integrity, PAMs were seeded at 2 × 10
5
 cells per well on 
LabTek II CC2 chamber slides (154941, Thermo Fisher). The cells were infected with the Sk02 
virus at an MOI of 1 for 7 h or they were stimulated with 200 ng/mL LPS for 16 h. After fixed 
with 4% paraformaldehyde for 10 min and permeabilized with 0.1% Triton X-100 in DPBS for 5 
min, the cells were incubated with 5% BSA in DPBS for 1 h. The cells were probed with mouse 
monoclonal anti-TOM20 antibody (sc-17764, Santa Cruz) and goat polyclonal anti-IAV 
antibody (AB1074, EMD Millipore) overnight at 4 °C, and the secondary antibodies (Alexa 
Fluor 488 donkey polyclonal anti-mouse IgGH+L (A21202; Invitrogen) and Alexa Fluor 633 
donkey polyclonal anti-goat IgGH+L (A21082; Invitrogen)) for 1 h at room temperature. 
Counterstaining was performed with DAPI (D1306, Invitrogen) for 5 min and the coverslips 
were mounted with ProLong Diamond Antifade Mountant (P36961, Invitrogen) overnight at 
room temperature. Images were obtained by using a confocal laser scanning microscope (TCS 
SP8, Leica). 
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5.3.11 Statistical analysis 
ANOVA with Tukey’s multiple comparison tests or unpaired t-test with Welch’s 
correction was performed using GraphPad Prism 7. The error bars indicate the mean ± SD. The 
p-values of less than 0.05 were considered to be statistically significant. 
 
5.4 Results 
5.4.1 SIV infection induces dynamin-related protein 1 (DRP1) phosphorylation and 
mitochondrial fission. 
It has been reported that virus-induced DRP1 phosphorylation at S616 leads to the 
mitochondrial fission in the early stages of viral infection (Keck et al., 2017, Mukherjee et al., 
2018, Wang et al., 2014c). Amino acid alignment indicated that S616 (location based on the 
transcript variant X1 of human DRP1) corresponds to S579 of porcine DRP1 (transcript variant 
X8) and is conserved among different isoforms of human DRP1 and porcine DRP1. It was of 
interest whether phosphorylation at S579 on porcine DRP1 and the subsequent mitochondrial 
fission would occur upon SIV infection. PAMs were infected with the Sk02 virus for 4 h at an 
MOI of 1 and the cell lysates were analyzed by Western blotting with antibodies specific for 
phospho-DRP1 (S616) or the total form of DRP1. The SIV infection indeed resulted in 
phosphorylation of DRP1 at S579, while the expression of total form was not changed (Figure 
5.1A). As a positive control, PAMs were treated with LPS, which is known to induce DRP1 
S616 phosphorylation or DRP1 S637 dephosphorylation-mediated mitochondrial fission in 
murine cells (Park et al., 2013a, Shen et al., 2018). As expected, LPS stimulation led to DRP1 
phosphorylation in the PAMs (Figure 5.1B). 
To test whether mitochondrial fission also occurs by SIV infection, the PAMs were 
infected with Sk02 for 7 h at an MOI of 1. Immunofluorescence staining was conducted by 
probing the cells with the antibody against translocase of outer mitochondrial membrane 20 
(TOM20), to observe the mitochondrial morphology. Confocal imaging revealed that in Sk02-
infected cells, mitochondria exhibited short and round forms owing to fragmentation; however, 
in mock-infected cells, normal tubular and networked mitochondria were observed (Figure 
5.1C). Likewise, mitochondrial fission was demonstrated in LPS-treated PAMs (Figure 5.1D). 
These data show that upon SIV infection, porcine DRP1 phosphorylation at S579 followed by 
mitochondrial fission occurs in PAMs. 
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Figure 5.1 SIV infection induces DRP1 phosphorylation and mitochondrial fission.  
PAMs were either infected with SIV Sk02 at an MOI of 1 for 4 h (A) or treated with 200 ng/mL 
lipopolysaccharide (LPS) for 12 h (B). Phospho-DRP1 at S579 and the total form of porcine 
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DRP1 were detected by Western blotting. The viral NP protein was also monitored by Western 
blotting in infected cells. PAMs were either infected with Sk02 at an MOI of 1 for 7 h (C) or 
treated with 200 ng/mL LPS for 16 h (D). Immunofluorescence and confocal microscopy were 
performed using an antibody against the mitochondrial protein, TOM20, and the influenza A 
virus (IAV) antibody, when infected. Nuclei were stained by DAPI. Boxed areas were magnified 
and displayed on the right side (for a mock or un-infected cell) or below (for an infected cell) the 
corresponding panels in (C). Scale bar, 10 μm. 
 
 
5.4.2 SIV-induced porcine IL-1β production is dependent on reactive oxygen species 
(ROS) production. 
Mitochondrial ROS from damaged mitochondria can induce NLRP3 inflammasome 
activation (Allen et al., 2009, Zhou et al., 2011) and whether IL-1β production by SIV infection 
is ROS-dependent was further examined. PAMs were infected with Sk02 in the presence of a 
ROS scavenger, NAC, or a vehicle for 20 h. The IL-1β level detected from the supernatant was 
considerably higher in SIV-infected cells than that in mock-infected cells (Figure 5.2A). 
Treatment of NAC significantly decreased IL-1β production in a dose-dependent manner. The 
expression of pro-IL-1β and the viral protein was not impaired, indicating the NAC eliminates a 
signal required for inflammasome activity. As a control, a decline in IL-1β levels was also 
achieved when the cells were treated with LPS in the presence of NAC (Figure 5.2B). This 
suggests that ROS generated from fragmented mitochondria enhances NLRP3 inflammasome-
dependent IL-1β production in PAMs upon SIV infection. 
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Figure 5.2 SIV-induced porcine IL-1β production is dependent on ROS production.  
PAMs were either infected with Sk02 at an MOI of 1 for 20 h (A) or stimulated with 200 ng/mL 
LPS for 16 h (B) in the presence of vehicle (distilled water) or increasing concentrations (2 and 
10 mM) of an ROS scavenger, NAC. Porcine IL-1β levels from the supernatants were measured 
by ELISA and the expression of pro-IL-1β, viral NS1, and β-actin was analyzed by Western 
blotting. Statistical analysis was performed with one-way ANOVA. **, p< 0.01; ***, p< 0.001. 
 
 
5.4.3 SIV-induced porcine IL-1β production is mediated by DRP1. 
The aforementioned data suggested that DRP1-mitochondrial fission axis is involved in the 
SIV-induced IL-1β production. To further confirm the role of DRP1, PAMs were treated with 
Mdivi-1, which inhibits the GTPase activity of DRP1 and mitochondrial fission (Cassidy-Stone 
et al., 2008), and were then infected with Sk02 at an MOI of 1 for 20 h. As seen before, the IL-1β 
level was appreciably elevated in SIV-infected cells compared to that in mock cells. The 
treatment with Mdivi-1 led to a decreased IL-1β production upon Sk02 infection in a dose-
dependent manner. Pro-IL-1β expression and viral replication as indicated by NS1 expression 
were not much affected (Figure 5.3A). LPS-induced inflammatory cytokine expression is shown 
to be mediated by DRP1 activity (Park et al., 2013a), hence the LPS-treated cells were also used 
as a control. With the pro-IL-1β expression unaffected, the IL-1β production upon LPS was 
declined by the Mdivi-1 treatment (Figure 5.3B). 
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To demonstrate the role of S579-phosphorylated DRP1 on pro-caspase-1 cleavage, a 
hallmark of inflammasome activation, NLRP3 inflammasome reconstitution was performed 
using HEK293T cells that are deficient for endogenous human NLRP3 inflammasome (Bryan et 
al., 2009). In this assay, the first signal required for NLRP3 inflammasome activation is provided 
by the overexpression of NLRP3 inflammasome components and pro-IL-1β; the regulatory effect 
on the second signal by the proteins and particular amino acids of interest can be examined by 
monitoring the levels of cleaved caspase-1 and/or mature IL-1β. Despite some limitations, as for 
all in vitro assays, such as excluding the roles of undefined co-factors, the system is especially 
useful when the cells, in this study PAMs, are difficult to be transfected. Among the different 
transcript variants of DRP1, porcine DRP1, which was the most identical to the variant X8 
(GenBank accession number XM_021092064), was cloned. S579 in porcine DRP1 corresponds 
to S616 in human DRP1 as explained above and as depicted in Figure 5.3C. Using this as the 
template, the phospho-mimetic (S579D) and phospho-deficient (S579A) mutants of DRP1 were 
generated. HEK293T cells were transfected with plasmids expressing NLRP3 inflammasome 
components and pro-IL-1β along with Myc-tagged vector or WT/mutant DRP1. The co-
expression of phospho-mimetic DRP1 (S579D) could significantly increase the caspase-1 
activity as shown by the increased level of an active form of caspase-1, p20, while not affecting 
the expression of pro-IL-1β (Figure 5.3D). In contrast, this was not observed with WT DRP1 or 
phospho-deficient DRP1 (S579A). Concomitantly, the porcine IL-1β level was also higher in the 
supernatant of cells co-expressing DRP1 (S579D) compared to other conditions. This data 
strongly indicate that porcine DRP1 phosphorylation at S579, which is required for 
mitochondrial fission, enhances the NLRP3 inflammasome activation. 
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Figure 5.3 SIV-induced porcine IL-1β production is mediated by DRP1.  
PAMs were either infected with Sk02 at an MOI of 1 for 20 h (A) or stimulated with 200 ng/mL 
LPS for 16 h (B) in the presence of vehicle (DMSO) or increasing concentrations (5 and 20 μM) 
of DRP1 inhibitor, Mdivi-1. Porcine IL-1β levels from supernatants were measured by ELISA 
and the expression of pro-IL-1β, viral NS1, and β-actin was analyzed by Western blotting. (C) 
Schematic representation of human DRP1 along with porcine DRP1. S579 in porcine DRP1 WT 
corresponds to S616 in human DRP1. D579 and A579 harbored by phospho-mimetic and 
phospho-deficient porcine DRP1 constructs, respectively, are displayed. (D) For NLRP3 
inflammasome reconstitution assay, HEK293T cells were co-transfected with plasmids 
expressing porcine NLRP3 inflammasome components (NLRP3, ASC, and procaspase-1) and 
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pro-IL-1β along with Myc-vector or Myc-tagged WT/mutant porcine DRP1 for 16 h. Porcine IL-
1β levels from supernatants were measured by ELISA. The expression of caspase-1 (active and 
precursor forms) and pro-IL-1β was analyzed by Western blotting. Statistical analysis was 
performed with one-way ANOVA. *, p< 0.05; ***, p< 0.001. 
 
 
5.4.4 Kinase activity of receptor-interacting protein 1 (RIPK1) is critical for SIV-
induced IL-1β production. 
Porcine RIPK1 was proposed as a DRP1 kinase upon SIV infection, based on a study 
showing that DRP1 phosphorylation upon VSV infection is mediated by RIPK1 (Wang et al., 
2014c). To demonstrate the requirement of RIPK1 for porcine NLRP3 inflammasome-mediated 
IL-1β production, the RIPK1 expression was silenced in PAMs by siRNA. At 24 hpt, the cells 
were infected with Sk02 for 16 h. IL-1β production from PAMs transfected with RIPK1 siRNA 
was significantly decreased compared to the cells transfected with an off-target control siRNA, 
while the pro-IL-1β expression was not affected by silencing the gene (Figure 5.4A). The 
knockdown efficiency determined by the mRNA level of RIPK1 was around 40% compared to 
that in negative control siRNA-transfected cells. Furthermore, to examine whether the RIPK1 
kinase activity is required for upregulation of NLRP3 inflammasome activity, Nec-1, an inhibitor 
of the RIPK1 kinase activity (Degterev et al., 2008), was used in PAMs. Nec-1 blocks the kinase 
function by acting on S161 on human RIPK1 (Xie et al., 2013) and this residue is conserved 
among different transcript variants of porcine RIPK1. Nec-1 treatment drastically reduced IL-1β 
production in response to the Sk02 infection in a dose-dependent manner, while not impairing 
the pro-IL-1β expression (Figure 5.4B).  
Aiming to confirm the requirement of the porcine RIPK1 kinase function on IL-1β 
production, the amino acid sequences of the N-terminal ends of the RIPK1 kinase domain from 
pigs, mice, and humans were aligned (Figure 5.4C). Lysine 45 (K45), indicated with an 
underline, of human RIPK1 is a critical residue for its kinase activity (Moriwaki and Chan, 
2013). While porcine and mouse RIPK1 also contain lysine at the corresponding location to K45 
of their human analog, they have two consecutive lysines as underlined, K41/K42 in porcine 
RIPK1 and K45/K46 in mouse RIPK1. The kinase-dead effects by K45A mutation or 
K45A/K46T mutation on mouse RIPK1 and their roles in IL-1β production are well documented 
(Berger et al., 2014, Shutinoski et al., 2016, Zhang et al., 2017c). Considering the higher 
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sequence identity of porcine RIPK1 to the human one, human RIPK1 constructs were used in the 
NLRP3 inflammasome reconstitution assay. The co-expression of human RIPK1 WT remarkably 
increased the porcine IL-1β production. In contrast, the co-expression of kinase-dead human 
RIPK1 (K45A) led to a decreased level of IL-1β production compared to that of WT RIPK1 
(Figure 5.4D). Another experiment after cloning porcine RIPK1 was performed in the same 
setting as above. Consistently with human RIPK1, porcine RIPK1 WT enhanced IL-1β 
production, however, the kinase-dead RIPK1 (K41A/K42A) did not (Figure 5.4E). In all 
samples, the pro-IL-1β expression levels were not affected (Figure 5.4D, E). These suggest that 
RIPK1 is a positive regulator of NLRP3 inflammasome-mediated IL-1β production and its 
kinase activity is required for this regulation. 
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Figure 5.4 Kinase activity of RIPK1 is critical for SIV-induced IL-1β production.  
(A) PAMs were transfected with a negative control siRNA (siControl) or RIPK1-targeting 
siRNA (siRIPK1) for 24 h and infected with Sk02 at an MOI of 1 for 16 h. Porcine IL-1β levels 
from supernatants were measured by ELISA. Expression of pro-IL-1β was analyzed by Western 
blotting. RIPK1 knockdown efficiency was determined by real-time PCR. (B) PAMs were 
infected with Sk02 at an MOI of 1 for 20 h in the presence of a vehicle (DMSO) or increasing 
concentrations (80 and 160 μM) of RIPK1 kinase inhibitor, Nec-1. Porcine IL-1β levels from 
supernatants were measured by ELISA. Expression of pro-IL-1β and viral NS1 was analyzed by 
Western blotting. (C) Amino acid sequences of the N-terminal ends of the kinase domains in 
porcine, murine, and human RIPK1 (based on the GenBank accession numbers XM_005665536, 
NM_009068, and NM_003804, respectively) were aligned using Clustal Omega. Amino acid 
positions are based on the human RIPK1 and asterisks indicate conserved residues among the 
three species. K41/K42 in porcine RIPK1, K45/K46 in murine RIPK1, and K45 in human RIPK1 
are underscored. (D) For the NLRP3 inflammasome reconstitution assay, HEK293T cells were 
co-transfected with plasmids expressing porcine NLRP3 inflammasome components (NLRP3, 
ASC, and procaspase-1) and pro-IL-1β along with Myc-vector or Myc-tagged WT/mutant human 
RIPK1 for 16 h. Porcine IL-1β levels from supernatants were measured by ELISA. Protein 
expression was analyzed by Western blotting. (E) HEK293T cells were transfected as in (D) 
along with the Myc-vector or Myc-tagged porcine RIPK1 WT/mutant for 16 h. ELISA and 
Western blotting were performed as in (D). Statistical analysis was performed with one-way 
ANOVA except for the knockdown efficiency data performed with an unpaired t-test. *,  < 0.05; 
**, p< 0.01; ***, p< 0.001. 
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5.4.5 RIPK1 interacts with DRP1. 
To provide the evidence that DRP1 is regulated by RIPK1, the interaction between the two 
proteins was examined by co-IP. Since the antibody that is against porcine RIPK1 was not 
available, proteins overexpressed in HEK293T, instead of endogenous proteins in PAMs, were 
utilized. HEK293T cells were co-transfected with Flag-vector or Flag-tagged porcine RIPK1 
plasmid along with Myc-tagged porcine DRP1 plasmid for 24 h and were subjected to co-IP 
using the anti-Flag antibody. Association of DRP1 with RIPK1 in IP complex was demonstrated 
by Western blotting (Figure 5.5), suggesting that RIPK1 and DRP1, by physically interacting, 
activate the downstream events including the NLRP3 inflammasome activity. 
 
 
 
Figure 5.5 RIPK1 interacts with DRP1.  
HEK293T cells were co-transfected with the Flag-vector or Flag-RIPK1 construct along with the 
DRP1-Myc construct for 24 h. Cell lysates were subjected to co-IP with Flag antibody, and the 
expression of Flag-RIPK1 and DRP1-Myc in input and IP samples was analyzed by Western 
blotting. 
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Figure 5.6 A proposed model of RIPK1/DRP1-mediated IL-1β production in SIV-infected 
PAMs.  
Recognition of IAV RNA by endosomal TLRs or RIG-I is known to induce pro-IL-1β synthesis. 
SIV infection turns on the RIPK1/DRP1 signaling for the NLRP3 inflammasome activation in 
PAMs. SIV seems to utilize the RIPK1 function, while how RIPK1 is activated by SIV or 
whether an upstream sensor plays a role in its activation is unclear. By interacting with DRP1 
and through its kinase activity, RIPK1 induces the phosphorylation of porcine DRP1 at S579. 
Upon DRP1 translocation to mitochondria, mitochondrial fission occurs and ROS is generated. 
This promotes the activation of NLRP3 that is required for the NLRP3 inflammasome assembly 
and caspase-1 activation. Active caspase-1 converts pro-IL-1β into mature IL-1β, which is 
critical for SIV-induced lung inflammation. Sensing LPS by TLR4 is known to induce the pro-
IL-1β expression, and this also induces the DRP1 phosphorylation leading to the NLRP3 
inflammasome activation in PAMs, although it is unclear whether LPS activates any upstream 
regulator of RIPK1. 
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5.5 Discussion  
NLRP3 inflammasome-mediated IL-1β production is one of the key pathways in 
inflammatory responses to IAV infection. Alveolar macrophages, as the first responders to lung 
infection, play critical roles in regulating IAV-induced pulmonary inflammation (Cardani et al., 
2017, Kim et al., 2008, Schneider et al., 2014), allowing them to be a useful model to investigate 
the mechanism of inflammasome activation. The SIV Sk02 strain caused pathogenicity in pigs 
with typical clinical signs of SIV infection (Masic et al., 2009a), and this virus induced NLRP3 
inflammasome-mediated IL-1β production in PAMs in the previous chapter. Here, the upstream 
mechanism of porcine IL-1β secretion from SIV-infected PAMs was explored. 
Changes in mitochondrial dynamics are crucial in modulating the NLRP3 inflammasome 
activity, and especially, ROS derived from damaged mitochondria is sensed by NLRP3 leading 
to the activation of NLRP3 inflammasome (Zhou et al., 2011). It was speculated that 
mitochondrial damage and ROS production would provoke the NLRP3 inflammasome activation 
upon SIV infection. Indeed, in SIV-infected PAMs, mitochondrial fission and phosphorylation of 
DRP1, a prerequisite for its fission activity, were observed along with the ROS-dependent IL-1β 
production. These early events, upon SIV infection, are suggested to provide the signals required 
for NLRP3 inflammasome activation. These results along with the finding that IL-1β levels were 
elevated between 8 and 16 h of SIV infection in the previous chapter support the positive 
regulatory role of DRP1, mitochondrial fission, and the ROS release axis in the inflammasome 
activation. The suppression of NLRP3 inflammasome activity by mitochondrial fission was 
reported in a human lung cell line in response to the mouse-adapted IAV, PR8 strain during the 
late phase of infection (Yoshizumi et al., 2014). Whether this discrepancy is attributed to the 
differences in cell types and virus strains warrants further investigation. 
The current study showed that RIPK1 has critical roles in IL-1β production in PAMs. 
RIPK1 silencing or inhibition of the RIPK1 kinase activity by Nec-1 sharply reduced the IL-1β 
production upon SIV infection. Deficiency of RIPK1 (or its kinase function) did not affect the 
pro-IL-1β expression, unlike mouse studies demonstrating that the RIPK1 kinase activity is 
required for the expression of inflammatory cytokines including IL-1β at the mRNA level 
(Najjar et al., 2016, Saleh et al., 2017, Shutinoski et al., 2016). In VSV-infected murine bone 
marrow-derived macrophages, RIPK1 promotes the NLRP3 inflammasome-mediated IL-1β 
production by the phosphorylation of DRP1 (Wang et al., 2014c). According to their study, 
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cytosolic RNA sensors such as RIG-I, MDA5, DEAH-box helicase 33 (DHX33), and TLR3 do 
not sense RNA viruses to initiate NLRP3 inflammasome activation (Wang et al., 2014c). Rather, 
ZBP1 senses viral proteins of IAV to induce RIPK1-mediated NLRP3 inflammasome activation 
and cytokine production (Kuriakose et al., 2016). In this regard, whether ZBP1 is also an 
upstream sensor for SIV-induced RIPK1/DRP1 signaling to activate the porcine NLRP3 
inflammasome will be an important subject for future investigation. 
The present study revealed the intervening role of DRP1 phosphorylation and its fission 
activity in upregulating the caspase-1 activity, which is required for IL-1β production. Caspase-1 
activation, in reverse, can induce mitochondrial damage, leading to pyroptotic cell death (Yu et 
al., 2014). However, apparent cytotoxicity by the overexpression of the phospho-mimetic DRP1 
was not noticeable (data not shown). It is postulated that in addition to phosphorylation, other 
post-translational modifications on DRP1 (Chang and Blackstone, 2010) may occur and facilitate 
cell death upon virus infection. While a report describes that cell death is not mediated by 
RIPK1/DRP1 signaling, which is required for inflammasome activation (Tao et al., 2018), it is 
hard to fully exclude the possibility that cell death pathways can be involved in RIPK1/DRP1-
mediated NLRP3 inflammasome activation in SIV-infected cells. Considering that RIPK1 
mediates necroptosis along with inflammasome activation upon virus infection (Kuriakose et al., 
2016, Wang et al., 2014c), and the inflammasome activation can lead to pyroptosis, it is possible 
that both cell death pathways are activated to a certain extent in SIV-infected PAMs. IAV 
infection induces both RIPK1/RIPK3-mediated NLRP3 inflammasome activation and RIPK3-
mediated apoptosis and necroptosis (Kuriakose et al., 2016). It is supposed that there are 
converging points between necroptotic and pyroptotic pathways. Further studies are required in 
terms of the crosstalk between the two events mediated by RIPK1. First, whether the 
RIPK1/RIPK3 complex is formed for necroptosis in SIV-infected cells; and second, whether 
RIPK1-mediated NLRP3 inflammasome activation also results in pyroptosis, if not, whether SIV 
interferes with the activation of gasdermin D, a caspase-1 substrate required for pyroptosis 
execution (Shi et al., 2015) warrant further investigation. 
DRP1-mediated mitochondrial fission upon LPS stimulation and LPS-induced IL-1β 
production mediated by DRP1 activity were shown in this study. In PAMs, IL-1β production 
upon different ligands may be related to destructive changes in mitochondrial integrity. Although 
the sensing of IAV ligands and LPS upstream of the NLRP3 inflammasome activation is 
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different between each other as illustrated in the proposed model (Figure 5.6), the downstream 
events may partially converge on the DRP1 activation and ROS production stages for IL-1β 
secretion. It is notable that TXNIP plays as a link between ROS and NLRP3 activation. While 
TXNIP binds and negatively regulates the antioxidant, thioredoxin, TXNIP is released from 
thioredoxin upon ROS production, which leads to the binding of TXNIP to NLRP3, thereby 
activating the NLRP3 inflammasome (Zhou et al., 2010). Hence, it is possible that this pathway 
is shared for IL-1β production by both SIV infection and LPS stimulation in PAMs. 
Taken together, as summarized in the proposed model (Figure 5.6), SIV induces DRP1 
phosphorylation at S579 and mitochondrial fission, which leads to porcine NLRP3 
inflammasome-mediated IL-1β production in PAMs. The kinase activity of RIPK1, which 
interacts with DRP1, is found to be critical for this process. While little is defined as to how 
mitochondrial dynamics fit in the innate immune response upon SIV infection, this study 
provides valuable information on the mechanism of SIV-induced inflammation. 
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CHAPTER 6 GENERAL DISCUSSION 
6.1 General discussion 
NLRP3 inflammasome activation involves the NLRP3-ASC interaction leading to the ASC 
speck formation and pro-caspase-1 recruitment, which are required for the caspase-1 activation 
and the maturation of IL-1β. NLRP3 inflammasome-mediated IL-1β production confers host 
protection in IAV-infected animals, which was demonstrated by using knockout mice (Allen et 
al., 2009, Ichinohe et al., 2009, Thomas et al., 2009), though its contribution to pathogenesis is 
also reported (McAuley et al., 2013, Ren et al., 2017). However, the knowledge on IAV-induced 
IL-1β production mediated by NLRP3 inflammasome in porcine innate immunity has been 
limited. The overarching aims of my PhD study were to characterize the porcine NLRP3 
inflammasome-mediated IL-1β production in IAV-infected alveolar macrophages and to explore 
the mechanisms of the inflammasome regulated by IAV NS1 protein.  
 
6.1.1 Alveolar macrophages (AMs) as the model for the IL-1β signaling research 
AMs are one of the first responders in the immune system upon respiratory viral infection 
(Joshi et al., 2018, Tumpey et al., 2005) and the indispensability of these cells in immunity to 
IAV infection has been well evidenced (Cardani et al., 2017, He et al., 2017, Kim et al., 2008, 
Purnama et al., 2014, Schneider et al., 2014). Data obtained from primary cells can hold more 
biological relevance to in vivo conditions. However, lack of information about the regulation of 
IL-1β production from primary porcine alveolar macrophages (PAMs) infected with IAVs has 
hindered our understanding on inflammation in infected pigs and thus, has necessitated the 
current study using primary PAMs. Moreover, IL-1β was not detected from PAM cell lines such 
as 3D4 cells infected with SIVs (data not shown). According to previous reports, primary PAMs 
secrete IL-1β in response to SIV (Zhang et al., 2015) and other swine viruses such as PRRSV 
and porcine circovirus that also target the PAMs (Han et al., 2017, Li et al., 2013, Qiao et al., 
2011). However, the inflammasome research utilizing the cells has been limited to PRRSV (Bi et 
al., 2014, Li et al., 2015, Wang et al., 2015a, Zhang et al., 2013). Regarding whether IAV 
replication in AMs is productive or abortive, contradicting reports are available and replication 
efficiency is believed to be strain-dependent (Cline et al., 2017, Short et al., 2012); H3N2 
subtype of SIV can replicate in primary PAMs (Zhang et al., 2015). In the current study, IAV 
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replication in primary PAMs was productive considering a time-dependent increase of viral titres 
and a viral dose-dependent NS1 expression. 
 
6.1.2 Signal 1 and 2 activation by SIV and pdm09 
The finding that less IL-1β was elicited by pdm09 than SIVs prompted investigation on the 
capability of pdm09 and SIVs to induce signal 1 and 2 for the NLRP3 inflammasome-mediated 
IL-1β production. The signal 1 activation by SIV infection was comparable to that by pdm09 
infection as displayed by similar levels of pro-IL-1β expression and NLRP3 transcription. 
Meanwhile, NLRP3 inflammasome inhibition by pdm09 NS1 C-terminus aa 100-219 was 
undoubtedly demonstrated by using multiple approaches: PAM infection with WT/NS1-mutant 
viruses; ectopic expression of WT/mutant NS1 proteins in the NLRP3 inflammasome 
reconstitution system; examination of the NLRP3-ASC interaction and ASC speck formation. As 
to the signal 2 induction in SIV-infected PAMs, investigation was performed in Chapter 5, but in 
pdm09-infected PAMs, how the signal 2 is triggered and whether NS1 protein also controls the 
signal 2 upstream of NLRP3 inflammasome are unexplored questions. Besides, if other proteins 
are also responsible for the signal 2 requires further research. At least, PB1-F2, which is known 
to contribute to NLRP3 inflammasome activation (McAuley et al., 2013, Pinar et al., 2017), is 
not expected to play that role, since pdm09 does not express the fully functional PB1-F2 protein 
(Hai et al., 2010). IAV M2 protein-induced ionic perturbation in Golgi network is sensed by 
NLRP3 and it provides the signal 2 for the NLRP3 inflammasome activation (Ichinohe et al., 
2010). Differences in the capability to cause ionic disturbances by M2 proteins from SIV and 
pdm09 may need investigation. In human DCs, NLRP3 inflammasome activation induced by a 
naturally emerged, swine-origin human H3N2 virus that acquired the M segment of pdm09 is 
more robust than H3N2 viruses that did not reassort with the segment (Cao et al., 2015). This 
points out that the M segment may dictate the capacity of signal 2 by certain IAV strains. 
However, the same study also demonstrates that a recombinant virus in the background of SIV 
Tx98 containing HA, NA and M segments from pdm09 does not induce as much IL-1β as 
another isogenic Tx98 virus containing only M segment of pdm09 (Cao et al., 2015). It implies 
that HA and NA are also involved in the signal 2, and it may explain why IL-1β production in 
response to Hf09 viruses with NS1 C-terminus deleted could not be fully restored to the IL-1β 
level upon Sk02 infection as observed in Chapter 3. 
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6.1.3 Interaction of NS1 with its host cellular partners for the inhibition of NLRP3 
inflammasome activity 
Studies on the NS1-mediated inhibition of NLRP3 inflammasome delineate that NS1 
proteins derived from either a high or low pathogenic strain interact with NLRP3 (Cheong et al., 
2015, Moriyama et al., 2016). Disruption of porcine NLRP3-ASC interaction by pdm09 NS1 C-
terminus in the current study is thought to be due to the ability of the NS1 C-terminus that 
interacts with NLRP3 or ASC, or even both. One may argue that NS1 C-terminus only supports 
any N-terminal region(s) that can be critical for binding to NLRP3 and/or ASC to downregulate 
the inflammasome activity. However, this possibility can be negated, since the expression of 
NS1 C-terminal aa 100-129 from pdm09 was sufficient to suppress the NLRP3 inflammasome 
activation. Host cellular proteins regulate the NLRP3 inflammasome; NS1 may interact with 
those proteins to downregulate the NLRP3 inflammasome activation. For example, NIMA 
(which refers to ‘never in mitosis gene A’)-related kinase 7 (NEK7) is reported to be a crucial 
regulator of NLRP3 inflammasome by binding to NLRP3 (He et al., 2016b); MAVS is another 
NLRP3-binding partner that upregulates NLRP3 inflammasome (Park et al., 2013b, 
Subramanian et al., 2013); PKR enhances the inflammasome activity by interacting with multiple 
NLRs including NLRP3 (Lu et al., 2012). Especially, NS1 interaction with PKR is a strategy for 
IAV to antagonize the host antiviral status, and NS1 C-terminal aa 123-127 constitute the PKR-
binding motif (Min et al., 2007), which has variable sequence patterns among IAV strains 
aligned in the current study. PKR-binding abilities of NS1 proteins from SIV and pdm09 need to 
be compared in this sense. 
 
6.1.4 Possible engagement of tripartite motif-containing protein 25 (TRIM25) in the 
IL-1β signaling 
Testing with a mouse-adapted PR8 strain shows that NS1 aa 40-80, R38/K41 or E96/E97 
are required for inhibiting IL-1β production (Moriyama et al., 2016, Stasakova et al., 2005). 
Although the pdm09 NS1-mediated inhibition of NLRP3 inflammasome in the current study 
does not involve the E96/E97 residues, it is worth paying attention to the TRIM25-binding motif, 
E96/E97. RIG-I signaling that involves MAVS and TRIM25 governs the IL-1β production in 
human cells, while NS1 from a 1918 pandemic strain targets both RIG-I and NLRP3 
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inflammasome pathways (Pothlichet et al., 2013), suggesting the interplay between type I IFN 
pathway and IL-1β secretion. Therefore, limitation of the NLRP3 inflammasome activation is 
believed to be another consequence of the NS1-TRIM25 interaction, which is already known to 
limit the IFN induction (Gack et al., 2009). Further work is required to answer whether IFNs 
positively or negatively regulate the porcine IL-1β production upon IAV infection since the 
effects of IFNs on NLRP3 inflammasome are disputed (Fernandez et al., 2016, Guarda et al., 
2011, Pothlichet et al., 2013). 
 
6.1.5 Post-translational modifications in regulating the NLRP3 inflammasome 
activity 
Ubiquitination of porcine ASC on the C-terminal CARD was critical for NLRP3 
inflammasome-mediated IL-1β production upon infection with NS1-mutant pdm09, and the 
modification was suppressed by pdm09 NS1 C-terminus as shown in Chapter 4. Three scenarios 
are suggested behind the suppressed ubiquitination of ASC exerted by pdm09 NS1: first, NS1 
may directly interact with ASC to prevent the ASC from being ubiquitinated; second, NS1 may 
interact with an E3 ligase that ubiquitinates the ASC; third, NS1 may interact with another host 
protein that forms a complex with an E3 ligase responsible for ASC ubiquitination. In either 
case, identification of the responsible E3 ligase will be critical to better understand the 
mechanism of porcine NLRP3 inflammasome activation. Given that NS1 C-terminal aa 126-225 
of avian H5N1 can interact with an E3 ligase, TRAF3 (Qian et al., 2017), the association of 
pdm09 NS1 C-terminus with TRAF3 will be a good starting point to examine. For the third 
scenario, particularly, the MAVS-NS1 C-terminus interaction seems to be plausible, based on the 
discoveries that MAVS can recruit different E3 ligases (Liu et al., 2013a); MAVS is central in 
forming E3 ligase-containing signaling complexes that are targeted by viruses (Shi et al., 2014, 
Zhang et al., 2018); and MAVS promotes the interaction between ASC and TRAF3, an E3 ligase 
for ASC ubiquitination upon viral infection (Guan et al., 2015).  
Other post-translational modifications may regulate the porcine NLRP3 inflammasome. 
With the SUMO consensus motif, porcine ASC is expected to undergo SUMOylation and 
deSUMOylation upon IAV infection. SUMOylation/deSUMOylation is involved in different 
cellular processes including the nuclear-cytoplasmic translocation and the stability of target 
proteins. Notably, ASC localizes from nucleus to cytoplasm to form perinuclear specks (Bryan et 
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al., 2009). DeSUMOylation of nuclear ASC may contribute to this step, inasmuch as many 
SUMO enzymes are located in the nucleus and the nuclear export of target proteins may occur 
upon inhibition of SUMOylation on them (Ptak and Wozniak, 2017). Moreover, phosphorylation 
of NLRP3 or ASC (Hara et al., 2013, Lin et al., 2015, Martin et al., 2014, Song et al., 2017, 
Spalinger et al., 2016), and neddylation of caspase-1 (Segovia et al., 2015) that are known to 
mediate the NLRP3 inflammasome activity remain to be elucidated. 
 
6.1.6 Additional events involved in the mitochondrial dynamics 
RIPK1-mediated DRP1 phosphorylation followed by mitochondrial fission was shown to 
be a trigger for IL-1β production in SIV-infected PAMs in Chapter 5. In this setting, ROS 
generated from fragmented mitochondria is thought to be the signal 2 for NLRP3 
inflammasome-mediated IL-1β production. In general, upon mitochondrial damage induced by 
viral infection, host antiviral proteins that interact with mitochondria may better associate with 
their mitochondrial partners due to the increased surface area of mitochondria, leading to the 
establishment of antiviral status. At the same time, mitophagy occurs to get rid of the fragmented 
mitochondria to maintain homeostasis and inhibit apoptosis (Kim et al., 2018); mitochondrial 
DAMPs including ROS can be eliminated via autophagy (Harris et al., 2017). It is notable that 
incomplete autophagy in virus-infected cells can support virus propagation (Ding et al., 2017, Gu 
et al., 2018). In SIV-infected PAMs, the autophagy/mitophagy signaling seems to be initially 
turned on, but this action may fail to completely remove the NLRP3-activating stimuli such as 
ROS. Still, mitophagy-mediated limitation of apoptosis is expected to occur, eventually 
supporting viral replication as in the case of infection with other RNA viruses (Kim et al., 2014, 
Li et al., 2016c, Mukherjee et al., 2018). Thus, SIV may exploit the mitochondrial dynamics to 
benefit its replication by turning on the mitophagy signal, but in return, the consequent host 
response represented by IL-1β production seems to be unavoidable. The capacity of NLRP3-
activating effects in SIV-infected cells may not be limited to ROS generated from damaged 
mitochondria. One such additional effect may be contributed by PB1-F2 that targets 
mitochondria and induces the dissipated mitochondrial membrane potential, which is reported to 
activate the NLRP3 inflammasome (Shimada et al., 2012). In view of that, whether PB1-F2 of 
SIV Sk02 strain is critical in modulating the mitochondrial dynamics can be further addressed. 
While PB1-F2 of PR8 strain can induce DRP1-meditaed mitochondrial fission (Yoshizumi et al., 
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2014), its roles on NLRP3 inflammasome activation are contradictory. Whether apoptosis is 
inhibited in the early phase of SIV infection in PAMs also requires elucidation. At least, 
apoptosis induction does not help the promotion of NLRP3 inflammasome activity, as 
cytochrome c released from apoptotic mitochondria suppresses the NLRP3 inflammasome (Shi 
and Kehrl, 2016).  
 
6.1.7 Possible sensors upstream of the NLRP3 inflammasome 
What plays a role as an upstream sensor for RIPK1/DRP1 signaling and which viral 
ligands are sensed remain to be examined, particularly focusing on ZBP1. Sensors that are in 
question also lie upstream of NLRP3. There may be two converging pathways for signal 2 
activation: apart from NLRP3 sensing of DAMPs (including ROS and viral M2-mediated ionic 
disturbance), viral RNA sensors seem to function upstream of NLRP3. Growing evidence 
suggests that signals are relayed to NLRP3 by upstream sensors for viral RNA; DEAD/H-box 
helicase (DDX/DHX) family members that sense cytosolic RNA can utilize different adaptor 
proteins (e.g. MAVS, TRIF or STING) for signal transduction. Two different domains of 
DHX33 bind viral dsRNA and NLRP3, respectively, to activate NLRP3 inflammasome (Mitoma 
et al., 2013). A similar model is demonstrated in PRRSV-infected PAMs. DDX19A, which binds 
to both viral RNA and NLRP3, functions as a sensor for the NLRP3 inflammasome activation 
(Li et al., 2015). Thus, a comprehensive view suggests that ROS-mediated and/or viral M2- as 
well as viral RNA-mediated NLRP3 activation may contribute to the NLRP3 inflammasome 
activation upon IAV infection. 
 
6.1.8 The roles of IL-1β in the swine host 
One of the foremost questions is whether IL-1β is beneficial to the swine host. IL-1β is a 
potent and pleiotropic cytokine. It is generally believed that IL-1β, like other inflammatory 
cytokines, plays a fundamental role as a mediator of inflammation, thereby protecting the host, 
but excessive secretion may contribute to pathogenesis. Due to its potency, it seems that a tightly 
regulated action of this cytokine necessitated the requirement of both signal 1 and 2 as well as 
the successful assembly of three components of NLRP3 inflammasome. While elevated levels of 
IL-1β, IL-6 and IFN-α are concurrent with pathological signs in SIV-infected pigs (Masic et al., 
2009b), there is not sufficient evidence to support that IL-1β alone is responsible for more 
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pathogenicity in pigs in response to SIV infection compared to pdm09 infection. Considering the 
surge in IL-1β release from SIV-infected PAMs observed in the current study, infected AMs in 
the lung seem to aggressively respond to protect the host, but this drastic action may affect the 
subsequent stages of inflammation, for example, neutrophil infiltration in a way that causes the 
detriment to the host. In the IAV-affected areas where pathology is shown, dysregulation and 
imbalance of cytokines or mediators like histamine (Jang et al., 2018) may also contribute to 
pathogenesis. Nonetheless, this degree of aggravation seems to be resolved in most cases, seeing 
that SIV infection is mild or subclinical (Van Reeth et al., 2012). Any mechanism to alleviate the 
side effects of IL-1β is thought to be co-functioning. For example, cytotoxicity exerted by T cells 
and natural killer cells upon production of IL-18 (Liu et al., 2004), which is another cytokine 
dependent on NLRP3 inflammasome, is thought to participate in the alleviation mechanism. 
 
6.1.9 Possible reasons for different IL-1β secretion phenotypes of SIV and pdm09 
What would be the reasons that possibly explain the different phenotypes of SIV and 
pdm09? During its long-time circulation in pigs, SIVs might have acquired abilities conferred on 
multiple viral proteins to exploit diverse cellular machineries, one of which is mitochondria, 
thereby productively replicating. Without reassortment, this strategy may cost significantly for 
SIVs to further expand its measures against the host responses. Hence, its NS1 activity to 
antagonize the host antiviral status could be minimal or limited to actions against the IFN 
responses, but its counteraction to the host inflammatory responses represented by IL-1β 
signalling may not be required to be strong. As a result, moderate but not lethally severe 
inflammation led by pro-inflammatory cytokines could be unavoidable. For pdm09, while it can 
replicate optimally as SIVs in pigs (Ma et al., 2011), it may be less equipped with strategies to 
exploit cellular machineries, rather, more with strategies to maintain its viral fitness in both pigs 
and its new hosts, humans. To support that, instead, its NS1 may exhibit multiple inhibitory 
mechanisms that counteract the host inflammatory responses to reduce the host pressure on other 
viral proteins. This may partially explain how pdm09 can evade the IL-1β response in both swine 
and human cells as shown in the present study. It will be important to carefully examine whether 
this is a new strategy gained by recent IAV isolates or an evolutionarily conserved one. 
In conclusion, the current study demonstrated the mechanism by which SIV induces 
NLRP3 inflammasome-mediated IL-1β production in PAMs, and revealed the mechanisms of 
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NS1-mediated counteraction held by pdm09 to escape the host innate responses represented by 
NLRP3 inflammasome activation. The obtained knowledge will expand our understanding on the 
innate immune regulation in IAV-infected hosts. 
 
6.2 Future directions 
First, discovering the interacting partners of pdm09 NS1 will enhance the understanding on 
the NS1-mediated inhibition of NLRP3 inflammasome. The ability of NS1 C-terminus to bind 
NLRP3 and/or ASC can be tested. Whether NS1 C-terminus associates with other host cellular 
proteins such as NEK7, MAVS and PKR that promote the NLRP3 inflammasome activity by 
binding NLRP3 can be accompanied. To determine the critical residues within the C-terminal aa 
100-219 of pdm09 NS1 for suppressing the NLRP3 inflammasome is another important area that 
needs scrutiny. For that, infection of PAMs with other IAV strains to obtain more porcine IL-1β 
secretion profiles has to be preceded before aligning the NS1 aa sequences.  
Second, the E3 ligase, responsible for ubiquitinating ASC remains to be determined. 
Identifying E3 ligases that are in the same IP complex as ubiquitinated ASC is ideally suggested, 
but interaction of NS1 C-terminus with TRAF family proteins can be an easier starting point to 
examine. MAVS is involved in many different signaling events and can recruit multiple TRAFs 
including TRAF3, which not only interacts with NS1 C-terminus of an avian strain, but also 
functions as an E3 ligase for ASC ubiquitination upon VSV infection. In case the NS1-MAVS 
interaction is confirmed, identification of E3 ligases in the same IP complex can be another task.  
Third, considering that SIV Sk02 NS1 did not suppress the IL-1β production, NS1 C-
terminus of Sk02 is not expected to suppress the ASC ubiquitination, but whether SIV infection 
also induces ASC ubiquitination on the same acceptor sites, K110 and K140 requires 
investigation. Other types of post-translational modifications on NLRP3 and ASC, especially 
SUMOylation/deSUMOylation on porcine ASC, and whether NS1 protein also regulates this 
modification will also be intriguing subjects to focus.  
Fourth, there are pending questions in the regulation of RIPK1/DRP1-mediated 
mitochondrial fission. Whether incomplete mitophagy followed by limitation of apoptosis takes 
place in SIV-infected cells, and as a result, viral replication is supported require to be clarified. 
In addition, an upstream sensor that initiates the RIPK1/DRP1 signaling needs to be identified. 
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APPENDIX 
A. SUPPLEMENTARY TABLES 
 
Supplementary Table 1 List of primers used to generate NS constructs in the pHW2000 
vector in Chapter 3. 
Construct Primer name Sequence (5’-3’) 
pHW-Hf09-NS-816 
pHW 3538-3559 Fw CTACGTATTAGTCATCGCTATT 
Hf09 NS11-73 Bw 
TCCCTCACTAGTCTAGGATTCCTCTTTCAAGAT
CCA 
Hf09 NS1 SpeI linker Fw TAGACTAGTGAGGGAGCAATAGTTGGAGA 
pHW 1417-1399 Bw ATAGAGCCCACCGCATCCC 
pHW-Hf09-NS-817 
pHW 3538-3559 Fw CTACGTATTAGTCATCGCTATT 
Hf09 NS11-99 Bw 
TCCCTCACTAGTCTATGACATTTCCTCGAGGGT
CA 
Hf09 NS1 SpeI linker Fw TAGACTAGTGAGGGAGCAATAGTTGGAGA 
pHW 1417-1399 Bw ATAGAGCCCACCGCATCCC 
pHW-Sk02/Hf09-
NS-930 
pHW T7 Fw CGAAATTAATACGACTCACTATAGGG 
Sk021-99/Hf09100-219 NS1 Bw 
CATGAGCATGAACCAGTCTCGGCTTATTTCCTC
TATGCTCATAT 
Sk021-99/Hf09100-219 NS1 Fw 
ATATGAGCATAGAGGAAATAAGCCGAGACTGG
TTCATGCTCATG 
pHW hPolI Bw ACAGGTGTCCGTGTCGCG 
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Supplementary Table 2 List of primers used to generate expression plasmids in Chapter 3. 
Construct Primer name Sequence (5’-3’) 
 pcDNA-NLRP3 
Porcine NLRP3 NheI Fw GCTGGCTAGCATGAGCATGGCAAGCGTCC 
Porcine NLRP3 1784 Bw GATTTTCTGAGAGATCT TACAAC 
Porcine NLRP3 1784 Fw GTTGTAAGATCT CTCAGAAAATC 
Porcine NLRP3 XhoI Bw 
GCCGCTCGAGCTACTGGGAAGGCTCAAAGA
C 
pcDNA-ASC 
Porcine ASC NheI Fw GCTGGCTAGCATGGGGTGCACGCGTGAC 
Porcine ASC XhoI Bw GCCGCTCGAGTCAGCTCTGCTCCAGGTCG 
pCMV-Flag-pro-
caspase-1 
Porcine pro-caspase-1 NotI 
Fw 
GCTTGCGGCCGCGATGGCTGACAAGATCCT
GAAG 
Porcine pro-caspase-1 BamHI 
Bw 
CCCGGGATCCTTAATATCCTGGAAAGAGGT
AG 
pcDNA-pro-IL-1β 
Porcine pro-IL-1β NheI Fw GCTGGCTAGCATGGCCATAGTACCTGAACC 
Porcine pro-IL-1β XhoI Bw 
GCCGCTCGAGTTAGGGAGAGAGGACTTCCA
TG 
pcDNA-NLRP3-Myc 
Porcine NLRP3 NheI Fw GCTGGCTAGCATGAGCATGGCAAGCGTCC 
Porcine NLRP3 NotI Bw 
AGTGGCGGCCGCCTGGGAAGGCTCAAAGA
CAA 
pCMV-Flag-NLRP3 
Porcine NLRP3 EcoRV Fw TGCAGATATCCATGAGCATGGCAAGCGTCC 
Porcine NLRP3 XhoI Bw 
GCCGCTCGAGCTACTGGGAAGGCTCAAAGA
C 
pcDNA-ASC-Myc 
Porcine ASC NheI Fw GCTGGCTAGCATGGGGTGCACGCGTGAC 
Porcine ASC EcoRI Bw GGTGGAATTCTGCTCTGCTCCAGGTCGGC 
pCMV-Flag-Hf09 NS1 
pcDNA-Myc KpnI Fw 
TATCGGTACCACTCACTATAGGGAGACCCA
A 
Hf09 NS1 XbaI Bw GCCCTCTAGATCATTTCTGCTCTGGAGGTA 
pCMV-Flag-Hf09-
NS11-73 
pcDNA-Myc KpnI Fw 
TATCGGTACCACTCACTATAGGGAGACCCA
A 
Hf09 NS11-73 XbaI Bw 
ATCCTCTAGATCAGGATTCCTCTTTCAAGAT
CCA 
pCMV-Flag-Hf09-
NS11-99 
pcDNA-Myc KpnI Fw 
TATCGGTACCACTCACTATAGGGAGACCCA
A 
Hf09 NS11-99 XbaI Bw 
ATCCTCTAGATCATGACATTTCCTCGAGGG
TCA 
pcDNA-Hf09 NS1100-
219-Myc 
Hf09 NS1100-219 NheI Fw 
GCTGGCTAGCATGCGAGACTGGTTCATGCT
CAT 
Hf09 NS1 NotI Bw 
AGTGGCGGCCGCTTTCTGCTCTGGAGGTAG
TG 
pcDNA-Sk02 NS1100-
230-Myc 
Sk02 NS1100-230 NheI Fw 
GCTGGCTAGCATGAGGGAATGGTACATGCT
CATG 
Sk02 NS1 NotI Bw 
AGTGGCGGCCGCAACTTCTGACTCAACTCT
TCTC 
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Supplementary Table 3 List of primers used to generate expression plasmids in Chapter 4. 
Construct Primer name Sequence (5’-3’) 
pCMV-Flag-ASC 
Porcine ASC NotI Fw GCTTGCGGCCGCGATGGGGTGCACGCGTGAC 
Porcine ASC BamHI Bw CCCGGGATCCTCAGCTCTGCTCCAGGTCG 
pcDNA-Hf09-NS1-
Myc 
Hf09 NS1 NheI Fw GCTGGCTAGCACCATGGACTCCAACACCATGTC 
Hf09 NS1 NotI Bw AGTGGCGGCCGCTTTCTGCTCTGGAGGTAGTG 
pcDNA-Hf09-NS11-99-
Myc 
Hf09 NS1 NheI Fw GCTGGCTAGCACCATGGACTCCAACACCATGTC 
Hf09 NS11-99 NotI Bw AGTGGCGGCCGCTGACATTTCCTCGAGGGTCA 
pCMV-Flag-huASC 
Human ASC KpnI Fw TATCGGTACCAATGGGGCGCGCGCGCGAC 
Human ASC XbaI Bw ATCCTCTAGATCAGCTCCGCTCCAGGTCC 
pCMV-Flag-ASC 
(K21R/K22R/K24R/K
26R) 
Porcine ASC 
K21/22/24/26R Fw 
AGGATGAGGCTGCTCTCAGTGCCACTG 
Porcine ASC 
K21/22/24/26R Bw 
AAACCTCCTGAGCTCGTCGGCTGTCA 
pCMV-Flag-ASC 
(K55R) 
Porcine ASC K55R Fw CTCACTGACAGGCTCGTCAACTAC 
Porcine ASC K55R Bw GTCGATGGCATCCAGGGG 
pCMV-Flag-ASC 
(K79R) 
Porcine ASC K79R Fw 
CTGCGTGACATCGGCATGCGGGAGGTGGCGGA
GCAGC 
Porcine ASC K79R Bw 
GCTGCTCCGCCACCTCCCGCATGCCGATGTCAC
GCAG 
pCMV-Flag-ASC 
(K87R) 
Porcine ASC K87R Fw 
GGAGGTGGCGGAGCAGCTCCAACGGACCCTGC
ACAAGGGCCC 
Porcine ASC K87R Bw 
GGGCCCTTGTGCAGGGTCCGTTGGAGCTGCTCC
GCCACCTCC 
pCMV-Flag-ASC 
(K91R) 
Porcine ASC K91R Fw 
GCAGCTGCAGAAGACCCTCCACAGGGGCCCTG
GAGCCAAGC 
Porcine ASC K91R Bw 
GCTTGGCTCCAGGGCCCCTGTGGAGGGTCTTCT
GCAGCTGC 
pCMV-Flag-ASC 
(K96R) 
Porcine ASC K96R Fw 
CAAGGGCCCTGGAGCCAGGCCTGCTGGAATCA
AAGCCCTTC 
Porcine ASC K96R Bw 
GAAGGGCTTTGATTCCAGCAGGCCTGGCTCCA
GGGCCCTTG 
pCMV-Flag-ASC 
(K101R) 
Porcine ASC K101R Fw 
GCCAAGCCAGCTGGAATCAGAGCTCTTCCCCTG
AAAGCAGAC 
Porcine ASC K101R Bw 
GTCTGCTTTCAGGGGAAGAGCTCTGATTCCAGC
TGGCTTGGC 
pCMV-Flag-ASC 
(K106R) 
Porcine ASC K106R Fw 
CTGGAATCAAAGCCCTTCCGCTGAGGGCAGAC
AACAAACCAGCAC 
Porcine ASC K106R Bw 
GTGCTGGTTTGTTGTCTGCCCTCAGCGGAAGGG
CTTTGATTCCAG 
pCMV-Flag-ASC 
(K110R) 
Porcine ASC K110R Fw GCAGACAACAGACCAGCACTG 
Porcine ASC K110R Bw TTTCAGGGGAAGGGCTTT 
pCMV-Flag-ASC Porcine ASC K140R Fw CTGTACGGGAGGGTGCTGACG  
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(K140R) 
Porcine ASC K140R Bw GGCATCCAGCAGCCCGTC 
pCMV-Flag-ASC 
(K159R) 
Porcine ASC K159R Fw AACCCCACCAGAATGAGGAGGCTCTTCAG 
Porcine ASC K159R Bw GGTGTGCTCCGCCCGCAC 
pCMV-Flag-ASC 
(K175R) 
Porcine ASC K175R Fw CTGACCTGCAGGGACCTGCTC 
Porcine ASC K175R Bw GTTCCAGGCCGGAGTGAA 
pCMV-Flag-ASC 
(K183R) 
Porcine ASC K183R Fw 
CTGCTCCTTCAGGCCCTGAGGGACACCCAGCCC
TACCTG 
Porcine ASC K183R Bw 
CAGGTAGGGCTGGGTGTCCCTCAGGGCCTGAA
GGAGCAG 
pCMV-Flag-ASC1-109 
Porcine ASC NotI Fw GCTTGCGGCCGCGATGGGGTGCACGCGTGAC 
Porcine ASC1-109 BamHI 
Bw 
CCCGGGATCCTCAGTTGTCTGCTTTCAGGGGAA
G  
pCMV-Flag-ASC1-158 
Porcine ASC NotI Fw GCTTGCGGCCGCGATGGGGTGCACGCGTGAC 
Porcine ASC1-158 BamHI 
Bw 
CCCGGGATCCTCAGGTGGGGTTGGTGTGCTC 
pcDNA-HA-ubiquitin 
(K48R) 
HA-Ubi K48R Fw TTTGCTGGCAGGCAGCTGGAA 
HA-Ubi K48R Bw GATCAGTCTCTGCTGATCAGGAGG 
pcDNA-HA-ubiquitin 
(K63R) 
HA-Ubi K63R Fw AATATTCAAAGGGAGTCTACTCTTC 
HA-Ubi K63R Bw GTAGTCAGACAAAGTACG 
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Supplementary Table 4 List of primers used to generate expression plasmids in Chapter 5. 
Construct Primer name Sequence (5’-3’) 
pcDNA-DRP1-Myc 
Porcine DRP1 XhoI Fw 
TAGACTCGAGATGGAGGCACTAATTCCTGT
T 
Porcine DRP1 BamHI Bw GTTCGGATCCCCAAAGATGAGTCTCTCGGA 
pcDNA-DRP1 (S579D)-
Myc 
Porcine DRP1 S579D Fw CATGCCCGCCGATCCACAAAAAG 
Porcine DRP1 S579D Bw ATTGGAATTGGTTTTGATTTC 
pcDNA-DRP1 (S579A)-
Myc 
Porcine DRP1 S579A Fw CATGCCCGCCGCTCCACAAAAAG 
Porcine DRP1 S579A Bw ATTGGAATTGGTTTTGATTTC 
pcDNA-huRIPK1 
(K45A)-Myc 
Human RIPK1 NheI Fw 
GCTGGCTAGCATGCAACCAGACATGTCCTT
G 
Human RIPK1 NotI Bw 
AGTGGCGGCCGCGTTCTGGCTGACGTAAAT
CAA 
pcDNA-RIPK1-Myc 
Porcine RIPK1 NheI Fw 
GCTGGCTAGCATGTCTCTGGATGACATTAA
GATG 
Porcine RIPK1 NotI Bw 
AGTGGCGGCCGCGTTCTGGCTGCTGCGGAT
C 
pCMV-Flag-RIPK1 
Porcine RIPK1 HindIII Fw 
CGACAAGCTTATGTCTCTGGATGACATTAA
GATG 
Porcine RIPK1 NotI Bw 
ATTCGCGGCCGCCTAGTTCTGGCTGCTGCG
GAT 
pCMV-Flag-RIPK1 
(K41A/K42A) 
Porcine RIPK1 
K41A/K42A Fw 
TGTGATTCTGGCGGCGGTGTACACGGGCCC 
Porcine RIPK1 
K41A/K42A Bw 
AGCCCGTGGGATTTGTGA 
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